Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3007368	li-igg	mg/l (mg/l)	2988	3465	0.00%
3007368	li-igg	— (—)	634	678	100.00%	Distribution not available
3007368	li-igg	g/l (mg/l)	36	37	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Autoimmune diseases related-to ILD

1030

2443

3.76

314.49

1.1

1.2

48.25

41.01

mg/l

3.45

841

2059

Postprocedural disorders of nervous system

297

232

14.05

313.00

1.2

1.1

31.71

34.78

mg/l

0.46

246

188

Other symptoms and signs involving the nervous and musculoskeletal systems

819

1078

7.87

307.65

1.2

35.78

42.34

mg/l

3.28

685

914

Symptoms and signs involving the nervous and musculoskeletal systems

1088

1440

7.80

307.65

1.2

38.70

44.78

mg/l

1.98

900

1222

Abnormal findings on diagnostic imaging of central nervous system

264

106

29.26

307.65

1.2

42.41

37.54

mg/l

0.51

208

Disturbances of skin sensation

662

858

8.08

307.65

1.2

1.1

39.78

41.60

mg/l

0.19

557

705

Neurological diseases

1214

654

9.51

307.65

1.2

1.1

43.53

38.33

mg/l

1.10

1012

544

MS-disease / Multiple Sclerosis

574

207

33.88

307.65

1.1

1.2

56.19

33.05

mg/l

12.69

467

175

Demyelinating diseases of the central nervous system

686

242

34.68

307.65

1.2

53.45

34.09

mg/l

9.71

562

207

Other demyelinating diseases of the central nervous system

351

46.38

307.65

1.2

50.71

32.88

mg/l

4.85

280

Polyneuropathies and other disorders of the peripheral nervous system

404

423

9.95

307.65

1.2

1.1

47.62

43.90

mg/l

0.59

357

349

Other degenerative diseases of the nervous system

785

163

38.60

307.65

1.2

1.1

52.49

34.54

mg/l

8.39

641

142

Visual disturbances and blindness

705

1399

5.15

307.65

1.2

44.91

41.50

mg/l

0.39

599

1163

Neurological diseases, wide definition

545

154

18.15

307.65

1.2

1.1

40.21

37.63

mg/l

0.25

449

126

Disorders of optic nerve and visual pathways

339

278

13.26

307.65

1.2

45.44

37.04

mg/l

0.88

273

234

Visual disturbances

679

1319

5.27

307.65

1.2

44.61

40.88

mg/l

0.42

579

1095

Other and unspecified polyneuropathies, also in other diseases

346

352

10.24

303.59

1.2

1.1

44.53

44.96

mg/l

0.05

304

290

Symptoms and signs involving the skin and subcutaneous tissue

847

2097

4.09

300.41

1.2

1.1

41.43

42.56

mg/l

0.14

707

1762

Headache

834

1656

4.28

297.73

1.2

1.1

35.30

44.49

mg/l

3.32

691

1389

Autoimmune diseases excluding thyroid diseases

1184

1884

3.53

283.25

1.2

1.1

48.34

39.59

mg/l

3.97

977

1581

Autoimmune diseases excluding thyroid diseases, strict definition

1159

1838

3.56

280.57

1.2

1.1

48.44

39.85

mg/l

3.73

956

1541

Optic neuritis

224

130

19.74

278.65

1.2

41.89

35.23

mg/l

0.91

174

105

Other neurological diseases

772

1467

4.30

273.82

1.2

1.1

40.76

44.71

mg/l

0.65

648

1231

General symptoms and signs

1104

1829

3.05

205.14

1.2

1.1

41.53

45.12

mg/l

0.65

923

1531

Concussion

353

476

6.48

202.66

1.2

1.1

39.56

35.50

mg/l

0.27

289

398

Encephalitis

145

24.85

199.47

1.4

1.1

56.42

39.17

mg/l

1.63

129

Autoimmune diseases

1099

1894

2.99

198.90

1.2

1.1

45.61

39.54

mg/l

2.12

915

1588

ILD medications: immunosuppressive drugs

694

1916

3.52

197.35

1.2

1.1

48.13

43.64

mg/l

1.13

559

1609

Abnormalities of gait and mobility

203

181

11.69

195.23

1.2

1.1

47.92

44.88

mg/l

0.20

155

153

Symptoms and signs involving cognition, perception, emotional state and behaviour

951

2228

3.02

194.34

1.2

1.1

40.06

43.41

mg/l

0.64

809

1850

Other encephalitis

138

25.24

190.83

1.4

1.1

58.20

40.47

mg/l

1.54

122

Used for control exclusion in common control thyroid runs

1039

1765

3.01

189.74

1.2

1.1

45.11

39.87

mg/l

1.64

863

1481

Diplopia

233

272

8.91

184.28

1.2

60.51

40.16

mg/l

1.07

194

224

Intracranial trauma

381

498

5.76

183.76

1.2

1.1

39.36

37.01

mg/l

0.15

315

415

Other symptoms and signs involving cognitive functions and awareness

417

834

4.76

177.13

1.2

1.1

44.62

42.40

mg/l

0.16

348

691

Inflammatory diseases of the central nervous system

204

226

9.54

168.62

1.4

1.1

64.55

41.57

mg/l

4.41

179

184

Subjective visual disturbances

325

618

5.39

161.65

1.2

1.1

38.00

40.32

mg/l

0.19

287

511

ILD medications

1082

2287

2.62

158.90

1.2

1.1

42.28

42.70

mg/l

0.08

909

1904

Spirochaetal infections, other/unspecified

181

190

10.05

155.75

1.1

1.2

60.81

39.52

mg/l

2.77

173

158

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

542

1465

3.47

149.68

1.2

1.1

41.96

45.52

mg/l

0.79

452

1222

Episodal and paroxysmal disorders

1035

2043

2.62

148.55

1.2

1.1

35.93

44.96

mg/l

5.97

872

1708

Malaise and fatigue

439

930

3.98

143.45

1.2

1.1

36.12

45.03

mg/l

3.61

358

775

Use of teriflunomide

38.56

140.58

1.1

1.2

54.45

31.74

mg/l

3.97

Migraine

558

1516

3.17

130.51

1.2

1.1

31.46

42.49

mg/l

6.74

477

1266

Other disorders of optic [2nd] nerve and visual pathways

147

160

9.72

123.25

1.2

48.69

37.57

mg/l

0.48

123

132

Other soft tissue disorders, not elsewhere classified

856

2105

2.53

122.27

1.2

1.1

37.37

44.76

mg/l

1.85

731

1729

Dorsalgia

899

1961

2.50

120.49

1.2

1.1

37.84

45.01

mg/l

2.91

769

1616

Dizziness and giddiness

607

1720

2.89

120.03

1.2

1.1

35.17

42.74

mg/l

4.92

525

1437

Medical observation and evaluation for suspected diseases and conditions

612

1012

3.12

119.38

1.2

1.1

35.84

45.66

mg/l

5.61

546

810

Diseases of the eye and adnexa

807

1547

2.63

116.56

1.2

1.1

38.53

42.49

mg/l

1.41

671

1291

Other dorsopathies, not elsewhere classified

902

1976

2.43

112.64

1.2

36.83

45.17

mg/l

4.14

781

1627

Nerve, nerve root and plexus disorders

876

2321

2.39

111.37

1.2

1.1

40.63

43.88

mg/l

0.90

732

1943

Cerebral cysts

132

148

9.41

108.19

1.2

1.1

44.87

39.71

mg/l

0.17

114

118

Cerebral palsy and other paralytic syndromes

185

304

6.29

107.79

1.3

1.2

50.29

41.01

mg/l

0.39

166

251

Papilloedema, unspecified

16.78

107.47

1.2

1.1

55.87

40.40

mg/l

0.37

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

322

349

4.67

104.73

1.2

1.1

38.96

50.39

mg/l

2.70

261

302

Epilepsy

306

796

3.89

102.07

1.1

47.09

44.67

mg/l

0.13

266

671

Other headache syndromes

404

1267

3.23

101.63

1.2

1.1

37.70

43.06

mg/l

1.25

331

1069

Benign intracranial hypertension

30.30

97.60

1.2

51.23

30.76

mg/l

0.41

Abnormal involuntary movements

162

259

6.41

96.86

1.2

1.1

36.64

41.51

mg/l

0.78

138

219

Pain in joint

484

1099

2.94

93.40

1.2

1.1

34.57

48.36

mg/l

7.36

419

894

Low back pain

607

1852

2.54

93.03

1.1

36.16

44.35

mg/l

3.45

517

1521

Dorsopathies

876

1994

2.26

92.70

1.2

37.72

44.93

mg/l

2.87

751

1643

Second line medication for Crohn's disease

516

1957

2.67

91.81

1.2

1.1

46.38

40.43

mg/l

2.06

425

1656

Guillain-Barre syndrome

22.01

91.76

1.3

1.1

75.55

41.69

mg/l

1.70

L04AA Selective immunosuppressants

263

671

4.00

90.92

1.1

1.2

52.50

38.98

mg/l

4.02

200

564

Pain in limb

659

1976

2.43

90.39

1.2

1.1

36.10

44.41

mg/l

4.03

557

1622

Care involving use of rehabilitation procedures

532

1949

2.62

90.36

1.2

1.1

38.40

42.46

mg/l

1.15

436

1640

Condition for Implicit Sepsis (Organ dysfunction codes)

656

1975

2.43

90.13

1.2

1.1

40.47

42.68

mg/l

0.26

544

1660

Systemic atrophies primarily affecting the central nervous system

12.54

89.94

1.2

1.1

37.39

41.66

mg/l

0.29

L04AX Other immunosuppressants

500

1894

2.67

89.21

1.2

1.1

46.27

40.04

mg/l

2.28

409

1608

Cerebrovascular diseases (FINNGEN)

330

676

3.54

87.22

1.2

44.98

41.87

mg/l

0.37

272

565

Other special examinations and investigations of persons without complaint or reported diagnosis

546

1012

2.75

85.99

1.2

1.1

36.17

45.66

mg/l

4.66

458

810

Anxiety disorders, excluding more controls

693

1986

2.33

84.87

1.2

35.43

46.12

mg/l

5.78

574

1654

ILD medications: prednisolone, methylprednisolone, prednisone

846

2228

2.16

83.10

1.2

1.1

38.77

42.93

mg/l

1.31

726

1857

Convulsions, not elsewhere classified

242

611

3.97

82.95

1.2

1.1

34.54

43.99

mg/l

3.29

199

508

Small fibre neuropathy

15.94

80.96

1.2

1.1

45.64

42.28

mg/l

0.15

Migraine with aura

272

776

3.56

79.83

1.2

1.1

31.78

42.13

mg/l

3.12

233

657

Mood disorders, excluding more controls

745

2064

2.21

79.09

1.2

37.29

46.37

mg/l

4.37

625

1725

General examination and investigation of persons without complaint and reported diagnosis

509

1012

2.70

78.75

1.2

1.1

42.40

45.66

mg/l

0.33

453

810

Paralytic strabismus

106

134

8.20

78.67

1.2

59.95

41.54

mg/l

0.53

110

Disorders of ocular muscles, binocular movement, accommodation and refraction

458

1754

2.62

78.62

1.2

40.94

40.20

mg/l

0.07

361

1484

Pain, not elsewhere classified

247

669

3.74

78.26

1.2

1.1

47.36

44.10

mg/l

0.14

202

559

Anxiety disorders

765

2552

2.14

77.76

1.2

34.89

44.87

mg/l

6.02

633

2134

Neurotic, stress-related and somatoform disorders

758

2542

2.14

76.68

1.2

34.90

44.65

mg/l

5.73

628

2127

Lower back pain or/and sciatica

801

2682

2.09

75.88

1.1

1.2

37.65

43.73

mg/l

2.79

687

2221

Other antidepressants

811

1996

2.13

75.70

1.2

1.1

38.20

47.10

mg/l

4.08

666

1693

Lyme disease

242

663

3.71

75.54

1.1

1.2

55.43

39.34

mg/l

2.85

231

548

Other spirochaetal diseases

244

675

3.67

75.07

1.1

1.2

55.36

39.60

mg/l

2.77

233

558

Cerebrovascular diseases

475

1318

2.60

74.96

1.2

1.1

44.75

45.55

mg/l

0.09

399

1104

Depression

782

2597

2.09

74.14

1.2

36.14

44.78

mg/l

4.60

652

2172

Mood [affective] disorders

812

2642

2.03

71.23

1.1

1.2

36.66

44.95

mg/l

4.37

679

2213

Mood disorders

812

2641

2.03

71.01

1.1

1.2

36.66

44.95

mg/l

4.37

679

2213

Infections, IBD-co-morbidities

9.51

69.72

1.2

1.1

68.29

40.15

mg/l

0.60

Pain (limb, back, neck, head abdominally)

552

1141

2.44

69.00

1.2

1.1

38.40

48.37

mg/l

4.51

475

927

Any reimbursement code in KELA

588

1255

2.37

68.84

1.2

43.05

38.66

mg/l

1.21

493

1058

Implicit Sepsis

513

1687

2.38

68.68

1.2

1.1

41.28

42.93

mg/l

0.15

430

1422

Myalgia

233

664

3.56

68.59

1.2

1.1

33.34

41.72

mg/l

3.27

203

533

Soft tissue disorders

832

2154

2.02

67.35

1.2

1.1

35.84

44.94

mg/l

6.33

723

1771

STROKE

437

1186

2.58

67.16

1.2

1.1

45.72

42.56

mg/l

0.50

366

989

Bell's palsy

140

287

4.99

64.19

1.2

1.1

47.82

40.28

mg/l

0.67

117

237

Opioids

803

2118

2.00

63.87

1.2

1.1

37.78

44.32

mg/l

2.64

659

1773

Fever of other and unknown origin

367

1312

2.61

62.27

1.2

1.1

42.94

44.50

mg/l

0.25

312

1102

Recurrent or chronic depression

368

999

2.69

61.96

1.2

1.1

37.87

45.75

mg/l

2.20

306

851

First line medication for Crohn's disease

858

2447

1.92

61.59

1.2

1.1

40.24

43.12

mg/l

0.58

732

2030

Disorders of thyroid, IBD co-morbidities

103

7.35

61.36

1.2

1.1

38.88

35.05

mg/l

0.24

Other and unspecified visual disturbances

119

221

5.53

61.11

1.2

1.1

37.78

38.85

mg/l

0.08

102

179

Migraine without aura

226

687

3.34

60.24

1.2

1.1

29.23

42.76

mg/l

5.94

189

579

Oral corticosteroids

786

2469

1.94

59.15

1.2

1.1

38.00

44.83

mg/l

3.03

660

2054

Extrapyramidal and movement disorders

252

828

3.07

58.83

1.2

1.1

37.12

41.85

mg/l

0.92

206

703

Focal epilepsy, strict definition

193

542

3.62

58.18

1.2

1.1

37.75

40.92

mg/l

0.54

166

447

Examination and observation for other reasons

411

1002

2.51

57.94

1.2

1.1

35.70

45.57

mg/l

3.61

374

802

Other intervertebral disc disorders

575

1641

2.16

57.91

1.1

39.75

44.68

mg/l

1.24

499

1349

Focal epilepsy

206

606

3.45

57.80

1.2

1.1

37.70

40.90

mg/l

0.58

175

500

Psychiatric diseases

793

2051

1.95

57.69

1.2

37.40

46.17

mg/l

4.25

673

1711

Ischaemic Stroke, excluding all haemorrhages

319

881

2.76

57.32

1.2

1.1

46.41

44.58

mg/l

0.20

267

738

Persons encountering health services for examination and investigation

478

1012

2.38

57.05

1.2

1.1

39.43

45.66

mg/l

1.97

409

810

Stroke, excluding SAH

341

963

2.65

56.55

1.2

1.1

46.85

46.40

mg/l

0.04

285

800

Sarcoidosis

145

340

4.35

56.36

1.2

1.1

41.90

40.09

mg/l

0.20

120

284

Strabismus

266

934

2.88

55.12

1.2

1.1

44.99

40.51

mg/l

0.29

210

778

Focal epilepsy, mode (most common among epilepsy diagnosis)

186

530

3.57

54.90

1.2

1.1

38.16

40.57

mg/l

0.36

158

435

Inflammatory bowel disease treatment related agents

848

2619

1.85

54.75

1.2

1.1

38.01

44.25

mg/l

2.76

716

2179

Systemic connective tissue disorders

267

946

2.85

54.52

1.2

1.1

41.01

41.44

mg/l

0.05

225

794

Anxiety (asthma-related co-morbidities)

529

1975

2.13

54.51

1.2

33.81

43.11

mg/l

4.52

442

1648

Speech disturbances, not elsewhere classified

100

176

5.82

54.40

1.1

38.91

42.61

mg/l

0.27

139

Sciatica+with lumbago

357

1382

2.47

54.31

1.2

1.1

39.96

45.03

mg/l

0.95

307

1142

Certain disorders involving the immune mechanism

188

544

3.51

54.23

1.3

1.1

40.08

41.02

mg/l

0.11

159

452

Neuromuscular dysfunction of bladder

108

206

5.37

53.86

1.2

1.1

66.42

42.85

mg/l

0.60

164

Stroke, including SAH

355

1050

2.52

53.20

1.2

1.1

47.05

45.69

mg/l

0.13

298

878

Depression or dysthymia

486

1226

2.23

51.89

1.2

1.1

40.09

48.97

mg/l

2.26

406

1048

Any mental disorder

780

2096

1.87

50.79

1.1

1.2

37.45

46.12

mg/l

4.14

663

1747

Depression medications

323

598

2.74

50.75

1.1

36.25

40.80

mg/l

1.01

263

496

Tramadol

550

1730

2.06

49.66

1.2

1.1

39.27

44.67

mg/l

1.38

467

1451

All anxiety disorders

535

2134

2.03

49.13

1.2

33.82

42.51

mg/l

4.22

448

1788

Codeine

706

2065

1.89

48.35

1.2

1.1

38.81

44.33

mg/l

1.82

582

1731

Diagnoses used for exclusion with ILD

193

612

3.19

48.02

1.2

52.81

42.29

mg/l

0.45

158

510

Lumbar disc prolapse

425

1544

2.20

47.95

1.1

39.36

45.11

mg/l

1.25

360

1271

Persons encountering health services for specific procedures and health care

771

2659

1.80

47.18

1.2

1.1

42.41

42.77

mg/l

0.04

638

2221

Diseases of the musculoskeletal system and connective tissue

458

1043

2.22

46.71

1.2

1.1

35.70

46.33

mg/l

3.94

386

841

Other disorders of lacrimal gland

258

975

2.67

46.64

1.2

1.1

36.78

41.97

mg/l

1.14

215

791

Other disorders of eye and adnexa

150

417

3.66

46.11

1.2

1.1

45.94

37.33

mg/l

1.24

138

345

Hemiplegia

109

6.71

44.35

1.3

1.2

32.77

37.30

mg/l

0.49

Use of glatiramer acetate

10.55

44.15

1.1

51.57

29.23

mg/l

3.24

Symptoms and signs involving the circulatory and respiratory systems

778

2199

1.78

43.48

1.2

1.1

36.44

45.16

mg/l

3.05

646

1854

Spondylopathies

471

1383

2.08

43.36

1.2

1.1

42.42

45.79

mg/l

0.59

390

1138

Symptoms and signs involving speech and voice

236

887

2.69

43.17

1.1

34.04

41.89

mg/l

2.20

202

740

Dysphagia

168

523

3.25

43.14

1.2

1.1

63.22

43.25

mg/l

0.87

147

436

Other/unspecified dorsalgia

259

1014

2.56

43.06

1.2

1.1

33.64

42.55

mg/l

4.75

221

834

GASTRO-related operations

638

1703

1.89

42.83

1.2

1.1

38.44

41.86

mg/l

0.97

538

1429

Any gastric operation

638

1703

1.89

42.83

1.2

1.1

38.44

41.86

mg/l

0.97

538

1429

Other extrapyramidal and movement disorders in other diseases

165

511

3.27

42.78

1.2

36.12

42.29

mg/l

1.03

139

431

Migraine with aura and triptan purchases

178

578

3.13

42.77

1.1

32.22

39.66

mg/l

1.51

156

479

Certain infectious and parasitic diseases

722

2011

1.81

42.19

1.2

1.1

42.82

40.27

mg/l

0.56

615

1660

Disorders of lacrimal system

287

1220

2.37

40.47

1.2

1.1

37.36

42.47

mg/l

1.21

240

1003

Cardiovascular diseases

582

1682

1.90

40.38

1.2

1.1

35.09

41.66

mg/l

2.73

506

1393

Parasetamol

627

1730

1.86

40.33

1.2

1.1

37.61

44.31

mg/l

2.42

529

1449

Other anxiety disorders

402

1739

2.07

39.45

1.2

35.21

42.03

mg/l

2.11

335

1454

Syncope and collapse

248

875

2.53

39.26

1.1

36.23

44.70

mg/l

2.50

208

736

Viral infections of the central nervous system

221

4.46

38.43

1.4

1.1

52.76

40.97

mg/l

1.20

179

Cervicalgia

150

469

3.23

38.32

1.1

39.35

42.31

mg/l

0.29

122

385

Visual field defects

170

4.98

38.24

1.1

47.91

39.60

mg/l

0.69

144

Ocular pain

231

4.34

38.04

1.2

46.71

37.48

mg/l

0.92

184

Other specific joint derangements/joint disorders

567

2085

1.83

37.28

1.2

1.1

35.26

42.99

mg/l

3.64

488

1726

Other systemic involvement of connective tissue (FG)

180

639

2.82

36.31

1.2

33.92

39.42

mg/l

1.57

152

522

Somatoform disorder

152

497

3.10

36.12

1.2

1.1

28.41

41.58

mg/l

7.51

123

416

Disorders of vestibular function (Vertigo)

275

1199

2.29

35.98

1.2

1.1

38.69

43.18

mg/l

1.13

230

991

Fibromyalgia

234

4.18

35.63

1.2

1.1

28.87

39.22

mg/l

3.21

192

Radiculopathy

111

300

3.74

35.57

1.2

1.1

38.53

43.25

mg/l

0.43

245

Other diseases of spinal cord

8.04

35.09

1.2

1.1

42.99

33.17

mg/l

0.44

Parkinson's disease, excluding more controls

7.55

34.93

1.3

1.1

43.56

41.80

mg/l

0.07

Cervicobrachial syndrome

162

562

2.91

34.62

1.2

1.1

36.60

42.45

mg/l

0.77

149

455

Parkinson's disease, strict definition, excluding more controls

8.01

34.57

1.3

1.1

44.55

43.61

mg/l

0.03

Other general symptoms and signs

102

6.06

34.55

1.2

1.1

27.50

35.95

mg/l

1.56

Pain in throat and chest

583

2013

1.78

34.13

1.2

1.1

37.65

46.02

mg/l

1.98

487

1700

Abnormalities of breathing

634

2180

1.74

33.97

1.2

1.1

34.73

45.15

mg/l

8.46

512

1836

Spondylosis

282

1087

2.24

33.89

1.1

40.97

47.05

mg/l

0.99

229

891

Codeine or tramadol medication

770

2593

1.65

33.85

1.2

38.75

43.97

mg/l

1.99

640

2166

Symptoms and signs involving the urinary system

450

1847

1.89

33.74

1.3

1.1

46.71

43.07

mg/l

0.32

381

1550

Antihypertensive medication - note that there are other indications

559

1700

1.81

33.70

1.2

34.77

43.27

mg/l

3.19

474

1409

Alzheimer disease, excluding more controls

6.83

33.47

1.1

41.54

42.72

mg/l

0.06

Migraine without aura and triptan purchases

174

640

2.76

33.46

1.1

29.82

38.81

mg/l

2.93

147

534

Chorioretinal inflammation

7.97

33.36

1.2

1.1

46.91

35.34

mg/l

0.64

Symptoms and signs involving the digestive system and abdomen

679

1995

1.71

33.34

1.2

1.1

39.88

45.16

mg/l

1.16

575

1664

ILD differential diagnosis

565

1573

1.81

33.25

1.2

1.1

39.21

43.55

mg/l

1.50

473

1305

COPD differential diagnosis

565

1574

1.81

33.19

1.2

1.1

39.21

43.56

mg/l

1.51

473

1306

Hypothyroidism, strict autoimmune

419

1434

1.94

32.94

1.2

1.1

37.75

38.92

mg/l

0.15

352

1195

Other and unspecified nerve root and plexus disorders, also in other diseases

145

488

3.01

32.79

1.1

41.38

40.93

mg/l

0.03

114

409

Oedema, not elsewhere classified

167

606

2.76

32.43

1.2

1.1

39.21

42.65

mg/l

0.40

146

512

Hypothyroidism (congenital or acquired)

239

560

2.47

32.39

1.2

1.1

37.16

40.53

mg/l

0.53

201

462

Cardiovascular diseases (excluding rheumatic etc)

563

1841

1.78

32.38

1.2

1.1

36.59

41.57

mg/l

1.70

480

1532

Hard cardiovascular diseases

428

1443

1.91

31.90

1.2

1.1

43.79

45.28

mg/l

0.19

358

1197

Excluding asthma or asthma-COPD overlap

559

1576

1.78

31.62

1.2

1.1

38.68

43.72

mg/l

1.91

465

1307

Other systemic involvement of connective tissue

185

722

2.59

31.54

1.2

35.02

39.61

mg/l

1.21

157

608

Temporomandibular joint disorders

120

371

3.27

31.33

1.1

32.46

47.46

mg/l

2.54

297

Sixth [abducent] nerve palsy

7.32

31.11

1.2

1.1

43.39

40.44

mg/l

0.13

Triptan medication for migraine, single purchase ok

580

2293

1.72

31.03

1.2

35.80

42.88

mg/l

2.65

490

1911

Migraine, single triptan purchase ok & required. ICD-code if available is included

580

2293

1.72

31.03

1.2

35.80

42.88

mg/l

2.65

490

1911

Third [oculomotor] nerve palsy

10.84

30.92

1.1

51.76

43.71

mg/l

0.21

Cervical disc disorders

207

862

2.42

30.70

1.1

38.01

45.96

mg/l

0.97

176

708

Viral Sepsis

132

438

3.05

30.61

1.3

1.1

39.10

42.79

mg/l

0.42

111

355

Other necrotizing vasculopathies (FG)

5.91

30.59

1.2

1.1

36.80

39.83

mg/l

0.24

Viral encephalitis, not elsewhere classified/unspecified

9.45

30.59

1.6

1.1

65.73

45.71

mg/l

0.76

Other disorders of binocular movement

7.04

30.40

1.2

36.17

40.62

mg/l

0.22

Diseases of the myoneural junction and muscle

272

3.66

30.33

1.2

1.1

51.07

43.29

mg/l

0.47

223

Hypothyroidism, levothyroxine purchases

233

558

2.42

30.29

1.2

1.1

35.82

40.51

mg/l

0.86

195

460

Hypothyroidism and >3 levothyroxin purchases

233

558

2.42

30.29

1.2

1.1

35.82

40.51

mg/l

0.86

195

460

Implicit viral Sepsis

131

436

3.04

30.23

1.3

1.1

39.13

42.85

mg/l

0.42

110

354

Diseases of inner ear

301

1439

2.06

30.10

1.2

1.1

38.30

43.57

mg/l

1.58

253

1199

Other reaction to severe stress, and adjustment disorders

305

1501

2.05

30.05

1.1

1.2

34.69

40.76

mg/l

2.25

248

1253

Polyuria

143

502

2.88

29.99

1.3

1.1

41.20

43.51

mg/l

0.32

119

416

Other pulmonary diagnosis

552

1576

1.76

29.98

1.2

1.1

38.35

43.72

mg/l

2.11

455

1307

Sleep disorders (combined)

628

2475

1.67

29.95

1.2

1.1

39.03

44.54

mg/l

1.96

504

2102

Symptoms and signs concerning food and fluid intake

177

4.35

29.88

1.2

1.1

41.03

41.97

mg/l

0.04

145

Asthma, excluding more controls

512

1532

1.79

29.74

1.2

1.1

38.61

43.59

mg/l

1.09

430

1267

Sequelae of cerebrovascular disease

164

540

2.68

29.39

1.2

1.1

47.17

43.47

mg/l

0.35

144

451

Organic, including symptomatic, mental disorders

213

641

2.41

29.32

1.2

39.66

45.42

mg/l

1.25

173

546

Enlarged lymph nodes

114

356

3.24

29.32

1.2

1.1

41.22

43.64

mg/l

0.24

299

Factors influencing health status and contact with health services

203

395

2.59

29.13

1.2

1.1

43.35

47.50

mg/l

0.46

170

323

Asthma

513

1560

1.77

28.89

1.2

1.1

38.61

43.63

mg/l

1.11

431

1292

Follow-up examination after treatment for conditions other than malignant neoplasms

266

798

2.19

28.85

1.1

41.38

44.84

mg/l

0.17

228

636

Non-invasive ventilation

160

568

2.67

28.77

1.1

1.2

56.14

42.60

mg/l

0.45

124

468

Meningitis

139

4.80

28.60

1.3

1.1

80.46

41.27

mg/l

3.43

109

Asthma (mode)

505

1573

1.77

28.58

1.2

1.1

38.75

43.55

mg/l

1.01

420

1305

ILD medications: azathioprine

126

424

3.01

28.58

1.3

1.1

51.09

38.97

mg/l

1.51

105

362

Nausea and vomiting

173

677

2.53

28.27

1.2

1.1

45.47

41.95

mg/l

0.14

138

555

Dissociative [conversion] disorders

130

4.92

27.99

1.1

1.2

27.00

36.05

mg/l

2.15

100

Coxibs

211

460

2.46

27.78

1.2

1.1

38.39

53.34

mg/l

2.00

172

382

Diseases of the ear and mastoid process

794

2583

1.56

27.36

1.2

38.03

44.18

mg/l

2.69

673

2143

Disorders of refraction and accommodation

211

938

2.26

26.80

1.2

32.62

39.84

mg/l

2.63

161

785

Other joint disorders

647

2127

1.63

26.76

1.2

1.1

36.20

43.28

mg/l

3.52

559

1763

Primary_lymphoid and hematopoietic malignant neoplasms

138

506

2.75

26.69

1.3

1.1

56.41

40.76

mg/l

2.14

112

428

Other diseases of urinary system

651

2275

1.62

26.57

1.2

1.1

44.13

41.37

mg/l

0.32

543

1908

SLE (Finngen)

7.08

26.39

1.3

1.1

50.06

40.97

mg/l

0.42

Primary_lymphoid and hematopoietic malignant neoplasms

138

510

2.73

26.32

1.3

1.1

56.41

41.64

mg/l

1.96

112

423

Selective serotonin reuptake inhibitors

620

2004

1.63

26.10

1.2

1.1

37.44

46.99

mg/l

4.35

519

1701

Disorders of eyelid, lacrimal system and orbit

490

2267

1.70

26.08

1.2

1.1

38.16

43.61

mg/l

1.78

413

1896

Trigeminal neuralgia

115

4.97

25.82

1.2

41.69

34.99

mg/l

0.34

Status epilepticus

6.53

25.72

1.3

1.1

40.25

45.83

mg/l

0.26

Neuralgia and neuritis, unspecified

112

5.02

25.63

1.2

67.62

40.90

mg/l

0.34

Anaemias

183

501

2.45

25.47

1.1

42.52

41.36

mg/l

0.11

146

414

Other meningitis

8.68

25.45

1.3

1.1

60.65

30.69

mg/l

1.95

Other strabismus

179

771

2.34

24.63

1.2

1.1

35.82

39.13

mg/l

0.57

145

653

Pain in thoracic spine

110

374

2.97

24.56

1.1

34.70

41.46

mg/l

0.81

303

Abdominal and pelvic pain

634

1994

1.60

24.54

1.2

1.1

40.75

45.16

mg/l

0.62

544

1664

Special screening examination for infectious and parasitic diseases

200

663

2.27

24.33

1.1

42.50

45.00

mg/l

0.30

183

533

Other necrotizing vasculopathies

134

4.48

24.10

1.2

1.1

38.53

40.93

mg/l

0.17

116

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

214

1006

2.14

23.94

1.2

38.18

42.66

mg/l

0.79

179

836

Transient ischemic attack

224

879

2.12

23.68

1.2

1.1

43.71

43.86

mg/l

0.01

192

729

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

116

4.76

23.66

1.1

1.2

97.75

37.22

mg/l

1.17

Spinal stenosis

210

757

2.18

23.60

1.2

1.1

49.85

47.21

mg/l

0.23

176

625

Arthropathies

657

2134

1.57

23.51

1.2

38.03

43.15

mg/l

1.89

557

1770

Asthma (only as main-diagnosis)

443

1560

1.72

23.33

1.2

1.1

33.67

43.63

mg/l

5.93

370

1292

Persons encountering health services in other circumstances, wide

749

2562

1.52

23.31

1.2

1.1

42.03

43.42

mg/l

0.17

624

2146

Other disorders of urethra and urinary system

418

1822

1.73

23.30

1.2

1.1

41.57

41.19

mg/l

0.02

343

1513

Asthma (only as main-diagnosis), excluding more controls

440

1532

1.72

23.01

1.2

1.1

33.75

43.59

mg/l

5.71

367

1267

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

574

2616

1.58

22.41

1.2

1.1

45.63

42.14

mg/l

0.38

467

2205

Cough

242

1168

2.00

22.40

1.1

29.79

45.38

mg/l

10.41

202

986

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

164

3.97

22.33

1.1

91.03

37.75

mg/l

1.26

135

Azathioprine

126

485

2.63

22.31

1.3

1.1

51.09

41.97

mg/l

0.98

105

409

Other disorders of nervous system

130

4.38

22.28

1.4

1.1

46.41

38.32

mg/l

0.71

108

Alzheimer’s disease, wide definition, excluding more controls

5.93

22.24

1.1

45.69

42.93

mg/l

0.12

Lesion of lateral popliteal nerve

112

4.65

21.78

1.2

35.68

43.48

mg/l

0.53

Acute upper respiratory infections

633

2585

1.54

21.62

1.2

37.59

43.49

mg/l

2.90

520

2169

Implicit bacterial Sepsis

173

710

2.25

21.53

1.2

1.1

56.96

45.13

mg/l

0.45

142

593

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

7.40

21.23

1.2

1.0

51.87

43.99

mg/l

0.27

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

106

4.68

21.19

1.3

1.1

36.30

41.07

mg/l

0.44

Brachial plexus disorders

288

3.10

21.12

1.3

1.1

38.82

38.53

mg/l

0.02

244

Finngen Rheumatological endpoints

648

2425

1.53

21.07

1.2

38.55

42.61

mg/l

1.19

551

2010

Other mental disorders due to brain damage and dysfunction and to physical disease

180

3.71

21.06

1.2

1.1

37.47

43.75

mg/l

0.85

150

Fasciculation

10.13

20.74

1.2

1.1

28.67

43.04

mg/l

0.43

Heterophoria

251

3.24

20.64

1.2

34.20

35.83

mg/l

0.15

203

Irritable bowel syndrome

195

942

2.09

20.42

1.2

1.1

35.38

40.78

mg/l

1.16

163

773

Cramp and spasm

123

4.33

20.27

1.1

1.2

41.02

38.39

mg/l

0.17

Oxycodone

169

749

2.19

20.11

1.2

1.1

51.62

45.74

mg/l

0.44

141

634

Persons encountering health services for other counselling and medical advice, not elsewhere classified

671

2558

1.50

20.03

1.2

1.1

41.55

43.41

mg/l

0.21

575

2142

Cervicocranial syndrome

241

3.23

19.90

1.2

1.1

50.42

40.24

mg/l

0.43

200

Dyspnoea

496

2421

1.57

19.50

1.2

1.1

33.32

44.34

mg/l

8.63

413

2031

Abnormal findings on diagnostic imaging of lung

198

952

2.03

19.41

1.2

1.1

44.12

44.30

mg/l

0.02

173

794

Asthma, unspecified (mode), excluding more controls

299

1314

1.79

19.32

1.2

1.1

35.84

44.16

mg/l

2.50

244

1097

Use of fingolimod

9.78

19.30

1.1

1.2

54.75

31.34

mg/l

1.41

Asthma, unspecified (mode)

300

1335

1.79

19.23

1.2

1.1

35.99

44.21

mg/l

2.47

245

1117

Triptan medication for migraine, min. 3 purchases

421

2047

1.63

19.22

1.2

35.22

40.03

mg/l

0.98

360

1697

Degenerative diseases of the nervous system

109

306

2.69

19.21

1.2

1.1

44.42

45.79

mg/l

0.07

261

Other and unspecified dermatitis

299

1700

1.77

19.11

1.2

1.1

41.90

41.89

mg/l

0.00

247

1437

Dermatitis

347

2056

1.69

19.10

1.2

1.1

40.59

43.11

mg/l

0.34

289

1738

Gastrointestinal diseases

458

1413

1.63

19.07

1.1

1.2

36.60

43.57

mg/l

2.46

383

1170

110

429

2.59

19.05

1.2

1.1

41.64

38.63

mg/l

0.26

356

Acute upper respiratory infections of multiple and unspecified sites

479

2284

1.58

18.91

1.2

43.52

42.16

mg/l

0.11

396

1915

Cystitis

508

1986

1.57

18.90

1.2

1.1

45.04

40.92

mg/l

0.38

421

1657

Bacterial Sepsis

196

864

2.03

18.75

1.2

1.1

59.51

44.09

mg/l

0.70

160

725

Viral hepatitis, IBD co-morbidity

7.36

18.65

1.2

1.0

48.89

41.98

mg/l

0.18

Visual impairment including blindness (binocular or monocular)

131

4.03

18.62

1.3

1.1

44.54

36.87

mg/l

0.61

108

Bacterial infection, other or unspecified

253

1242

1.85

18.39

1.2

1.1

54.16

42.57

mg/l

0.73

212

1042

Retention of urine

154

591

2.21

18.32

1.3

1.1

56.25

44.46

mg/l

0.40

130

487

Intracranial injury

332

1900

1.70

18.23

1.2

40.47

42.22

mg/l

0.10

269

1604

Provisional assignment of new diseases of uncertain etiology

296

1703

1.75

18.19

1.2

44.34

39.99

mg/l

0.26

252

1415

Codes for special purposes

296

1704

1.75

18.15

1.2

44.34

39.98

mg/l

0.26

252

1416

Shoulder lesions

404

1512

1.64

18.13

1.1

39.98

46.21

mg/l

1.41

357

1247

Lesion of ulnar nerve

337

2.76

18.04

1.2

1.1

41.22

42.14

mg/l

0.06

277

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

256

3.04

18.01

1.2

1.1

72.42

39.25

mg/l

3.24

211

Benzodiazepine use

591

2829

1.49

17.95

1.2

36.46

44.19

mg/l

2.97

482

2371

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

303

1723

1.73

17.93

1.2

1.1

41.55

44.43

mg/l

0.43

249

1426

Other symptoms and signs involving the urinary system

226

3.18

17.90

1.3

1.1

36.57

41.69

mg/l

0.55

179

Exclusions for E4_PCOS_BROAD

130

566

2.32

17.72

1.2

1.1

39.14

38.87

mg/l

0.02

471

Malignant neoplasm of brain

4.99

17.64

1.1

1.2

98.08

44.09

mg/l

0.66

Abnormalities of heart beat

204

1048

1.94

17.55

1.2

1.1

32.04

45.64

mg/l

7.62

167

879

Bronchitis

635

2849

1.47

17.48

1.2

38.33

42.80

mg/l

1.69

518

2386

Any dementia, excluding more controls

110

298

2.57

17.42

1.1

37.54

47.92

mg/l

2.01

254

Other facial nerve disorders

5.66

17.03

1.2

1.1

31.40

38.91

mg/l

0.52

Sleep apnoea

494

2193

1.53

16.98

1.2

1.1

40.39

44.68

mg/l

1.19

392

1856

Other sleep disorders

249

3.00

16.98

1.2

1.1

41.33

46.13

mg/l

0.26

202

Vocal cord dysfunction

310

2.72

16.97

1.2

1.1

41.12

42.49

mg/l

0.10

254

Other diseases of upper respiratory tract

648

2315

1.46

16.94

1.1

40.50

44.22

mg/l

0.86

557

1904

Hypertensive diseases (excluding secondary)

364

1282

1.66

16.78

1.2

1.1

42.31

41.94

mg/l

0.04

305

1076

Systemic lupus erythematosus

4.55

16.66

1.3

1.2

50.06

35.03

mg/l

1.16

Delirium, not induced by alcohol and other psychoactive substances

161

3.50

16.55

1.2

1.1

46.55

42.14

mg/l

0.21

133

Other disorders of fluid, electrolyte and acid-base balance

137

606

2.19

16.37

1.2

45.30

40.51

mg/l

0.59

114

512

Gastro-oesophageal reflux disease

367

2029

1.61

16.26

1.1

1.2

36.77

44.88

mg/l

2.32

310

1707

Other functional intestinal disorders

240

1279

1.79

16.16

1.2

1.1

41.50

41.97

mg/l

0.04

189

1055

Dermatitis and eczema

645

2948

1.44

16.14

1.2

1.1

38.93

43.46

mg/l

1.28

531

2469

Personality disorders, excluding more controls

180

925

1.96

15.99

1.2

30.79

42.19

mg/l

4.75

152

772

Nonorganic sleeping disorders, excluding more controls

124

555

2.25

15.89

1.2

30.71

42.69

mg/l

5.79

107

458

Dementia, including avohilmo

143

453

2.19

15.87

1.1

35.86

46.35

mg/l

3.22

115

389

Speech and linguistic disorders, excluding more controls

251

2.85

15.47

1.2

1.1

46.92

42.92

mg/l

0.20

201

Other external causes of accidental injury

535

1798

1.49

15.45

1.2

1.1

41.56

42.59

mg/l

0.18

442

1503

Diseases of the respiratory system

407

1289

1.59

15.36

1.2

1.1

39.71

43.09

mg/l

0.79

342

1070

Atypical facial pain

109

4.01

15.34

1.2

1.1

30.50

36.05

mg/l

0.48

Dementia

131

407

2.23

15.29

1.1

33.50

45.69

mg/l

4.39

105

355

Acute sinusitis

341

1984

1.61

15.29

1.2

33.71

42.03

mg/l

4.72

277

1670

Temporomandibular joint disorders, including avohilmo

299

1815

1.65

15.10

1.1

1.2

34.42

39.15

mg/l

0.89

246

1509

Diseases of oesophagus, stomach and duodenum

614

2610

1.43

14.90

1.1

1.2

37.16

43.94

mg/l

2.46

517

2177

Use of pramipexole

109

476

2.31

14.83

1.2

40.01

41.69

mg/l

0.12

404

Benign neoplasm of meninges

189

3.15

14.78

1.2

1.1

55.04

36.02

mg/l

1.19

158

Endocrine, nutritional and metabolic diseases

569

1987

1.46

14.78

1.1

1.2

41.69

41.84

mg/l

0.02

476

1666

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

4.56

14.74

1.3

1.1

52.90

37.82

mg/l

1.04

Chronic sinusitis

252

1475

1.72

14.65

1.2

37.85

43.38

mg/l

1.00

210

1222

Rheumatism, unspecified

300

2.65

14.53

1.3

1.1

31.77

41.68

mg/l

1.60

249

Viral meningitis

114

3.86

14.47

1.4

1.1

49.06

37.25

mg/l

0.91

Chronic diseases of tonsils and adenoids

503

2161

1.48

14.46

1.2

37.82

43.97

mg/l

1.84

439

1775

Obesity related asthma

190

1030

1.86

14.40

1.2

1.1

35.67

42.16

mg/l

1.84

156

857

Functional dyspepsia

156

793

1.98

14.36

1.2

38.14

42.63

mg/l

0.41

132

662

Benign paroxysmal vertigo

140

685

2.06

14.33

1.2

41.91

41.08

mg/l

0.09

117

576

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

133

3.57

14.33

1.3

1.1

50.74

37.50

mg/l

1.11

113

Cluster headache, strict

4.46

14.30

1.2

1.1

32.30

43.99

mg/l

1.10

Restless leg syndrome

297

2.65

14.30

1.2

1.1

39.05

40.20

mg/l

0.07

251

Diseases of pulp and periapical tissues

203

1127

1.81

14.24

1.2

39.23

46.14

mg/l

1.35

177

943

Any dementia

112

345

2.30

14.10

1.1

37.47

45.36

mg/l

1.37

294

Fourth [trochlear] nerve palsy

5.97

14.06

1.2

1.1

117.47

41.65

mg/l

0.40

SLE, ICD10

4.20

13.99

1.3

1.1

42.26

31.90

mg/l

1.35

SLE, strict definition

4.20

13.99

1.3

1.1

42.26

31.90

mg/l

1.35

Benign neoplasm: Cerebral meninges

175

3.18

13.96

1.2

1.1

53.12

34.85

mg/l

1.03

148

653

2459

1.41

13.92

1.2

37.46

43.53

mg/l

3.11

532

2066

Other symptoms and signs involving the circulatory and respiratory systems

161

3.27

13.82

1.2

1.1

75.35

46.82

mg/l

0.34

127

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

4.65

13.80

1.3

1.1

75.08

35.64

mg/l

2.11

Accidents

524

1798

1.46

13.73

1.2

1.1

42.13

42.59

mg/l

0.07

432

1503

Non-follicular lymphoma, hilmo, excluding all cancers

177

3.14

13.70

1.2

1.1

72.68

37.61

mg/l

2.33

148

Other shoulder lesions

225

2.87

13.67

1.2

52.92

42.49

mg/l

0.39

182

Metatarsalgia

209

2.95

13.65

1.2

1.1

43.80

40.65

mg/l

0.22

168

Asthma, including avohilmo

690

2908

1.38

13.57

1.2

1.1

37.19

43.87

mg/l

2.31

566

2437

Metabolic disorders

505

2157

1.46

13.57

1.2

1.1

40.72

43.42

mg/l

0.61

424

1804

Cluster headache, wide

4.24

13.45

1.2

1.1

32.30

43.05

mg/l

1.03

Intestinal infectious diseases

541

2963

1.42

13.35

1.2

43.19

42.38

mg/l

0.07

450

2474

Disorders of other endocrine glands

251

1482

1.67

13.35

1.1

1.2

36.38

40.31

mg/l

0.81

201

1245

Non-follicular lymphoma

180

3.09

13.33

1.2

1.1

72.68

40.19

mg/l

2.07

149

Asthma-related infections

324

2037

1.57

13.31

1.2

1.1

37.55

41.63

mg/l

0.71

270

1702

Asthma, hospital admission 2, infections

324

2037

1.57

13.31

1.2

1.1

37.55

41.63

mg/l

0.71

270

1702

Abnormal findings on diagnostic imaging of other body structures

268

2.67

13.26

1.2

41.97

40.80

mg/l

0.10

224

Other and unspecified types of non-Hodgkin lymphoma, hilmo

4.46

13.12

1.3

1.1

75.08

39.97

mg/l

1.70

Asthma (diagnoses ohter than nonallergic)

492

2929

1.44

13.09

1.2

1.1

34.80

43.59

mg/l

4.40

413

2447

Disorders of sclera, cornea, iris and ciliary body

303

1918

1.59

13.03

1.2

42.60

41.85

mg/l

0.08

252

1628

Voice disturbances

143

731

1.97

13.01

1.1

31.23

41.04

mg/l

3.97

124

608

267

1628

1.63

12.96

1.2

34.80

40.17

mg/l

1.50

225

1353

Hypo-osmolality and hyponatraemia

300

2.54

12.87

1.2

1.1

49.02

39.81

mg/l

0.89

245

Complications of medical and surgical care

375

2365

1.51

12.86

1.2

40.59

42.51

mg/l

0.13

316

1991

Malignant neoplasm of eye, brain and central nervous system

105

3.78

12.85

1.1

95.17

42.96

mg/l

0.66

Other enthesopathy of foot (+metatarsalgia)

233

2.77

12.83

1.2

1.1

42.81

40.82

mg/l

0.14

188

Genitourinary diseases

394

1295

1.53

12.81

1.2

1.1

38.20

44.49

mg/l

2.04

337

1077

Dislocation, sprain and strain of joints and ligaments at neck level

122

594

2.07

12.76

1.2

1.1

32.57

38.38

mg/l

1.08

107

497

Benign neoplasm of meninges

207

2.88

12.68

1.2

1.1

55.04

38.53

mg/l

0.95

176

Viral infections characterized by skin and mucous membrane lesions

239

1438

1.67

12.62

1.3

1.1

44.31

40.32

mg/l

0.72

206

1211

COPD/asthma/ILD related infections

621

2235

1.39

12.57

1.2

1.1

38.51

42.64

mg/l

1.23

513

1876

COPD/asthma related infections

621

2235

1.39

12.57

1.2

1.1

38.51

42.64

mg/l

1.23

513

1876

Other disorders of bladder

237

2.72

12.43

1.3

1.1

41.12

47.73

mg/l

0.80

194

Enthesopathies of lower limb, excluding foot

117

566

2.08

12.42

1.2

1.1

44.10

42.12

mg/l

0.10

101

459

Disorders of muscles

232

2.74

12.38

1.2

69.38

43.61

mg/l

0.38

187

Injuries to the head

627

2977

1.37

12.28

1.2

1.1

43.84

42.19

mg/l

0.17

512

2497

Constipation

431

2113

1.46

12.22

1.1

1.2

43.12

42.69

mg/l

0.05

339

1786

Alzheimer’s disease (Late onset), excluding more controls

4.66

12.14

1.1

51.17

43.89

mg/l

0.30

Sleep apnoea, including avohilmo

515

2361

1.42

12.13

1.2

40.92

44.63

mg/l

0.89

410

2008

Somnolence, stupor and coma

4.08

12.13

1.3

1.1

50.20

37.13

mg/l

0.53

Panic disorder

117

572

2.06

12.12

1.2

31.42

40.44

mg/l

2.66

475

Falls/tendency to fall

683

2513

1.36

12.12

1.2

40.77

42.06

mg/l

0.26

568

2109

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

214

1267

1.70

12.10

1.2

38.18

38.90

mg/l

0.09

179

1064

Other diseases of intestines

638

2715

1.37

11.94

1.2

1.1

37.96

43.03

mg/l

1.79

535

2265

Exposure to unspecified factor

548

3067

1.39

11.80

1.1

1.2

44.52

42.25

mg/l

0.21

444

2574

Chronic lower respiratory diseases

713

2872

1.35

11.80

1.2

1.1

41.76

42.92

mg/l

0.12

595

2397

Other symptoms and signs involving the digestive system and abdomen

384

2.28

11.66

1.1

38.85

39.06

mg/l

0.01

320

Rotator cuff syndrome

275

1285

1.59

11.64

1.1

1.2

39.49

46.52

mg/l

1.83

247

1058

Benign neoplasm: Cerebral meninges

195

2.85

11.63

1.2

1.1

53.12

38.03

mg/l

0.77

165

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

4.23

11.55

1.2

1.1

93.35

34.31

mg/l

2.13

Diffuse large B-cell lymphoma, helper endpoint

4.23

11.55

1.2

1.1

93.35

34.31

mg/l

2.13

Injuries to the neck

155

849

1.84

11.50

1.2

46.74

40.63

mg/l

0.19

137

707

Fall on same level

684

2850

1.34

11.31

1.2

42.63

42.17

mg/l

0.07

571

2384

Diffuse large B-cell lymphoma

4.11

11.16

1.2

1.1

93.35

38.82

mg/l

1.90

Disorders of the thyroid gland

533

2515

1.39

11.15

1.2

1.1

39.42

42.28

mg/l

0.59

452

2098

External causes of morbidity and mortality

432

1491

1.46

11.13

1.1

38.98

43.77

mg/l

1.15

352

1242

Unspecific neurodegenerative disorder

109

359

2.10

11.13

1.1

37.13

47.21

mg/l

1.96

307

Sleep disorders

147

801

1.85

11.11

1.2

31.63

39.81

mg/l

2.98

123

669

Transport accidents

276

1571

1.56

11.06

1.1

48.38

42.20

mg/l

0.35

240

1315

Hypertension, essential

445

1771

1.44

11.05

1.2

41.77

43.72

mg/l

0.30

370

1493

Hypermetropia

207

2.74

10.99

1.2

28.55

38.12

mg/l

1.35

166

Acetic acid derivatives and related substances

161

453

1.86

10.92

1.2

1.1

39.93

53.36

mg/l

1.60

135

375

Other diseases of blood and blood-forming organs, wide

115

581

1.99

10.91

1.2

67.97

40.76

mg/l

0.67

489

Unknown and unspecified causes of morbidity

148

3.07

10.88

1.5

1.1

30.34

43.27

mg/l

2.10

126

Cluster headache, strict, including avohilmo

154

3.04

10.83

1.3

1.2

30.68

41.84

mg/l

1.85

124

Dystonia

128

3.25

10.83

1.1

1.2

28.84

37.94

mg/l

1.28

105

Undetermined asthma, excluding more controls

297

2.41

10.77

1.2

1.1

42.29

43.31

mg/l

0.05

247

Cardiac arrhythmias

378

1709

1.47

10.71

1.2

1.1

37.35

41.38

mg/l

0.87

304

1440

Polyarteritis nodosa and related conditions

6.73

10.69

1.1

64.52

29.19

mg/l

0.73

Undetermined asthma

298

2.40

10.69

1.2

1.1

42.29

43.61

mg/l

0.06

247

Osteopathies and chondropathies

269

1647

1.55

10.64

1.1

1.2

37.97

42.00

mg/l

0.85

217

1381

Hypermobility syndrome

200

2.74

10.60

1.1

27.70

33.66

mg/l

1.19

161

Hypothyroidism, other/unspecified

499

2374

1.39

10.59

1.2

1.1

38.25

42.02

mg/l

0.88

421

1974

Diseases of the skin and subcutaneous tissue

610

2260

1.36

10.55

1.2

1.1

41.63

42.57

mg/l

0.17

504

1908

Non-selective monoamine reuptake inhibitors

168

939

1.74

10.47

1.2

1.1

33.73

44.45

mg/l

3.53

136

800

Hypothyreosis and Thyroxine purchase for inclusion criteria

511

2447

1.38

10.43

1.2

1.1

38.59

41.92

mg/l

0.74

430

2036

Ptosis of eyelid

207

2.68

10.42

1.3

1.1

35.65

42.22

mg/l

0.84

166

Other diseases of hard tissues of teeth

366

1873

1.46

10.42

1.1

39.97

44.25

mg/l

0.88

289

1562

Covid-19 confirmed case

158

898

1.77

10.40

1.2

55.86

40.76

mg/l

0.50

120

743

Paracetamol of NSAID medication

120

299

2.03

10.38

1.1

41.77

54.29

mg/l

0.81

257

Dentofacial anomalies [including malocclusion]

181

1060

1.70

10.29

1.1

1.2

34.16

40.53

mg/l

1.37

151

890

Mixed connective tissue disease

170

2.86

10.23

1.2

40.60

38.25

mg/l

0.16

139

Internal derangement of knee

206

1260

1.64

10.23

1.1

1.2

37.90

43.10

mg/l

1.08

173

1055

Adrenocortical insufficiency

3.76

10.18

1.3

1.1

63.44

36.64

mg/l

0.65

Injuries to the wrist and hand

560

3008

1.35

10.16

1.2

42.76

42.60

mg/l

0.01

468

2511

Cluster headache, wide,, including avohilmo

160

2.92

10.15

1.3

1.2

30.68

42.52

mg/l

2.04

129

Persons encountering health services in other circumstances

214

1330

1.61

10.05

1.2

1.1

52.66

40.72

mg/l

0.51

157

1111

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

247

2.50

10.00

1.1

1.2

35.54

41.92

mg/l

0.56

208

All influenza

136

749

1.82

9.97

1.2

1.1

35.02

41.31

mg/l

1.71

121

627

Zoster [herpes zoster]

378

2.18

9.96

1.5

1.1

46.59

42.14

mg/l

0.45

315

Asthma, hospital admissions , main diagnosis only

458

2969

1.38

9.96

1.2

1.1

33.56

43.80

mg/l

6.28

385

2473

Other enthesopathies

149

844

1.77

9.94

1.2

1.1

45.99

42.20

mg/l

0.33

129

692

Neoplasms

530

2079

1.37

9.91

1.1

1.2

41.59

39.51

mg/l

0.26

445

1729

Disorders of synovium and tendon

268

1584

1.53

9.82

1.2

1.1

37.89

44.85

mg/l

1.79

226

1310

Use of hypnotics and sedatives

584

2520

1.34

9.78

1.2

1.1

38.94

43.81

mg/l

1.39

488

2107

Diarrhoea and gastroenteritis of presumed infectious origin

399

2577

1.41

9.70

1.2

37.46

41.66

mg/l

1.47

330

2147

Disorders of choroid and retina

351

1764

1.45

9.70

1.2

1.1

45.85

44.90

mg/l

0.13

282

1483

Abnormal weight loss

192

2.68

9.70

1.2

1.1

43.24

41.50

mg/l

0.05

158

Sicca syndrome [Sjögren]

198

2.65

9.67

1.4

1.1

32.70

36.25

mg/l

0.42

168

Dental caries

145

814

1.77

9.66

1.1

1.2

43.37

42.59

mg/l

0.08

121

676

Implicit fungal Sepsis

4.07

9.54

1.3

1.1

42.77

38.98

mg/l

0.14

Other specified/unspecified systemic involvement of connective tissue

139

2.99

9.47

1.2

35.68

38.91

mg/l

0.25

116

Astigmatism

172

2.76

9.44

1.2

31.43

35.35

mg/l

0.32

137

Other respiratory disorders and diseases

394

2.12

9.38

1.1

1.2

75.54

45.05

mg/l

0.54

325

Other diseases of the respiratory system

394

2.12

9.38

1.1

1.2

75.54

45.05

mg/l

0.54

325

Faecal incontinence

167

2.78

9.38

1.1

1.2

37.92

39.22

mg/l

0.06

141

Other and unspecified mononeuropathies, also in other diseases

4.41

9.36

1.3

1.1

27.80

41.58

mg/l

1.19

Deforming dorsopathies

133

748

1.79

9.14

1.2

1.1

38.13

41.75

mg/l

0.54

107

603

Hypopituitarism

216

2.53

9.12

1.2

1.1

30.97

43.10

mg/l

2.13

169

Generalized anxiety disorder

111

593

1.89

9.04

1.2

29.26

41.25

mg/l

5.34

100

495

Use of levodopa decarboxylase inhibitor

205

2.55

9.03

1.3

1.1

54.09

47.36

mg/l

0.19

171

Retinal detachments and breaks

133

751

1.78

9.02

1.2

1.1

46.40

41.17

mg/l

0.66

107

645

Trochanteric bursitis

266

2.35

8.98

1.2

41.12

42.24

mg/l

0.05

220

Irregular menses

311

1738

1.46

8.91

1.2

33.65

38.56

mg/l

1.54

259

1439

Fungal Sepsis

3.75

8.91

1.3

1.1

42.46

42.06

mg/l

0.01

Other specified/unspecified arthritis

141

813

1.74

8.91

1.1

1.2

54.93

41.44

mg/l

0.42

118

666

Explicit Sepsis

171

994

1.65

8.89

1.2

1.1

67.73

42.77

mg/l

1.10

136

840

Abnormal findings on examination of blood, without diagnosis

193

1129

1.60

8.85

1.1

44.33

44.97

mg/l

0.06

161

953

Behavioural syndromes associated with physiological disturbances and physical factors

209

1336

1.57

8.81

1.2

32.39

40.15

mg/l

2.10

171

1108

N06DA Anticholinesterases

306

2.12

8.80

1.1

32.03

47.01

mg/l

4.75

261

Use of anticholinesterases

306

2.12

8.80

1.1

32.03

47.01

mg/l

4.75

261

Chronic laryngitis and laryngotracheitis

332

2.18

8.80

1.1

40.73

41.89

mg/l

0.06

270

Dentinal caries

129

724

1.78

8.80

1.1

42.01

41.32

mg/l

0.07

112

603

Bipolar affective disorders

125

699

1.80

8.80

1.1

1.2

34.23

40.97

mg/l

1.36

106

578

Propionic acid derivatives

170

502

1.71

8.78

1.1

37.54

52.04

mg/l

1.97

141

422

Other arthritis (FG)

157

939

1.68

8.69

1.1

1.2

55.07

40.45

mg/l

0.53

131

770

Disorders of adult personality and behaviour

197

1248

1.59

8.67

1.2

31.03

39.92

mg/l

4.30

165

1046

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

202

1273

1.58

8.65

1.1

1.2

32.11

38.48

mg/l

2.50

157

1066

Unspecified dementia

3.38

8.65

1.0

1.1

34.28

45.99

mg/l

1.33

Carpal tunnel syndrome

266

1620

1.49

8.61

1.2

1.1

41.32

44.34

mg/l

0.48

229

1353

Pain and other conditions associated with female genital organs and menstrual cycle

152

867

1.69

8.57

1.1

1.2

30.04

38.07

mg/l

3.22

126

713

Emotional disorders starting during childhood or adolecense, excluding more controls

155

2.75

8.55

1.1

29.36

40.44

mg/l

1.30

120

Hypertensive diseases

447

1851

1.37

8.54

1.2

42.31

43.73

mg/l

0.20

372

1560

Vitamin deficiency, wide

110

3.13

8.54

1.1

1.2

33.55

34.34

mg/l

0.06

Vitamin deficiency

110

3.13

8.54

1.1

1.2

33.55

34.34

mg/l

0.06

Post-traumatic stress disorder

319

2.18

8.43

1.2

25.52

39.69

mg/l

4.67

264

Hypertension

445

1848

1.37

8.36

1.2

42.37

43.77

mg/l

0.20

371

1557

Hypothyroidism, drug reimbursement

317

2.02

8.35

1.2

1.1

33.51

37.93

mg/l

0.58

263

Respiratory insufficiency

106

3.13

8.33

1.0

1.1

115.92

46.51

mg/l

0.51

Exposure to other specified factors

410

2823

1.37

8.32

1.2

43.90

42.34

mg/l

0.11

339

2372

Vestibular neuronitis

208

2.47

8.30

1.2

1.1

32.64

42.22

mg/l

1.60

168

Other disorders of ear

442

2172

1.36

8.29

1.2

38.39

44.52

mg/l

1.82

381

1819

Acute bronchitis

197

1235

1.57

8.28

1.1

1.2

45.37

41.01

mg/l

0.16

159

1041

Other heart diseases

287

1297

1.47

8.27

1.2

37.23

42.18

mg/l

1.08

234

1085

Other viral diseases

192

1220

1.58

8.26

1.2

1.1

40.07

39.28

mg/l

0.09

160

1014

Iridocyclitis

123

698

1.77

8.26

1.2

38.09

40.85

mg/l

0.47

588

Benign neoplasms

504

2138

1.34

8.25

1.2

1.1

37.33

39.59

mg/l

0.66

433

1766

Memory loss

156

2.71

8.24

1.2

1.1

32.95

47.03

mg/l

2.35

131

Benign neoplasms

582

2486

1.31

8.24

1.2

1.1

37.84

42.52

mg/l

1.71

502

2052

Soft tissue disorders related to use, overuse and pressure

113

626

1.81

8.22

1.2

1.1

42.34

42.97

mg/l

0.04

502

Diseases of pulp and periapical tissues, including avohilmo

614

2455

1.30

8.20

1.2

38.39

44.38

mg/l

2.16

506

2057

Dental pulpitis 1

615

2460

1.30

8.20

1.2

38.42

44.37

mg/l

2.14

507

2061

Dental pulpitis 4

615

2460

1.30

8.19

1.2

38.42

44.37

mg/l

2.14

507

2061

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

285

1969

1.45

8.14

1.1

1.2

41.10

42.37

mg/l

0.06

240

1661

Other diseases of stomach and duodenum

124

2.93

8.13

1.2

1.1

35.04

44.51

mg/l

0.71

106

Speech and linguistic disorders

348

2.09

8.12

1.2

1.1

46.92

35.20

mg/l

0.84

283

Other hearing loss

491

1.91

8.11

1.1

1.2

35.56

43.49

mg/l

1.39

410

Continuous positive airway pressure

392

1.97

8.11

1.2

66.09

44.11

mg/l

0.51

330

Diseases of oral cavity, salivary glands and jaws

497

1908

1.34

8.09

1.2

1.1

39.37

44.26

mg/l

1.41

420

1592

TMD related operations

105

573

1.84

8.05

1.2

1.1

30.39

38.74

mg/l

2.73

482

Inflammatory diseases of female pelvic organs

353

1909

1.40

8.03

1.1

1.2

33.39

39.19

mg/l

1.59

301

1576

Weight loss

224

2.39

8.00

1.2

1.1

42.52

40.84

mg/l

0.06

184

Disorders of lens

274

1178

1.47

7.98

1.2

1.1

46.50

46.51

mg/l

0.00

222

993

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

171

1070

1.60

7.96

1.2

38.98

40.71

mg/l

0.18

138

898

Specific development disorders of speech and language

217

2.38

7.86

1.2

52.02

37.75

mg/l

0.75

170

Covid-19 suspected case

140

837

1.68

7.83

1.2

1.1

48.64

39.02

mg/l

0.31

131

691

Correction of physiology of bite - demanding therapy visit

239

2.33

7.82

1.2

1.1

28.00

36.40

mg/l

1.48

201

Other and unspecified drugs and medicaments

227

2.36

7.78

1.1

1.2

36.25

41.12

mg/l

0.35

187

Convergent concomitant strabismus

197

2.46

7.75

1.2

34.28

37.12

mg/l

0.24

159

Tinnitus

113

639

1.78

7.71

1.2

35.41

42.10

mg/l

0.88

100

539

Septicaemia

159

946

1.62

7.71

1.2

67.52

41.44

mg/l

1.10

129

801

Herpesviral [herpes simplex] infections

331

2.10

7.69

1.3

1.1

52.15

39.76

mg/l

1.14

278

Injuries to the ankle and foot

406

2749

1.35

7.64

1.2

41.52

41.15

mg/l

0.05

329

2309

Nonorganic sleeping disorders

124

723

1.73

7.62

1.2

30.71

38.65

mg/l

3.33

107

610

Chronic periapical parodontitis

104

576

1.81

7.61

1.2

1.1

39.86

43.40

mg/l

0.49

477

Spondyloarthritis

470

1.90

7.56

1.1

33.56

38.06

mg/l

0.59

392

Osteoporosis

434

1.92

7.54

1.1

1.2

47.03

40.18

mg/l

0.54

373

Myocarditis

113

2.95

7.54

1.5

1.2

37.04

38.38

mg/l

0.09

471

2229

1.33

7.52

1.2

1.1

49.71

42.68

mg/l

0.70

394

1873

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

471

2229

1.33

7.52

1.2

1.1

49.71

42.68

mg/l

0.70

394

1873

Infections with a predominantly sexual mode of transmission

216

1443

1.50

7.52

1.2

35.01

38.58

mg/l

0.74

182

1201

Anterior Iridocyclitis

111

631

1.77

7.46

1.2

1.1

39.34

40.77

mg/l

0.19

526

Other bacterial diseases

450

2343

1.33

7.45

1.2

1.1

54.23

41.23

mg/l

1.62

373

1967

Injuries to the knee and lower leg

648

2921

1.27

7.43

1.2

43.20

42.41

mg/l

0.13

547

2438

Disorders of psychological development

497

1.84

7.40

1.2

1.1

41.12

37.72

mg/l

0.23

403

Other/unspecified soft tissue disorders related to use, overuse and pressure

3.65

7.32

1.1

33.08

41.72

mg/l

0.61

Anti-inflammatory and antirheumatic products, non-steroids

163

502

1.64

7.29

1.1

39.19

52.04

mg/l

1.54

134

422

Asthma-related pneumonia or sepsis

153

952

1.61

7.28

1.2

1.1

41.36

41.70

mg/l

0.02

125

795

Asthma, hospital admissions 3, pneumonia

153

952

1.61

7.28

1.2

1.1

41.36

41.70

mg/l

0.02

125

795

Non-allergic asthma (mode)

458

1.89

7.26

1.2

1.1

39.23

44.95

mg/l

0.28

380

Non-allergic asthma (mode), excluding more controls

458

1.89

7.26

1.2

1.1

39.23

45.19

mg/l

0.29

381

Tonsillectomy and adenotomy

402

2085

1.35

7.24

1.1

1.2

39.58

39.59

mg/l

0.00

343

1742

Hyperkinetic disorders, excluding more controls

376

1.98

7.23

1.2

39.59

40.97

mg/l

0.09

304

Complications of surgical and medical care, not elsewhere classified

495

2726

1.30

7.19

1.2

1.1

38.80

43.23

mg/l

0.48

413

2279

Undefined dementia

2.98

7.15

1.0

1.1

34.28

45.59

mg/l

1.25

Benign neoplasm: Pituitary gland, craniopharyngeal duct

128

2.77

7.13

1.2

36.52

36.32

mg/l

0.02

Intermittent heterotropia

205

2.37

7.13

1.1

38.65

34.77

mg/l

0.22

162

Asthma-related pneumonia

152

950

1.60

7.12

1.3

1.1

41.36

41.61

mg/l

0.02

125

793

Other medical care

157

967

1.59

7.09

1.2

1.1

45.27

41.76

mg/l

0.40

129

809

Other disorders of adrenal gland

123

2.80

7.08

1.3

1.1

63.27

34.80

mg/l

0.77

Personality disorders

180

1174

1.54

7.07

1.2

30.79

39.82

mg/l

3.61

152

988

Dementia in other diseases classified elsewhere

3.64

7.03

1.2

1.0

29.19

42.92

mg/l

1.08

Hydrocephalus

135

2.69

6.99

1.1

71.01

34.65

mg/l

1.45

106

Urticaria and erythema

208

1402

1.49

6.98

1.2

39.89

39.46

mg/l

0.04

161

1175

Specific personality disorders

157

997

1.58

6.95

1.2

30.25

39.77

mg/l

3.95

130

832

Insomnia

102

579

1.77

6.94

1.2

1.1

31.36

38.88

mg/l

2.68

484

Injury, poisoning and certain other consequences of external causes

337

1220

1.39

6.91

1.1

39.02

44.83

mg/l

1.24

278

1018

Benign neoplasm of other and unspecified endocrine glands

305

2.08

6.90

1.1

1.2

39.32

37.21

mg/l

0.22

251

Other acute lower respiratory infections

257

1729

1.42

6.77

1.2

45.08

41.37

mg/l

0.17

210

1455

Congenital malformations of the nervous system

3.35

6.73

1.0

1.2

64.51

33.63

mg/l

0.83

Polymyalgia rheumatica

198

2.34

6.71

1.1

38.24

42.97

mg/l

0.44

170

Other and unspecified mood [affective] disorders

256

2.17

6.69

1.2

35.59

40.37

mg/l

0.45

205

Heartburn

256

2.16

6.68

1.1

31.21

41.59

mg/l

2.01

214

Diseases of male genital organs

253

885

1.45

6.64

1.2

44.05

52.95

mg/l

1.47

212

748

Other skin changes

365

1.95

6.60

1.2

1.1

34.03

44.24

mg/l

1.63

306

Thyroiditis, ILD-related definition

297

2.07

6.60

1.3

1.1

34.79

34.00

mg/l

0.05

251

Acute and subacute iridocyclitis

102

588

1.74

6.59

1.2

1.1

39.06

40.78

mg/l

0.23

492

Disorders of lipoprotein metabolism and other lipidaemias

341

1576

1.36

6.58

1.1

43.61

44.94

mg/l

0.19

289

1319

Alzheimer disease, including avohilmo

288

1.93

6.57

1.1

39.44

45.87

mg/l

0.71

247

Other arrhythmias

329

1852

1.36

6.57

1.1

1.2

36.53

41.96

mg/l

1.22

264

1572

Diabetic neuropathy

193

2.33

6.54

1.2

1.1

42.61

46.90

mg/l

0.32

160

Hypothyroidism, strict autoimmune, 3 medication purchases required

440

2298

1.31

6.53

1.2

38.82

40.92

mg/l

0.38

369

1914

Scleritis and episcleritis

170

2.44

6.53

1.1

1.2

47.28

39.30

mg/l

0.18

142

Other disorders of bone

115

688

1.68

6.50

1.1

32.03

39.38

mg/l

2.18

580

Benign neoplasm: Pituitary gland, craniopharyngeal duct

135

2.62

6.47

1.2

1.1

36.52

40.13

mg/l

0.31

105

Urticaria

176

1166

1.52

6.47

1.2

40.91

39.48

mg/l

0.15

135

973

Other septicaemia

137

841

1.60

6.46

1.2

49.32

42.19

mg/l

0.84

111

716

Disturbances of smell and taste

3.23

6.43

1.3

1.1

48.42

36.32

mg/l

0.27

Injuries to the thorax

192

1296

1.49

6.43

1.1

1.2

55.37

41.81

mg/l

0.59

157

1097

Other specified/unspecified dorsopathies

3.32

6.43

1.1

48.83

40.35

mg/l

0.30

Poisoning by drugs, medicaments and biological substances

150

965

1.56

6.32

1.2

38.28

39.12

mg/l

0.08

122

810

Use of amantadine

4.30

6.32

1.0

1.1

47.00

41.24

mg/l

—

Deviated nasal septum

149

956

1.56

6.32

1.2

1.1

45.80

46.65

mg/l

0.06

132

796

Myopia

471

1.82

6.31

1.2

1.1

36.43

38.25

mg/l

0.23

395

Other and unspecified effects of external causes

164

1078

1.53

6.27

1.2

33.18

40.40

mg/l

2.13

132

901

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

257

1841

1.40

6.24

1.1

41.29

42.63

mg/l

0.06

217

1550

Dental pulpitis 4, only avohilmo

607

2529

1.25

6.22

1.2

37.47

44.63

mg/l

2.99

500

2121

Disorders of mineral metabolism

187

2.32

6.17

1.2

1.1

38.67

37.38

mg/l

0.09

149

Other complications of surgical and medical care, not elsewhere classified

258

2.11

6.17

1.3

1.2

36.56

40.83

mg/l

0.42

214

Pain associated with micturition

305

2.01

6.17

1.1

74.65

39.65

mg/l

0.44

241

3.34

6.16

1.2

1.1

37.05

40.15

mg/l

0.16

Early lumbar disc prolapse, operated

333

1.97

6.14

1.1

38.48

41.65

mg/l

0.32

262

Paroxysmal tachycardia

115

587

1.66

6.14

1.1

1.2

35.68

40.38

mg/l

0.59

482

Retinal vascular occlusion

194

2.28

6.11

1.2

1.1

54.75

41.68

mg/l

0.76

163

Other diseases of pleura

152

873

1.55

6.08

1.1

69.84

44.19

mg/l

0.79

124

733

Alzheimer disease

247

1.99

6.08

1.1

40.24

46.25

mg/l

0.57

207

Substance abuse, excluding more controls

248

1549

1.40

6.08

1.2

37.62

47.04

mg/l

3.10

208

1297

Persistent mood disorders

573

1.72

6.06

1.2

1.1

39.43

41.59

mg/l

0.21

481

Benign neoplasm of colon, rectum, anus and anal canal

216

1360

1.44

6.04

1.2

50.33

45.36

mg/l

0.48

194

1131

Deposits [accretions] on teeth

188

2.28

6.04

1.2

32.06

41.22

mg/l

1.10

152

Acute myeloid leukaemia

6.40

5.99

1.4

1.0

28.30

37.91

mg/l

—

Retinal vascular disorders

196

2.26

5.97

1.2

1.1

54.75

41.49

mg/l

0.77

165

Complications of procedures, not elsewhere classified

390

2586

1.31

5.95

1.2

1.1

38.63

43.42

mg/l

0.40

325

2172

Other problems related to primary support group, including family circumstances

475

1.78

5.94

1.2

1.1

32.36

36.93

mg/l

0.71

399

Benign neoplasm of other and unspecified endocrine glands

324

1.96

5.90

1.1

39.32

39.42

mg/l

0.01

267

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

153

913

1.53

5.89

1.2

46.52

38.16

mg/l

0.32

115

758

Ménière disease

204

2.22

5.87

1.1

35.33

41.48

mg/l

0.57

170

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

255

1158

1.40

5.86

1.2

38.56

41.52

mg/l

0.51

218

962

Pure hypercholesterolaemia

282

1381

1.37

5.82

1.1

46.87

44.76

mg/l

0.28

247

1157

Benign neoplasm: Colon

174

1152

1.48

5.82

1.1

1.2

51.38

43.97

mg/l

0.72

159

957

Other specified/unspecified soft tissue disorders

3.02

5.80

1.1

30.94

44.32

mg/l

1.17

Influenza and pneumonia

564

2974

1.25

5.80

1.2

1.1

46.97

41.73

mg/l

0.61

478

2477

Allergic asthma (mode)

138

873

1.56

5.79

1.2

1.1

35.18

41.29

mg/l

1.22

120

732

Allergic asthma (mode), excluding more controls

138

873

1.56

5.79

1.2

1.1

35.18

41.43

mg/l

1.26

120

730

Fracture of rib(s), sternum and thoracic spine

116

718

1.62

5.78

1.1

1.2

65.76

43.09

mg/l

0.60

594

Chronic rhinitis, nasopharyngitis and pharyngitis

160

1066

1.51

5.78

1.3

1.1

34.30

40.94

mg/l

2.15

138

886

Fitting and adjustment of other devices

108

610

1.65

5.74

1.2

56.63

42.96

mg/l

0.35

511

Other nutritional deficiencies

346

2574

1.32

5.72

1.1

1.2

42.11

41.77

mg/l

0.04

294

2147

Psychotic depression

126

2.56

5.70

1.3

1.2

28.00

48.46

mg/l

3.36

106

Asthma/COPD (KELA code 203)

510

2860

1.26

5.69

1.2

1.1

40.69

42.94

mg/l

0.19

425

2385

Dental pulpitis 1, only avohilmo

603

2539

1.24

5.69

1.2

38.18

44.60

mg/l

2.29

495

2131

Other disorders of eyelid

144

909

1.53

5.66

1.2

1.1

38.05

44.86

mg/l

1.15

123

756

Malnutrition

4.12

5.65

1.1

44.91

31.19

mg/l

—

Reimbursement for rheumatic diseases

272

1999

1.36

5.64

1.2

1.1

40.36

41.25

mg/l

0.13

226

1682

Other disorders of teeth and supporting structures

580

1.68

5.56

1.1

44.21

43.59

mg/l

0.04

485

Inflammatory disease of uterus

558

1.69

5.55

1.1

1.2

31.96

35.57

mg/l

0.34

464

Senile cataract

222

971

1.42

5.55

1.2

1.1

45.69

47.00

mg/l

0.13

186

827

Poisoning by medicine

137

892

1.54

5.54

1.2

38.56

39.46

mg/l

0.08

110

748

Hypokalaemia

236

2.09

5.52

1.2

1.1

42.97

37.66

mg/l

0.37

187

Persons with potential health hazards related to communicable diseases

248

1793

1.38

5.51

1.2

46.70

39.56

mg/l

0.29

167

1517

Episcleritis

147

2.41

5.48

1.1

46.35

38.74

mg/l

0.13

120

Chronic iridocyclitis

135

2.47

5.46

1.2

1.1

40.41

39.77

mg/l

0.04

108

Phobic anxiety disorders

508

1.72

5.45

1.2

34.99

40.54

mg/l

0.54

424

Benign neoplasm of colon, rectum, anus and anal canal

211

1062

1.42

5.45

1.2

1.1

51.12

40.81

mg/l

1.40

189

879

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

227

1633

1.39

5.43

1.2

44.63

40.36

mg/l

0.54

187

1378

Disorders of conjunctiva

437

2886

1.27

5.41

1.1

1.2

37.45

41.65

mg/l

1.43

370

2411

Menorrhagia

210

813

1.43

5.39

1.1

38.03

40.34

mg/l

0.19

175

671

Injuries to the abdomen, lower back, lumbar spine and pelvis

175

1198

1.45

5.36

1.1

1.2

42.84

40.89

mg/l

0.19

147

1014

Presence of other functional implants

190

933

1.44

5.35

1.2

1.1

44.50

44.84

mg/l

0.03

137

795

Social phobias

329

1.90

5.35

1.2

32.00

41.11

mg/l

1.60

271

Injuries to the shoulder and upper arm

382

2488

1.29

5.35

1.1

1.2

40.82

44.07

mg/l

0.63

326

2085

Behavioural disorders, excluding more controls

3.22

5.33

1.3

1.1

123.03

49.53

mg/l

0.36

Parkinson's disease, strict definition

227

2.08

5.27

1.3

1.1

44.55

47.06

mg/l

0.10

189

Pulmonary embolism

103

635

1.63

5.25

1.2

1.1

48.43

41.21

mg/l

0.55

528

Presbyopia

169

2.27

5.24

1.2

34.10

39.84

mg/l

0.55

145

Oxicams

105

361

1.66

5.23

1.2

1.1

33.15

55.94

mg/l

3.04

297

Other specified/unspecified inflammatory spondylopathies

132

2.45

5.21

1.2

26.33

44.70

mg/l

3.60

106

Other disorders of white blood cells

132

2.45

5.21

1.2

37.32

40.52

mg/l

0.17

108

Pulmonary heart disease

103

637

1.62

5.19

1.2

48.43

41.16

mg/l

0.55

530

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

248

1176

1.37

5.16

1.1

1.2

32.33

35.81

mg/l

0.83

217

961

Spondylopathies (FG)

457

1.74

5.15

1.2

31.14

39.82

mg/l

2.91

375

Benign neoplasm: Colon

174

920

1.45

5.12

1.1

51.38

41.68

mg/l

1.05

159

769

Infections of the skin and subcutaneous tissue

293

2211

1.32

5.07

1.2

44.44

42.57

mg/l

0.27

244

1862

Disorders of skin appendages

257

1912

1.35

5.04

1.2

42.43

40.29

mg/l

0.21

211

1616

Dermatographic urticaria

218

2.08

5.04

1.0

1.2

29.55

35.45

mg/l

0.77

178

Spondylolisthesis/Spondylolysis

372

1.81

5.02

1.1

38.38

42.40

mg/l

0.45

306

Other disorders of the genitourinary system

259

1.98

5.01

1.0

1.2

33.82

37.30

mg/l

0.39

222

Impingement syndrome of shoulder

559

1.65

5.00

1.2

44.99

45.13

mg/l

0.01

459

Excessive attrition of teeth

225

879

1.39

4.96

1.1

40.06

38.98

mg/l

0.13

182

736

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

105

662

1.59

4.94

1.2

35.46

36.37

mg/l

0.07

553

Pulmonary heart disease, diseases of pulmonary circulation

108

687

1.58

4.87

1.2

1.1

47.26

41.52

mg/l

0.43

577

Congenital malformations, deformations and chromosomal abnormalities

342

2549

1.29

4.87

1.1

1.2

37.15

40.97

mg/l

0.80

292

2132

Calculus of kidney and ureter

120

783

1.54

4.85

1.1

37.60

42.76

mg/l

1.06

104

655

Disorders of synovium and tendon in diseases classified elsewhere

3.84

4.83

1.1

1.0

49.34

40.08

mg/l

—

Emotionally unstable personality disorder

550

1.65

4.82

1.2

1.1

30.64

37.77

mg/l

2.17

453

Unspecified/other endometriosis

415

1.75

4.79

1.1

24.30

35.17

mg/l

5.84

348

Appendectomy

351

2645

1.28

4.79

1.2

33.24

42.56

mg/l

5.95

300

2208

Other noninfective gastroenteritis and colitis

117

761

1.54

4.79

1.2

1.1

38.53

40.00

mg/l

0.11

629

Dental pulpitis 3, only avohilmo

102

465

1.61

4.78

1.1

1.2

28.07

38.55

mg/l

3.01

381

Schizophrenia or delusion, excluding more controls

143

964

1.48

4.77

1.1

1.2

36.88

44.04

mg/l

1.99

118

807

Ganglion

100

629

1.60

4.76

1.2

1.1

34.33

41.84

mg/l

1.56

513

Melanocytic naevi of trunk

357

1.80

4.76

1.2

1.1

44.39

36.67

mg/l

0.85

292

Mycoses

121

795

1.53

4.75

1.2

1.1

40.38

40.84

mg/l

0.03

100

664

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

140

949

1.48

4.74

1.2

39.98

40.53

mg/l

0.06

119

803

Dislocation, sprain and strain of joints and ligaments of knee

333

2407

1.29

4.73

1.2

42.27

43.28

mg/l

0.11

280

2014

Aneurysms, operations, SAH

343

1.81

4.72

1.1

46.03

43.83

mg/l

0.12

287

Parkinson's disease

258

1.95

4.71

1.3

1.1

43.56

46.82

mg/l

0.15

217

Oter anti-inflammatory and antirheumatic agents, non-steroids

290

1.69

4.70

1.2

1.1

38.41

59.10

mg/l

1.70

234

Problems related to lifestyle

344

1.81

4.69

1.2

1.1

33.32

40.28

mg/l

1.23

288

Unspecified fall

212

1538

1.37

4.69

1.1

1.2

41.85

41.42

mg/l

0.04

163

1293

Venous thromboembolism

197

1382

1.39

4.67

1.2

1.1

44.59

43.26

mg/l

0.12

173

1147

Cerebral aneurysm, nonruptured

191

2.11

4.66

1.1

42.27

42.05

mg/l

0.01

160

Vertical strabismus

2.71

4.60

1.2

35.83

41.18

mg/l

0.26

Alzheimer’s disease, wide definition

204

1.97

4.58

1.1

44.59

45.67

mg/l

0.06

168

Acute myeloid leukaemia and myelodysplastic syndromes

4.46

4.57

1.4

1.0

28.36

52.09

mg/l

0.81

Other obstetric conditions, not elsewhere classified

248

1202

1.35

4.57

1.1

1.2

32.57

35.87

mg/l

0.77

216

982

Other retinal disorders

226

1343

1.35

4.53

1.1

46.35

43.37

mg/l

0.50

185

1135

Acute pharyngitis

595

1.59

4.50

1.2

1.1

40.18

40.16

mg/l

0.00

498

Other and unspecified tonsillitis

219

1372

1.36

4.49

1.2

39.00

39.67

mg/l

0.09

181

1148

Other heart diseases, wide

510

2586

1.23

4.48

1.2

37.42

43.06

mg/l

1.83

415

2178

Polyarthropathies

325

1683

1.29

4.48

1.1

50.93

43.73

mg/l

0.52

273

1397

Melanocytic naevi of trunk

364

1.77

4.48

1.2

1.1

44.39

39.05

mg/l

0.49

298

Other peripheral vertigo

201

2.05

4.48

1.3

1.1

33.21

42.50

mg/l

0.88

170

Dental pulpitis 3

107

495

1.56

4.46

1.1

1.2

28.25

41.29

mg/l

2.53

405

Other coagulation defects

215

2.02

4.46

1.1

1.2

43.43

37.88

mg/l

0.41

177

Suicide or other Intentional self-harm

141

970

1.46

4.46

1.2

38.41

39.86

mg/l

0.15

115

814

Other diseases of jaws

188

2.09

4.46

1.3

1.1

43.27

40.80

mg/l

0.10

150

Keratitis

167

1186

1.41

4.44

1.2

42.94

40.82

mg/l

0.20

142

1003

Ovarian cyst

223

948

1.36

4.44

1.2

1.1

32.09

40.41

mg/l

2.09

188

781

Methotrexate

365

1.76

4.43

1.2

1.1

37.80

41.67

mg/l

0.33

308

False labour

218

1006

1.37

4.43

1.2

29.21

37.91

mg/l

3.61

181

828

DVT of lower extremities and pulmonary embolism

144

992

1.45

4.43

1.2

45.07

41.84

mg/l

0.28

125

833

Diseases of liver

140

963

1.46

4.42

1.2

43.58

41.81

mg/l

0.11

113

813

Other CVD (FINNGEN)

162

2.05

4.39

1.3

1.2

37.90

40.67

mg/l

0.19

133

All influenza (not pneumonia)

479

1.66

4.39

1.2

1.1

34.64

41.71

mg/l

1.18

393

Parkinson's disease, including avohilmo

272

1.88

4.38

1.3

1.1

43.56

46.40

mg/l

0.13

229

Fibroblastic disorders

464

1.66

4.37

1.1

40.28

45.26

mg/l

0.43

385

Diseases of tongue

144

2.24

4.34

1.2

1.1

32.16

45.29

mg/l

1.47

112

Diseases of the digestive system

176

1264

1.39

4.32

1.2

1.1

40.55

41.51

mg/l

0.08

144

1067

Superficial injury of abdomen, lower back and pelvis

489

1.64

4.32

1.2

1.1

47.13

40.19

mg/l

0.48

404

Supplementary factors related to causes of morbidity and mortality classified elsewhere

149

1044

1.43

4.29

1.2

1.1

34.67

41.18

mg/l

1.92

128

875

Car occupant injured in other and unspecified transport accidents

110

727

1.52

4.26

1.2

1.1

54.23

39.51

mg/l

0.38

100

603

Adverse effects, not elsewhere classified

109

719

1.52

4.26

1.2

1.1

32.91

38.60

mg/l

1.06

604

Glaucoma suspect

122

824

1.48

4.25

1.2

39.65

42.34

mg/l

0.32

100

689

Other disorders of skin and subcutaneous tissue

277

1959

1.30

4.23

1.2

1.1

49.64

42.11

mg/l

0.44

228

1649

Noninfective enteritis and colitis

229

1723

1.33

4.23

1.1

1.2

40.68

40.78

mg/l

0.01

186

1454

Use of rivastigmine

152

2.17

4.21

1.0

1.1

29.27

46.08

mg/l

3.15

122

Coagulation defects, purpura and other haemorrhagic conditions

595

1.57

4.18

1.2

1.1

47.25

40.16

mg/l

0.66

495

Polycystic ovarian syndrome, consortium definition

391

1891

1.25

4.14

1.2

34.50

38.97

mg/l

1.53

330

1563

Conjunctivitis

399

2813

1.24

4.11

1.1

1.2

35.79

41.46

mg/l

2.29

339

2347

Other and unspecified erythematous conditions

2.73

4.10

1.2

1.1

25.33

37.88

mg/l

1.38

Excessive, frequent and irregular menstruation

239

1000

1.33

4.10

1.1

33.69

39.75

mg/l

1.35

198

824

Lung diseases due to external agents

250

1.89

4.10

1.2

1.1

89.02

45.09

mg/l

0.44

199

Arthropathies in other diseases classified elsewhere

2.73

4.09

1.3

1.2

42.47

40.26

mg/l

0.09

Tuberculosis, IBD comorbidity

116

2.34

4.08

1.2

1.1

43.29

41.54

mg/l

0.08

Superficial injury of lower leg

124

848

1.47

4.08

1.1

34.24

39.28

mg/l

1.03

105

702

Drug-induced adrenocortical insufficiency

3.39

4.06

1.3

1.1

116.40

31.96

mg/l

—

Emotional disorders and disorders of social functioning with onset specific to childhood

248

1.89

4.05

1.1

30.15

38.06

mg/l

0.89

201

Myeloid leukaemia

3.37

4.05

1.4

1.0

27.14

45.18

mg/l

1.08

Fenamates

294

1.68

4.05

1.1

36.52

54.30

mg/l

1.44

240

Procreative management

195

1215

1.36

4.04

1.2

1.1

40.74

42.36

mg/l

0.13

173

1008

Diaphragmatic hernia

130

899

1.45

4.03

1.1

38.17

44.21

mg/l

0.62

112

746

Emotional disorders starting during childhood or adolescence

222

1.94

4.03

1.1

29.36

37.73

mg/l

0.90

181

Urolithiasis

122

834

1.47

4.02

1.1

37.39

43.09

mg/l

1.25

105

703

Sequelae of injuries, of poisoning and of other consequences of external causes

116

786

1.48

4.01

1.1

53.56

41.52

mg/l

0.30

658

Disorders of vitreous body and globe

170

1203

1.38

4.00

1.1

43.67

43.97

mg/l

0.03

149

1003

Pneumonia, organism unspecified

431

2544

1.23

3.99

1.2

1.1

49.00

41.37

mg/l

0.74

358

2132

Early onset COPD, excluding more controls

392

1.69

3.98

1.3

1.1

72.48

45.26

mg/l

0.38

341

Other predominantly sexually transmitted diseases, not elsewhere classified

116

788

1.48

3.97

1.1

1.2

40.10

37.42

mg/l

0.26

100

652

Abnormal results of function studies

204

1.97

3.96

1.2

1.1

30.17

45.00

mg/l

2.07

167

Chronic gastritis

564

1.56

3.93

1.1

1.2

35.61

43.16

mg/l

1.32

470

Hyperplasia of prostate

120

460

1.49

3.93

1.2

1.1

50.16

56.18

mg/l

0.47

386

Secondary and unspecified malignant neoplasm of lymph nodes

171

2.06

3.90

1.1

55.61

40.73

mg/l

0.52

139

Sensorineural hearing loss

275

1495

1.29

3.90

1.2

1.1

43.00

45.49

mg/l

0.32

236

1243

Diseases of middle ear and mastoid

334

2183

1.26

3.89

1.2

40.16

39.95

mg/l

0.03

277

1824

Adhesive capsulitis of shoulder

335

1.74

3.89

1.1

1.2

34.55

43.62

mg/l

1.47

274

Disorders of vitreous body

165

1173

1.38

3.88

1.1

44.26

44.00

mg/l

0.03

146

978

Tuberculosis, wide

119

2.28

3.87

1.2

1.1

43.29

41.37

mg/l

0.09

100

Meniscus derangement

240

1254

1.31

3.86

1.1

1.2

39.09

44.64

mg/l

1.29

205

1038

Melanocytic naevi

140

992

1.42

3.83

1.2

39.13

39.01

mg/l

0.01

120

828

Other erythematous conditions

2.56

3.81

1.1

25.50

37.13

mg/l

1.45

Obsessive-compulsive disorder

257

1.84

3.81

1.3

1.1

31.41

42.73

mg/l

2.02

207

Injury of muscle and tendon at shoulder and upper arm level

129

902

1.43

3.80

1.1

1.2

43.37

46.30

mg/l

0.27

110

761

Dental pulpitis 2, only avohilmo

343

1397

1.26

3.80

1.1

1.2

39.53

46.81

mg/l

1.83

273

1190

Dental pulpitis 2

335

1364

1.26

3.74

1.1

1.2

39.17

46.58

mg/l

1.83

267

1158

Behavioural disorders

2.60

3.74

1.3

1.1

123.03

34.31

mg/l

0.45

Malignant melanoma, excluding all cancers (controls excluding all cancers)

332

1.72

3.73

1.1

1.2

88.32

38.23

mg/l

0.71

281

Brain glioblastoma

4.07

3.72

1.0

1.1

48.80

51.64

mg/l

—

Asthma and allergy

465

1.60

3.69

1.2

1.1

34.36

40.85

mg/l

0.99

378

Rash and other nonspecific skin eruption

231

1.87

3.68

1.2

1.1

43.22

40.18

mg/l

0.12

197

Myeloid leukaemia

3.14

3.66

1.4

1.1

27.14

35.87

mg/l

0.92

Preparation and fitting of bite rail to mouth

465

1.60

3.64

1.2

29.63

39.41

mg/l

2.95

390

Asthma and allergy, excluding more controls

467

1.59

3.63

1.2

1.1

34.36

40.64

mg/l

0.95

380

Sudden idiopathic hearing loss

225

1.88

3.63

1.0

1.1

34.28

45.11

mg/l

1.03

184

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

103

698

1.48

3.61

1.2

38.67

38.96

mg/l

0.02

587

Dementia in Alzheimer disease

138

2.05

3.58

1.1

37.70

48.95

mg/l

1.10

113

Dental caries 2

425

2760

1.21

3.57

1.1

1.2

42.64

41.06

mg/l

0.15

361

2306

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

482

2828

1.20

3.57

1.2

1.1

50.46

41.57

mg/l

1.03

407

2369

Other metabolic disorders

390

1.65

3.57

1.3

1.2

40.76

34.96

mg/l

0.38

328

Appendicitis, broad definition

377

2821

1.22

3.56

1.1

1.2

39.35

43.52

mg/l

0.81

317

2361

Conjunctivitis (acute, non atopic)

142

1020

1.39

3.56

1.1

1.2

40.54

39.70

mg/l

0.09

123

845

Conductive and sensorineural hearing loss

300

1652

1.26

3.55

1.1

1.2

41.86

45.10

mg/l

0.49

257

1381

Vasomotor and allergic rhinitis

203

1523

1.32

3.55

1.2

34.41

41.29

mg/l

2.12

174

1261

Volume depletion

157

2.05

3.55

1.1

47.80

38.04

mg/l

0.34

119

Other diseases of liver

492

1.57

3.54

1.2

44.24

41.01

mg/l

0.12

412

Status post-ami

0.00

3.54

0.0

1.1

—

52.11

—

Diseases of appendix

379

2832

1.22

3.52

1.1

1.2

39.36

43.48

mg/l

0.80

319

2370

Other and unspecified anaemias

127

870

1.41

3.50

1.1

1.2

44.57

42.21

mg/l

0.23

740

Malignant neoplasm of breast

106

1104

0.69

3.50

1.2

40.28

40.38

mg/l

0.00

927

All pneumoniae

501

2903

1.19

3.50

1.2

1.1

49.93

41.91

mg/l

0.93

423

2422

Aplastic and other anaemias

141

964

1.39

3.49

1.1

44.48

41.62

mg/l

0.33

102

822

Acute appendicitis, no complications

294

2345

1.25

3.49

1.1

1.2

34.49

42.21

mg/l

3.68

246

1965

Conduct disorder

2.50

3.48

1.3

1.1

123.03

39.05

mg/l

0.42

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

758

0.62

3.47

1.2

1.1

51.46

42.68

mg/l

0.66

643

Atopic dermatitis

319

2194

1.24

3.47

1.2

33.53

40.65

mg/l

3.34

265

1840

Other anaemias

128

878

1.41

3.46

1.1

1.2

44.48

42.17

mg/l

0.23

746

Acute lymphadenitis

208

1.89

3.44

1.3

1.2

36.38

38.55

mg/l

0.18

167

Pneumonias (Asthma/COPD co-morbidities)

497

2895

1.19

3.42

1.2

1.1

50.16

41.96

mg/l

0.95

419

2418

Dental caries, including avohilmo

366

1520

1.23

3.42

1.2

39.74

46.04

mg/l

1.56

295

1293

Dental caries 1

366

1520

1.23

3.41

1.2

39.74

46.04

mg/l

1.56

295

1293

Other and unspecified urticaria

105

723

1.46

3.41

1.2

46.41

38.45

mg/l

0.78

612

Type of accident

133

956

1.40

3.40

1.2

33.57

41.16

mg/l

2.41

113

801

Secondary hypertension

172

1.97

3.39

1.1

1.2

44.12

40.11

mg/l

0.19

137

Inflammatory diseases of prostate (prostatitis)

282

1.74

3.38

1.1

1.2

34.65

51.90

mg/l

4.33

234

Ehlers-Danlos syndrome

3.78

3.37

1.1

22.60

31.56

mg/l

—

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

3.77

3.37

1.0

1.1

48.80

37.18

mg/l

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

100

946

0.69

3.35

1.2

1.1

41.48

38.61

mg/l

0.14

783

Tongue abnormality

134

2.10

3.34

1.2

32.92

39.21

mg/l

0.47

111

Unspecified urinary incontinence

175

1.95

3.33

1.1

47.35

40.06

mg/l

0.23

138

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

100

945

0.69

3.33

1.2

1.1

41.48

38.55

mg/l

0.14

782

Achilles tendinitis

225

1.83

3.32

1.2

1.1

36.13

41.10

mg/l

0.37

184

Agranulocytosis

269

1.76

3.31

1.1

1.2

107.63

39.22

mg/l

0.68

225

Spinal instabilities

2.64

3.31

1.1

30.71

42.30

mg/l

0.74

Use of donepezil

209

1.84

3.31

1.2

1.1

35.18

46.31

mg/l

1.97

173

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

284

1.73

3.31

1.1

1.2

90.31

37.63

mg/l

0.63

237

Contact with and exposure to communicable diseases

202

1549

1.30

3.30

1.2

34.55

38.12

mg/l

0.56

130

1317

Other disorders starting during childhood or adolecense, excluding more controls

156

1.99

3.29

1.3

1.1

29.12

41.55

mg/l

1.29

119

Haemorrhage from respiratory passages

113

736

1.43

3.28

1.1

1.2

38.96

46.76

mg/l

1.38

626

Melanocytic naevi

140

1022

1.37

3.28

1.2

39.13

40.53

mg/l

0.17

120

851

Degenerative macular diseases

190

1.90

3.28

1.1

56.88

39.24

mg/l

1.39

160

Disturbance of activity and attention

480

1.55

3.27

1.2

1.1

38.91

36.75

mg/l

0.16

396

Endometriosis

198

897

1.32

3.25

1.1

37.12

40.41

mg/l

0.28

162

742

Sequelae of injuries of upper limb

286

1.72

3.24

1.1

1.2

35.70

41.98

mg/l

0.61

234

Exclusions for E4_PCOS_CONSORTIUM

394

2043

1.21

3.22

1.1

1.2

35.58

39.64

mg/l

1.01

316

1700

Glaucoma

173

1146

1.33

3.21

1.2

1.1

43.69

43.20

mg/l

0.04

140

958

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

317

1.68

3.20

1.1

55.69

39.51

mg/l

0.89

263

Acute appendicitis

354

2752

1.22

3.19

1.1

1.2

40.00

43.52

mg/l

0.60

300

2298

Other cataract

140

792

1.37

3.16

1.2

1.1

48.36

44.95

mg/l

0.26

116

673

Pneumonitis due to solids and liquids

144

2.02

3.15

1.2

1.1

112.26

45.01

mg/l

0.41

120

Fall on and from stairs and steps

106

744

1.43

3.14

1.2

1.1

41.03

40.29

mg/l

0.07

618

Other female pelvic inflammatory diseases

508

1.52

3.12

1.1

1.2

29.99

35.30

mg/l

0.84

429

Other diseases of arteries and capillaries

201

1.85

3.11

1.2

1.1

37.96

40.67

mg/l

0.15

167

Lung cancer and mesothelioma

233

1.73

3.11

1.0

1.1

59.59

45.40

mg/l

0.98

202

Other and unspecified vascular occlusions

145

2.01

3.09

1.2

1.1

41.40

39.08

mg/l

0.17

124

Obesity and other hyperalimentation

309

2497

1.23

3.08

1.1

1.2

41.94

41.63

mg/l

0.04

266

2084

Hernia of abdominal wall, postoperative

367

1.61

3.08

1.2

1.1

43.72

40.84

mg/l

0.14

313

Divergent concomitant strabismus

231

1.78

3.08

1.2

38.23

39.73

mg/l

0.10

189

Dermatopolymyositis

3.49

3.06

1.2

63.90

32.34

mg/l

—

Benign neoplasm: Colon, unspecified

444

1.55

3.05

1.1

59.19

41.45

mg/l

0.82

380

Persons encountering health services for specific procedures, not carried out

217

1.81

3.05

1.4

1.1

46.21

38.64

mg/l

0.26

169

Dental caries 3

391

1658

1.21

3.03

1.2

39.64

45.12

mg/l

1.37

312

1411

Pruritus

285

1.69

3.01

1.2

1.1

49.29

39.89

mg/l

0.39

239

Other and unspecified disorders of vitreous body

129

939

1.37

3.01

1.1

1.2

42.30

43.64

mg/l

0.14

113

789

Hyperlipidaemia, other/unspecified

116

789

1.39

2.99

1.1

47.38

42.93

mg/l

0.52

658

Malignant neoplasm of breast, HER2-negative

103

1064

0.71

2.99

1.2

40.39

40.88

mg/l

0.02

891

Cardiodefibrillation

745

0.60

2.98

1.2

1.1

44.28

46.31

mg/l

0.16

637

Gingivitis and periodontal diseases

438

1900

1.19

2.97

1.2

1.1

38.69

44.37

mg/l

1.37

368

1587

Obesity

306

2485

1.22

2.95

1.1

1.2

41.95

41.70

mg/l

0.03

263

2073

Other CVD

325

1.63

2.94

1.2

1.1

36.75

43.59

mg/l

0.79

265

Dental caries 2, only avohilmo

413

2744

1.19

2.91

1.1

1.2

42.41

41.04

mg/l

0.12

354

2293

Dental caries 2 and operation codes

412

2757

1.19

2.91

1.1

1.2

42.04

41.24

mg/l

0.07

351

2306

Obesity due to excess calories

229

1824

1.26

2.90

1.1

1.2

43.32

40.04

mg/l

0.49

195

1528

Hypotension

258

1.71

2.89

1.3

1.1

37.47

44.94

mg/l

0.71

207

Dental caries 1, only avohilmo

369

1566

1.21

2.87

1.2

39.40

46.03

mg/l

1.75

300

1332

Decubitus ulcer and pressure area

2.30

2.84

1.2

1.1

173.86

42.49

mg/l

0.51

Osteoporosis with pathological fracture (FG)

2.30

2.84

1.2

1.1

53.21

34.66

mg/l

0.41

Arthrosis

317

1429

1.22

2.83

1.1

41.98

44.57

mg/l

0.36

270

1185

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

2.42

2.81

1.1

1.2

38.01

34.04

mg/l

0.19

Specific development disorders of scholastic skills

178

1.85

2.78

1.1

36.15

38.68

mg/l

0.13

140

Hypothyroidism, autoimmune, DX-based

8.58

2.77

1.6

1.2

19.26

25.30

mg/l

—

Other/unspecified enthesopathies, not elsewhere classified

173

1.86

2.76

1.1

1.2

42.05

44.04

mg/l

0.06

142

Ankylosing spondylitis

232

1.73

2.75

1.1

31.42

43.73

mg/l

2.73

185

Unspecified haematuria

128

813

1.35

2.73

1.2

1.1

58.58

44.04

mg/l

0.47

118

678

Sequelae of external causes of morbidity and mortality

648

1.42

2.72

1.2

1.1

60.38

41.36

mg/l

0.33

541

Other viral diseases, not elsewhere classified

697

1.41

2.71

1.3

1.1

35.69

38.94

mg/l

0.47

576

Glomerular diseases

485

1.49

2.69

1.2

45.76

42.94

mg/l

0.20

394

Open wound of wrist and hand

207

1631

1.26

2.67

1.1

1.2

38.70

43.39

mg/l

1.14

170

1377

Diseases of external ear

136

1025

1.33

2.67

1.1

1.2

38.37

41.40

mg/l

0.56

119

859

Ingrowing nail

161

1.88

2.67

1.3

1.2

47.64

39.97

mg/l

0.30

131

Mouth breathing

170

1322

1.29

2.64

1.2

40.01

44.36

mg/l

0.61

129

1123

Malignant melanoma

304

1.62

2.64

1.2

1.1

50.00

42.15

mg/l

0.46

256

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

291

1959

1.21

2.63

1.1

1.2

36.41

40.06

mg/l

0.73

238

1640

Statin medication

371

1747

1.19

2.62

1.2

46.72

43.03

mg/l

0.51

328

1448

Rheumatoid arthritis

119

800

1.35

2.62

1.1

1.2

42.83

42.47

mg/l

0.03

659

Other diseases of blood and blood-forming organs

148

1.90

2.60

1.1

55.32

43.73

mg/l

0.35

120

Retinal detachment with retinal break

259

1.67

2.60

1.2

1.1

39.64

44.12

mg/l

0.41

217

Hyperkinetic disorders

516

1.46

2.58

1.2

1.1

39.59

36.14

mg/l

0.28

425

Other specified acquired deformities of limbs

7.31

2.56

1.0

21.58

39.26

mg/l

—

Maltreatment syndromes

200

1.76

2.56

1.3

1.2

31.08

41.19

mg/l

1.07

156

Nail disorders

245

1.68

2.56

1.2

42.68

40.16

mg/l

0.12

197

Disorders in reading

2.45

2.55

1.0

1.1

37.70

40.37

mg/l

—

Orchitis and epididymitis

200

1.76

2.55

1.1

1.2

48.66

55.14

mg/l

0.30

166

Chondropathies

524

1.46

2.55

1.1

1.2

30.51

39.95

mg/l

3.37

437

Benign neoplasm: Colon, unspecified

468

1.48

2.51

1.1

1.2

59.19

43.48

mg/l

0.69

396

Stomatitis and related lesions

254

1.66

2.51

1.1

38.56

42.10

mg/l

0.29

205

Fracture at wrist and hand level

160

1244

1.29

2.51

1.2

45.67

42.70

mg/l

0.30

137

1054

Diabetic retinopathy, excluding more controls

351

1.43

2.51

1.1

54.47

50.04

mg/l

0.33

291

Dental caries 1 and operation codes

403

1754

1.18

2.51

1.1

1.2

38.80

46.05

mg/l

2.21

324

1496

Unspecified mental disorder

205

1644

1.25

2.50

1.1

1.2

35.69

41.53

mg/l

1.62

170

1385

Leisure time condition

561

1.43

2.47

1.2

1.1

32.46

41.22

mg/l

2.24

467

Female infertility, cervigal, vaginal, other or unspecified origin

167

872

1.29

2.45

1.2

1.1

34.53

39.87

mg/l

0.98

142

719

Postprocedural endocrine and metabolic disorders, not elsewhere classified

358

1.54

2.45

1.3

1.1

33.05

34.43

mg/l

0.15

301

Use of memantine

222

1.65

2.42

1.1

37.15

47.39

mg/l

1.39

186

Use of other anti-dementia drugs

222

1.65

2.42

1.1

37.15

47.39

mg/l

1.39

186

Other bursopathies

249

1.65

2.42

1.1

1.2

54.39

44.14

mg/l

0.38

199

Symptoms and signs involving emotional state

2.30

2.42

1.1

1.2

38.61

30.15

mg/l

0.47

Haemorrhoids and perianal venous thrombosis

689

1.38

2.41

1.1

49.28

43.62

mg/l

0.41

567

Autoimmune hyperthyroidism

117

1.97

2.40

1.3

1.1

42.14

35.96

mg/l

0.31

102

Coeliac disease

392

1.51

2.40

1.3

1.1

40.13

39.32

mg/l

0.03

325

Misadventures to patients during surgical and medical care

360

1.53

2.39

1.3

1.1

32.61

40.16

mg/l

1.12

300

Malignant melanoma of skin

227

1.68

2.39

1.2

1.1

46.74

43.90

mg/l

0.12

189

Renal tubulo-interstitial diseases

379

2480

1.17

2.36

1.2

46.79

41.18

mg/l

0.45

319

2063

Generalized epilepsy

132

1.91

2.36

1.1

1.2

31.46

40.44

mg/l

0.68

105

Dental caries 3 and operation codes

427

1879

1.17

2.35

1.2

39.53

45.22

mg/l

1.58

344

1604

Glomerulonephritis

259

1.63

2.35

1.2

47.53

43.23

mg/l

0.24

214

Superficial injury of thorax

410

1.49

2.35

1.2

1.1

75.85

40.47

mg/l

0.50

337

Thrombocytopenia, unspecified

161

1.81

2.35

1.1

62.81

40.56

mg/l

1.02

134

Other disorders of patella

609

1.40

2.34

1.1

1.2

31.08

39.93

mg/l

2.88

495

Anogenital herpesviral [herpes simplex] infection

260

1.63

2.33

1.3

1.2

26.69

35.91

mg/l

2.65

210

Flat foot [pes planus] (acquired)

214

1.69

2.32

1.2

42.22

36.79

mg/l

0.26

183

Disorders of orbit

105

2.01

2.31

1.3

1.2

39.88

38.57

mg/l

0.06

Fall on same level involving ice and snow

238

1959

1.22

2.31

1.1

1.2

46.13

41.13

mg/l

0.59

196

1659

Monoamine oxidase A inhibitors

276

1.60

2.30

1.1

1.2

34.96

43.68

mg/l

1.08

232

Heart failure and coronary heart disease

402

0.59

2.30

1.3

1.1

43.40

47.69

mg/l

0.27

338

Assault

553

1.42

2.29

1.2

1.1

33.81

40.42

mg/l

0.95

461

Other and unspecified iron deficiency

116

876

1.33

2.29

1.1

1.2

46.59

39.62

mg/l

0.76

733

Torticollis

2.71

2.28

1.4

1.1

41.82

42.96

mg/l

0.03

Bacterial intestinal infections, IBD co-morbidities

429

1.47

2.28

1.1

1.2

82.00

42.69

mg/l

0.57

349

Dental caries 3, only avohilmo

390

1703

1.17

2.28

1.2

39.60

45.11

mg/l

1.39

311

1451

Nontraumatic intracranial haemmorrhage

348

1.53

2.28

1.1

56.13

45.34

mg/l

0.65

287

Endometriosis of pelvic peritoneum

646

1.38

2.28

1.1

1.2

27.60

37.28

mg/l

3.36

537

Iron deficiency anaemia

145

1120

1.28

2.26

1.2

45.61

40.63

mg/l

0.58

117

938

Nephropathy related operations

309

1.56

2.26

1.4

1.2

45.81

45.36

mg/l

0.02

249

Pyogenic arthritis

134

1.87

2.26

1.2

58.11

43.77

mg/l

0.45

104

Superficial injury of head

698

1.36

2.26

1.2

1.1

41.13

41.25

mg/l

0.01

595

Perforation of tympanic membrane

286

1.58

2.24

1.2

1.1

52.93

43.47

mg/l

0.53

233

Malignant neoplasm of digestive organs

717

0.66

2.24

1.2

1.1

54.42

44.42

mg/l

0.57

607

Gonarthrosis [arthrosis of knee](FG)

288

1416

1.20

2.24

1.1

1.2

44.04

44.03

mg/l

0.00

247

1168

Benign neoplasm: Rectum

326

1.54

2.23

1.2

42.29

40.28

mg/l

0.12

274

Other bacterial intestinal infections

448

1.45

2.23

1.2

1.1

86.19

42.72

mg/l

0.67

366

Thyroiditis

194

1.71

2.22

1.4

1.2

32.73

35.09

mg/l

0.19

164

Other disorders of conjunctiva

295

1.56

2.21

1.1

49.88

41.88

mg/l

0.60

242

Dialysis, with operation codes

327

1.53

2.21

1.4

1.2

44.18

46.74

mg/l

0.16

267

Striking against or struck by other objects

161

1277

1.26

2.21

1.2

1.1

52.74

41.66

mg/l

0.35

125

1082

Lymphoid leukaemia

107

1.97

2.20

1.2

1.1

54.47

35.34

mg/l

0.76

Acute tubulo-interstitial nephritis

253

1866

1.20

2.19

1.2

1.1

50.33

41.85

mg/l

0.48

216

1550

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

280

1.58

2.19

1.2

44.35

40.38

mg/l

0.08

223

Other sexually transmitted chlamydial diseases

328

1.53

2.19

1.1

1.2

29.58

38.20

mg/l

1.73

257

Speech therapy

728

1.35

2.19

1.2

37.18

40.21

mg/l

0.39

613

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

451

2666

1.15

2.18

1.2

40.09

42.77

mg/l

0.70

363

2239

Disorders of breast

222

1693

1.22

2.17

1.2

1.1

40.19

39.29

mg/l

0.07

188

1418

Other disorders of glucose regulation and pancreatic internal secretion

234

1.63

2.16

1.1

1.2

41.65

43.25

mg/l

0.08

188

KRA_PSY_EATING, excluding more controls

312

1.54

2.16

1.2

34.10

39.79

mg/l

0.24

250

Lymphoid leukaemia

108

1.95

2.15

1.2

1.1

54.48

38.25

mg/l

0.60

Myocardial infarction, strict

836

0.73

2.13

1.1

46.43

48.18

mg/l

0.13

712

Hypoglycaemia, other or unspecified

189

1.70

2.13

1.1

1.2

37.61

42.76

mg/l

0.29

152

Complications of internal orthopaedic prosthetic devices, implants and grafts

428

1.45

2.12

1.0

1.2

43.51

44.22

mg/l

0.05

360

Benign neoplasm of other and ill-defined parts of digestive system

379

1.48

2.12

1.2

1.1

37.65

38.76

mg/l

0.11

321

Heart failure and bmi 25plus

498

0.66

2.12

1.1

45.78

46.63

mg/l

0.05

423

Diabetic retinopathy

463

1.35

2.11

1.1

52.40

47.89

mg/l

0.40

384

Other inflammation of eyelid

331

1.52

2.10

1.2

1.1

40.20

40.58

mg/l

0.02

268

Childhood asthma (age<16), excluding more controls

491

1.38

2.10

1.3

1.2

39.01

39.62

mg/l

0.04

395

L04AC Interleukin inhibitors

160

1.76

2.10

1.2

47.29

41.08

mg/l

0.25

126

Noninfectious colitis NAS

413

1.46

2.09

1.2

1.1

44.86

41.07

mg/l

0.17

340

Benign neoplasm: Rectum, anus and anal canal

372

1.48

2.09

1.2

1.1

43.49

40.25

mg/l

0.22

318

Female infertility, associated with anovulation

397

1.47

2.09

1.1

1.2

35.48

36.81

mg/l

0.10

331

Other gastritis (incl. Duodenitis)

530

1.40

2.08

1.2

40.02

44.51

mg/l

0.43

442

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

229

1.62

2.08

1.1

1.2

40.16

40.20

mg/l

0.00

193

Drug-induced neutropenia

168

1.73

2.07

1.1

167.68

38.41

mg/l

0.70

140

Secondary uncertain malignant neoplasm

253

1.59

2.06

1.1

51.58

42.44

mg/l

0.34

202

Other and unspecified nonorganic psychotic disorders

108

823

1.32

2.05

1.1

35.42

41.73

mg/l

1.11

694

Infectious mononucleosis

399

1.46

2.04

1.2

1.1

50.11

38.42

mg/l

0.70

320

Pedestrian injured in transport accident

184

1.69

2.04

1.2

32.18

40.40

mg/l

1.01

150

Collagenous colitis

238

1.60

2.04

1.1

1.2

35.14

40.07

mg/l

0.50

196

Other disorders of the musculoskeletal system and connective tissue

358

1.48

2.04

1.2

1.1

36.48

41.14

mg/l

0.62

295

Childhood asthma (age<16)

494

1.37

2.04

1.3

1.2

39.01

39.44

mg/l

0.03

398

Secondary polycythaemia

2.42

2.03

1.1

46.25

43.89

mg/l

—

Other keratitis

367

1.48

2.02

1.1

49.26

41.28

mg/l

0.44

304

Septal defects

196

1.66

2.00

1.1

1.2

24.93

35.07

mg/l

2.09

156

Candidiasis

409

1.45

2.00

1.2

1.1

42.88

39.03

mg/l

0.19

339

Acute laryngitis and tracheitis

518

1.39

1.99

1.2

1.1

29.70

39.60

mg/l

2.62

428

Lateral epicondylitis

328

1.50

1.98

1.2

55.27

44.80

mg/l

0.42

266

Ovarian dysfunction

353

1.48

1.97

1.1

33.82

34.18

mg/l

0.04

289

Open wound of head

199

1615

1.21

1.96

1.2

49.64

43.39

mg/l

0.58

154

1381

Nutritional anaemias

164

1289

1.24

1.95

1.2

45.89

41.08

mg/l

0.61

134

1077

Direct fill therapy

436

1.43

1.95

1.1

1.2

44.34

40.07

mg/l

0.41

363

Acute generalized exanthematous pustulosis

113

1.87

1.92

1.1

1.2

45.67

40.43

mg/l

0.16

Recurring oral aphthae, including avohilmo

413

1.43

1.91

1.1

1.2

42.17

39.16

mg/l

0.20

344

Assault by bodily force

299

1.51

1.90

1.3

1.2

37.79

41.18

mg/l

0.23

240

Acute peritonitis

128

1.80

1.89

1.1

156.29

41.44

mg/l

0.51

110

Superficial injury of wrist and hand

101

773

1.31

1.89

1.2

1.1

53.98

39.23

mg/l

0.33

650

DVT of lower extremities

414

1.43

1.89

1.1

1.2

41.65

42.08

mg/l

0.03

344

Dermatitis due to substances taken internally

143

1.76

1.89

1.2

43.47

39.86

mg/l

0.12

118

Congenital malformations and deformations of the musculoskeletal system

347

1.47

1.87

1.1

1.2

27.45

38.58

mg/l

0.96

283

Other and unspecified acne

2.42

1.86

1.9

1.2

23.58

42.52

mg/l

1.25

Abnormal findings on antenatal screening of mother

441

1.41

1.86

1.2

40.69

35.04

mg/l

0.30

362

Atopic dermatitis, strict definition with reimbursement

173

1372

1.22

1.86

1.2

32.24

39.27

mg/l

2.56

142

1157

Benign neoplasm: Long bones of lower limb

1.95

1.85

1.1

1.2

27.44

36.73

mg/l

1.32

Superficial injury of hip and thigh

333

1.47

1.85

1.1

38.55

43.21

mg/l

0.40

264

Adenomyosis (Endometriosis of uterus)

391

1.44

1.85

1.2

42.39

37.09

mg/l

0.17

330

All-cause Heart Failure

919

0.77

1.84

1.2

1.1

39.02

46.18

mg/l

1.21

778

Other disorders of breast

400

1.43

1.84

1.3

1.1

31.65

34.81

mg/l

0.44

340

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

271

2274

1.17

1.83

1.1

1.2

33.13

41.54

mg/l

3.46

228

1890

Suppurative and unspecified otitis media

212

1569

1.20

1.83

1.2

37.94

39.86

mg/l

0.27

173

1313

Rheumatoid arthritis, including avohilmo

136

1086

1.25

1.83

1.1

1.2

41.30

41.81

mg/l

0.05

114

902

Myocardial infarction, unclassifiable

305

0.55

1.83

1.0

1.1

48.24

48.08

mg/l

0.01

252

Invasive ventilation

175

1.66

1.82

1.3

1.2

50.10

43.35

mg/l

0.31

143

Bleeding

308

1927

1.16

1.82

1.1

1.2

51.57

42.80

mg/l

0.63

258

1617

Other disorders of skin and subcutaneous tissue, not elsewhere classified

351

1.46

1.82

1.1

41.91

42.71

mg/l

0.04

288

Heart failure, strict

100

932

0.77

1.81

1.2

1.1

39.35

46.04

mg/l

1.14

789

Viral warts

327

1.47

1.81

1.1

1.2

35.49

39.83

mg/l

0.26

270

Otitis externa

718

1.31

1.80

1.1

36.63

40.04

mg/l

0.50

600

Other specified and unspecified disorders of eye and adnexa

1.97

1.80

1.1

1.2

58.18

32.49

mg/l

0.74

Tuberculosis

1.92

1.80

1.2

1.1

40.92

42.71

mg/l

0.08

Recurrent dislocation and subluxation of joint

239

1.55

1.78

1.2

47.74

41.24

mg/l

0.12

191

Coronary revascularization (ANGIO or CABG)

750

0.75

1.77

1.1

40.04

49.49

mg/l

0.97

635

Early lumbar disc prolapse operation

471

1.39

1.76

1.1

1.2

38.48

38.97

mg/l

0.04

388

Atopic dermatitis, strict definition

170

1370

1.22

1.76

1.2

32.34

38.34

mg/l

2.06

139

1147

Other local infections of skin and subcutaneous tissue

264

1.52

1.76

1.1

1.2

39.51

41.50

mg/l

0.17

217

Benign neoplasm: Long bones of lower limb

1.91

1.76

1.1

27.44

42.75

mg/l

1.98

Dental operations

279

1221

1.17

1.75

1.1

1.2

38.32

47.80

mg/l

2.34

227

1030

FESS (DNB20)

379

1.43

1.75

1.1

46.50

41.17

mg/l

0.25

318

Sequelae with surgical and medical care as external cause

480

1.38

1.75

1.1

1.2

71.16

42.51

mg/l

0.38

402

Polyarthrosis

371

1.42

1.75

1.1

1.2

30.03

42.75

mg/l

4.49

312

Bacterial pneumonia (organism specified)

154

1141

1.23

1.74

1.3

1.1

62.71

41.58

mg/l

0.85

132

972

Other specified and unspecified personality disorders

338

1.46

1.74

1.2

26.03

39.44

mg/l

5.00

279

Background retinopathy and retinal vascular changes

2.52

1.74

1.1

57.00

40.00

mg/l

—

Female infertility

178

904

1.22

1.73

1.2

1.1

37.29

39.83

mg/l

0.30

153

741

Emergency coronary revascularization (for ACS)

818

0.76

1.72

1.1

39.60

48.95

mg/l

1.06

696

Alzheimer’s disease (Late onset)

185

1.58

1.72

1.1

49.25

46.50

mg/l

0.13

151

Preterm labour and delivery

124

989

1.26

1.71

1.1

1.2

39.15

38.49

mg/l

0.04

100

826

Female genital prolapse

126

576

1.26

1.70

1.1

1.2

33.33

41.89

mg/l

1.61

478

Hallux rigidus

274

1.50

1.70

1.0

1.2

48.55

39.71

mg/l

0.35

230

Streptococcal septicaemia

171

1.64

1.70

1.1

147.96

43.09

mg/l

0.71

144

Cellulitis

655

1.32

1.70

1.1

55.01

40.47

mg/l

1.39

548

Viral and other specified intestinal infections

117

906

1.26

1.69

1.1

1.2

33.19

40.05

mg/l

1.57

750

Localized swelling, mass and lump of skin and subcutaneous tissue

105

822

1.28

1.69

1.2

1.1

58.03

41.64

mg/l

0.90

684

Other diseases of oesophagus

187

1.61

1.68

1.1

30.74

46.75

mg/l

3.81

153

Medicines for HER+ breast cancer

934

0.75

1.67

1.3

1.1

45.34

40.03

mg/l

0.19

781

Fracture of lower leg, including ankle

222

1874

1.18

1.67

1.2

45.38

44.05

mg/l

0.15

186

1581

Mental disorders, not otherwise specified

325

1.45

1.67

1.2

31.40

36.80

mg/l

0.65

264

Other pleural conditions

172

1.63

1.67

1.1

35.41

45.75

mg/l

1.00

140

Respiratory disorders in diseases classified elsewhere

2.61

1.66

1.5

1.1

60.92

36.35

mg/l

—

Obesity, other/unspecified

159

1308

1.22

1.66

1.1

1.2

40.25

39.47

mg/l

0.10

139

1098

Gonarthrosis

244

1189

1.18

1.66

1.1

1.2

41.89

44.88

mg/l

0.47

211

981

Other (seronegative) rheumatoid arthritis, wide

460

1.37

1.65

1.1

1.2

43.94

39.50

mg/l

0.34

387

Seronegative rheumatoid arthritis

244

1.52

1.64

1.1

1.2

41.64

38.89

mg/l

0.16

199

Other diseases of gallbladder

1.94

1.64

1.3

1.1

56.73

34.60

mg/l

0.37

Benign neoplasm of other and ill-defined parts of digestive system

401

1.40

1.64

1.2

1.1

37.65

41.33

mg/l

0.46

337

Fissure and fistula of anal and rectal regions

755

1.29

1.64

1.1

1.2

45.35

42.48

mg/l

0.22

618

Intestinal malabsorption

127

1.74

1.64

1.1

1.2

27.65

41.09

mg/l

2.00

101

Other arthrosis

186

1108

1.20

1.64

1.1

1.2

38.86

44.85

mg/l

1.07

158

918

Nonspecific lymphadenitis

173

1.63

1.64

1.3

1.2

30.96

39.18

mg/l

0.88

143

Inflammatory bowel disease

147

1202

1.23

1.63

1.1

1.2

40.23

41.00

mg/l

0.08

120

1007

Papulosquamous disorders

149

1220

1.22

1.63

1.1

1.2

40.54

42.14

mg/l

0.16

120

1025

Abnormal serum enzyme levels

642

1.31

1.63

1.1

41.11

50.37

mg/l

0.92

537

Colonic or urogenital fistula

105

827

1.27

1.62

1.1

1.2

45.22

41.34

mg/l

0.36

685

Phlebitis and thrombophlebitis (not including DVT)

591

1.32

1.61

1.2

40.57

40.61

mg/l

0.00

491

Other disorders of veins

144

1176

1.23

1.61

1.2

56.98

41.62

mg/l

0.54

125

976

Mental and behavioural disorders due to psychoactive substance use

257

2087

1.16

1.60

1.2

1.1

37.49

45.12

mg/l

2.45

214

1758

Ethmoidectomy

395

1.40

1.60

1.1

46.00

40.96

mg/l

0.24

331

Purpura and other haemorrhagic conditions

370

1.41

1.59

1.2

1.1

49.40

41.98

mg/l

0.41

302

Degeneration of macula and posterior pole

106

689

1.27

1.59

1.2

1.1

49.83

44.32

mg/l

0.66

580

Medical abortion

315

1490

1.15

1.57

1.1

1.2

38.79

38.05

mg/l

0.10

267

1232

Allergic conjunctivitis

281

2405

1.15

1.55

1.1

1.2

33.39

41.60

mg/l

3.50

236

2001

Fracture of lumbar spine and pelvis

465

1.36

1.54

1.1

38.76

42.40

mg/l

0.26

378

Other deformities of toe(s)

2.04

1.54

1.1

1.2

52.89

34.59

mg/l

0.34

Neovascular glaucoma

1.98

1.54

1.3

1.1

41.57

35.52

mg/l

—

Substance abuse

248

2044

1.16

1.52

1.2

37.62

45.21

mg/l

2.34

208

1720

Alcohol use disorder, Swedish definition

222

1762

1.17

1.52

1.2

39.40

44.89

mg/l

1.26

180

1476

Other inflammatory liver diseases

169

1.60

1.52

1.1

1.2

36.94

38.42

mg/l

0.11

138

Nonsuppurative otitis media

130

914

1.23

1.51

1.2

41.46

41.21

mg/l

0.02

112

760

Disorder of lipoprotein metabolism, unspecified

241

1.50

1.51

1.1

47.59

42.62

mg/l

0.23

197

Amputation of foot

0.00

1.51

0.0

1.1

—

49.17

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

2.89

1.51

1.5

1.1

28.17

34.36

mg/l

—

Endometriosis diagnosis and infertility diagnosis occurring together

451

1.36

1.51

1.2

27.91

33.53

mg/l

2.14

376

Other diseases of the digestive system

712

1.28

1.50

1.2

1.1

44.66

43.48

mg/l

0.07

595

Amenorrhoea

316

1.43

1.50

1.2

43.99

34.61

mg/l

0.55

262

Anomalies of dental arch relationship, including avohilmo

101

719

1.26

1.49

1.2

1.1

34.61

38.50

mg/l

0.56

598

Complications predominantly related to the puerperium

135

1107

1.22

1.49

1.1

1.2

33.95

36.26

mg/l

0.29

110

934

Type 2 diabetes, wide definition

300

1707

1.15

1.49

1.1

47.61

43.50

mg/l

0.66

249

1434

Endometriosis ASRM stages 1,2

705

1.28

1.48

1.1

1.2

27.60

36.69

mg/l

3.60

600

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

218

1.52

1.48

1.2

27.62

40.22

mg/l

1.82

174

Maternal care for other conditions predominantly related to pregnancy

126

1013

1.23

1.48

1.2

38.54

35.71

mg/l

0.28

836

Explicit bacterial Sepsis

218

1.52

1.48

1.2

1.1

134.10

45.34

mg/l

0.70

179

Bacterial pneumonia, not elsewhere classified

134

971

1.22

1.48

1.3

1.1

65.78

42.43

mg/l

0.82

116

827

Other complications of labour and delivery, not elsewhere classified

628

0.72

1.47

1.2

35.28

35.02

mg/l

0.01

511

Congenital malformations of the circulatory system

489

1.33

1.46

1.1

1.2

29.05

41.46

mg/l

3.49

401

Other and specified injuries of hip and thigh

2.38

1.46

1.1

41.22

43.12

mg/l

—

Postzoster neuralgia

2.52

1.45

1.4

1.2

47.14

47.04

mg/l

—

GI-bleeding

707

1.27

1.45

1.2

1.1

44.44

43.84

mg/l

0.03

590

Crohn disease

463

1.34

1.45

1.1

1.2

35.31

39.58

mg/l

0.49

385

Rosacea

319

1.41

1.43

1.2

1.1

32.32

38.60

mg/l

0.71

270

Diseases of peritoneum

228

1.50

1.43

1.1

112.20

40.53

mg/l

0.47

190

Exposure to other and unspecified man-made environmental factors

2.33

1.43

1.1

29.44

34.67

mg/l

—

Viral pneumonia

353

1.39

1.43

1.1

43.49

41.70

mg/l

0.15

286

Dental caries 2 and operation codes, only avohilmo

357

1963

1.13

1.43

1.1

1.2

41.27

39.62

mg/l

0.14

311

1618

Benign neoplasm: Rectum, anus and anal canal

404

1.36

1.42

1.2

43.49

44.03

mg/l

0.03

339

Primary open-angle glaucoma, strict

421

1.35

1.41

1.1

45.00

43.82

mg/l

0.05

362

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

242

1.47

1.41

1.3

1.1

35.11

38.36

mg/l

0.19

190

Sequelae of other external causes

126

1.67

1.40

1.1

1.2

34.81

38.51

mg/l

0.17

102

Biological medication for rheuma

588

1.30

1.40

1.2

1.1

39.02

39.77

mg/l

0.05

495

Colorectal cancer

423

0.66

1.40

1.2

1.1

43.24

44.01

mg/l

0.04

359

Mental and behavioural disorders due to opioids

134

1.65

1.39

1.1

32.38

38.76

mg/l

0.65

106

Other congenital malformations

321

1.41

1.39

1.1

1.2

25.96

36.70

mg/l

2.29

259

Glaucoma secondary to other eye disorders

1.90

1.39

1.3

1.1

41.57

37.80

mg/l

—

Schizophrenia

587

0.71

1.39

1.1

1.2

47.91

40.94

mg/l

0.82

493

Disorders of parathyroid gland

401

1.36

1.38

1.1

30.37

39.50

mg/l

2.20

337

Perineal laceration during delivery

808

0.77

1.38

1.1

1.2

35.84

34.44

mg/l

0.10

662

Focal brain injury

2.08

1.38

1.2

1.0

48.67

37.87

mg/l

—

Benign neoplasm: Rectum

364

1.38

1.2

1.1

42.29

44.17

mg/l

0.11

302

Chronic kidney disease

560

1.30

1.38

1.1

48.89

45.10

mg/l

0.27

464

Bacterial pneumoniae

142

1045

1.20

1.37

1.3

1.1

63.60

42.06

mg/l

0.79

123

890

Abnormal findings in secretions and smears from cervix uteri vagina vulva

251

1717

1.15

1.37

1.1

1.2

33.44

38.70

mg/l

1.47

208

1441

Bacterial, viral and other infectious agents

306

1.41

1.36

1.1

1.2

46.37

41.69

mg/l

0.21

247

L04AD Calcineurin inhibitors

332

1.39

1.34

1.2

51.09

41.92

mg/l

0.56

272

Congenital malformations of the musculoskeletal system, not elsewhere classified

2.15

1.34

1.1

22.60

27.47

mg/l

—

Other specific arthropathies, wide

2.16

1.34

1.1

1.2

53.73

31.57

mg/l

—

Other hammer toe(s) (acquired)

311

1.39

1.33

1.2

1.1

49.62

42.73

mg/l

0.27

261

Toxic effects of substances chiefly nonmedicinal as to source

375

1.36

1.33

1.2

26.59

40.46

mg/l

4.98

312

Myocardial infarction

102

905

0.81

1.33

1.1

44.81

47.78

mg/l

0.28

769

Heart failure,strict

885

0.81

1.33

1.2

1.1

39.70

45.99

mg/l

1.02

748

Vasomotor rhinitis (mode)

200

1.51

1.32

1.2

1.1

30.88

42.01

mg/l

1.15

166

Allergic rhinitis

165

1385

1.18

1.32

1.2

34.12

39.38

mg/l

1.28

141

1154

Mental and behavioural disorders due to alcohol, excluding acute intoxication

175

1489

1.18

1.31

1.2

1.1

39.11

44.96

mg/l

1.17

145

1256

Other and unspecified psoriasis

152

1.58

1.31

1.1

1.2

46.00

43.02

mg/l

0.06

124

Artrosis, including avohilmo

394

1937

1.12

1.30

1.1

1.2

39.40

45.41

mg/l

1.38

342

1609

Otitis media, unspecified

426

1.32

1.30

1.1

1.2

27.02

38.46

mg/l

2.81

339

Alcohol use disorder, ICD-based

161

1364

1.18

1.29

1.2

1.1

39.07

44.83

mg/l

1.04

131

1157

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

236

1.44

1.28

1.0

1.1

51.03

41.39

mg/l

0.57

199

Colorectal cancer, excluding all cancers (controls excluding all cancers)

514

0.71

1.28

1.2

1.1

40.92

41.06

mg/l

0.01

439

Gout

423

1.32

1.27

1.0

1.2

56.16

49.30

mg/l

0.42

354

Fistulae involving female genital tract

2.30

1.27

1.0

1.1

35.13

33.06

mg/l

—

Adjustment and management of implanted device

285

1.41

1.27

1.1

41.57

44.10

mg/l

0.15

229

250

1964

1.14

1.26

1.2

39.16

44.90

mg/l

1.48

203

1653

Extracorporeal dialysis

138

1.60

1.26

1.2

1.1

54.44

43.47

mg/l

0.44

119

Other and unspecified glaucoma

107

1.69

1.25

1.1

49.62

41.87

mg/l

0.21

Failure and rejection of transplanted organs and tissues

2.24

1.25

1.3

1.1

50.88

37.77

mg/l

—

Evidence of alcohol involvement determined by level of intoxication

2.42

1.25

1.5

1.3

47.15

34.21

mg/l

—

Phakomatoses, not elsewhere classified

2.42

1.25

1.0

1.1

28.57

31.70

mg/l

—

234

1879

1.14

1.24

1.2

1.1

39.65

44.64

mg/l

1.13

192

1576

Mixed conductive and sensorineural hearing loss

261

1.42

1.24

1.1

1.2

35.85

42.79

mg/l

0.88

219

Iron deficiency

1.87

1.24

1.0

1.1

88.43

39.03

mg/l

—

Hypertrophic disorders of skin

195

1.49

1.24

1.3

1.2

49.40

38.77

mg/l

0.34

160

Substance use, excluding alcohol

733

1.24

1.2

1.1

33.12

41.34

mg/l

2.38

625

Other abnormal products of conception

189

1082

1.17

1.23

1.1

1.2

33.15

35.96

mg/l

0.62

158

898

Retinal breaks without detachment

355

1.35

1.23

1.2

42.36

40.99

mg/l

0.08

304

Superficial injury of shoulder and upper arm

321

1.37

1.23

1.2

36.14

39.74

mg/l

0.33

264

Endometriosis ASRM stages 3,4

102

833

1.23

1.1

1.2

37.95

36.75

mg/l

0.08

705

Diseases of salivary glands

556

1.28

1.22

1.3

1.2

32.28

42.43

mg/l

2.58

458

Glucosamine medication

124

822

1.20

1.22

1.1

41.36

45.03

mg/l

0.36

701

Later onset COPD

304

0.67

1.22

1.0

1.1

42.59

48.44

mg/l

0.33

254

Sequelae of infectious and parasitic diseases

204

1.47

1.22

1.2

1.1

47.67

40.70

mg/l

0.29

165

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

403

2369

1.11

1.21

1.2

1.1

44.13

43.23

mg/l

0.06

344

1981

Benign neoplasm: Skin of other and unspecified parts of face

229

1.44

1.21

1.1

1.2

40.13

37.49

mg/l

0.21

190

Hypertrophic scar

172

1.52

1.20

1.3

1.2

52.24

38.79

mg/l

0.41

140

L02BG Aromatase inhibitors

707

0.76

1.20

1.2

48.88

41.57

mg/l

0.19

597

Other noninflammatory disorders of vulva and perineum

297

1.38

1.20

1.2

33.79

35.26

mg/l

0.07

248

Other and unspecified local infections of skin and subcutaneous tissue

255

1.42

1.19

1.1

36.74

41.03

mg/l

0.48

209

Transplanted organ and tissue status

272

1.40

1.19

1.2

1.1

43.29

45.89

mg/l

0.16

226

Infections of genitourinary tract in pregnancy

384

1.33

1.18

1.1

34.58

36.16

mg/l

0.11

320

Injury of muscle and tendon at wrist and hand level

410

1.32

1.18

1.2

38.67

42.37

mg/l

0.37

345

Care involving dialysis

165

1.52

1.17

1.2

54.44

43.05

mg/l

0.47

127

Inflammatory disorders of breast

231

1.43

1.17

1.1

29.95

33.19

mg/l

0.43

190

Open wound of ankle and foot

307

1.37

1.17

1.2

28.57

38.72

mg/l

1.56

247

Gastroduodenal ulcer

479

1.29

1.17

1.1

1.2

39.72

46.07

mg/l

0.70

404

Other disorders starting during childhood or adolescence

221

1.44

1.17

1.3

1.1

29.12

37.99

mg/l

0.81

171

Excessive vomiting in pregnancy

359

1.34

1.16

1.1

27.90

35.36

mg/l

1.60

294

Dermatophytosis

316

1.36

1.16

1.2

34.79

45.46

mg/l

1.68

256

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

130

0.46

1.15

1.5

1.1

84.10

38.37

mg/l

—

111

Other diseases of lip and oral mucosa

403

1.32

1.15

1.1

35.40

42.88

mg/l

0.64

337

Alcohol abuse, main dg, excluding more controls

412

1.31

1.14

1.2

34.07

45.53

mg/l

2.06

344

Injuries to the elbow and forearm

296

2390

1.12

1.14

1.1

1.2

44.59

41.02

mg/l

0.39

237

2024

Atrial fibrillation and flutter with reimbursement

403

1.26

1.14

1.1

1.2

72.36

45.10

mg/l

0.47

337

Nasal polyp

500

1.28

1.14

1.1

43.54

43.40

mg/l

0.01

409

Allergic contact dermatitis

430

1.31

1.14

1.1

35.59

40.06

mg/l

0.35

362

Diabetes, insulin treatment (Kela reimbursement)

370

2503

0.90

1.14

1.1

1.2

46.31

43.57

mg/l

0.43

314

2095

Sulfonylureas

524

0.76

1.13

1.1

54.48

44.08

mg/l

0.90

441

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

1.91

1.12

1.0

1.2

34.45

36.54

mg/l

0.09

Other respiratory diseases principally affecting the interstitium

318

1.35

1.12

1.2

1.1

48.72

43.49

mg/l

0.29

263

Parapsoriasis

2.01

1.12

1.0

1.2

26.50

46.54

mg/l

—

Polycystic ovarian syndrome, broad definition

573

1.26

1.12

1.1

1.2

35.59

35.74

mg/l

0.01

476

Prolonged pregnancy

750

0.79

1.12

1.2

32.41

36.41

mg/l

0.57

625

Other puerperal infections

388

1.32

1.11

1.1

37.39

34.28

mg/l

0.22

321

Seropositive rheumatoid arthritis

616

1.25

1.11

1.1

1.2

42.92

40.18

mg/l

0.22

510

Corneal ulcer

610

1.25

1.10

1.2

1.1

36.41

40.40

mg/l

0.45

508

Intestinal stricture

709

1.23

1.09

1.2

1.1

39.68

42.18

mg/l

0.26

598

Noninflammatory disorders of female genital tract

235

1040

1.14

1.09

1.1

32.13

39.44

mg/l

2.32

200

856

Mental and behavioural disorders due to alcohol

207

1768

1.14

1.09

1.2

1.1

38.66

45.15

mg/l

1.57

172

1483

Kela-code for severe mental illness

167

1444

1.16

1.09

1.1

1.2

36.50

41.51

mg/l

1.10

137

1216

Ischemic heart diseases

266

1480

1.13

1.09

1.1

1.2

39.45

45.97

mg/l

1.55

221

1230

Atherosclerosis, excluding cerebral and coronary sclerosis

593

0.78

1.08

1.1

49.01

45.15

mg/l

0.30

509

Fracture of foot, except ankle

107

892

1.20

1.08

1.2

39.12

39.40

mg/l

0.02

749

Gestational diabetes (for exclusion)

223

1390

1.14

1.08

1.2

37.79

36.06

mg/l

0.24

194

1157

Follicular cysts of skin and subcutaneous tissue

558

1.26

1.08

1.2

1.1

37.90

41.74

mg/l

0.29

462

Dysplasia of cervi uteri

128

837

1.18

1.08

1.1

1.2

33.33

39.35

mg/l

1.07

101

691

Injuries to the hip and thigh

146

1144

1.17

1.07

1.1

1.2

38.74

41.92

mg/l

0.52

124

968

Hyperparathyroidism

334

1.33

1.07

1.1

29.30

39.44

mg/l

2.73

281

LSIL lesion of the cervix uteri, vagina or vulva

577

1.25

1.06

1.1

1.2

33.61

35.65

mg/l

0.21

486

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

356

1.30

1.06

1.1

63.38

40.88

mg/l

1.91

304

Early syphilis

2.14

1.06

1.1

1.2

39.91

53.77

mg/l

—

Acute suppurative otitis media

154

1239

1.16

1.05

1.2

40.36

40.01

mg/l

0.03

124

1037

Presence of other devices

435

1.29

1.05

1.2

42.92

41.47

mg/l

0.14

369

Crohn's disease NAS

228

1.41

1.05

1.0

1.2

36.30

40.29

mg/l

0.28

188

Unspecified acute lower respiratory infection

462

1.28

1.05

1.3

1.2

43.17

41.46

mg/l

0.11

379

Ulcerative colitis

107

895

1.20

1.05

1.2

41.04

41.08

mg/l

0.00

756

Diabetic retinopathy, strict definition

352

1.30

1.03

1.1

50.63

45.48

mg/l

0.32

298

Sulfasalazine

108

906

1.19

1.03

1.1

37.43

42.55

mg/l

0.89

757

Crushing injury of wrist and hand

2.07

1.03

1.3

1.1

39.57

51.83

mg/l

—

Malignant neoplasm of cervix uteri

2.07

1.03

1.1

27.43

25.62

mg/l

—

Peroneal tendinitis

2.07

1.03

1.0

1.1

39.00

36.71

mg/l

—

Renal failure

110

844

1.19

1.03

1.2

1.1

43.87

44.21

mg/l

0.03

703

Oligomenorrhoea

138

1.53

1.03

1.2

1.1

39.74

32.78

mg/l

0.67

111

Open wound of forearm

272

1.36

1.02

1.1

1.2

40.68

41.69

mg/l

0.04

222

Osteonecrosis

122

1.56

1.02

1.1

35.68

44.24

mg/l

0.71

106

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

335

0.69

1.02

1.1

51.11

39.87

mg/l

0.55

283

Chronic pancreatitis

281

1.36

1.01

1.2

1.1

50.69

45.95

mg/l

0.19

228

Other maternal disorders predominantly related to pregnancy

291

1644

1.11

1.01

1.2

35.79

38.14

mg/l

0.40

249

1355

Other and unspecified injuries of lower leg

239

1.38

1.00

1.1

1.2

60.99

40.17

mg/l

0.70

193

Hereditary retinal dystrophy

2.01

1.00

1.1

35.90

28.29

mg/l

—

Toxic liver disease

2.01

1.00

1.1

33.29

30.34

mg/l

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

417

1.24

1.00

1.2

48.31

44.72

mg/l

0.25

348

Peripheral artery disease

670

0.80

1.00

1.1

79.63

45.61

mg/l

0.54

571

Open wound of lower leg

413

1.29

0.99

1.2

1.1

41.63

42.61

mg/l

0.06

333

Injury of eye and orbit

502

1.26

0.99

1.1

37.61

42.71

mg/l

0.64

422

Mesothelioma

0.00

0.98

0.0

1.1

—

49.04

—

Ankylosing spondylitis, ICD10

292

1.34

0.97

1.2

31.42

42.05

mg/l

2.45

235

Non-small cell lung cancer

266

1.36

0.97

1.0

1.1

51.03

45.92

mg/l

0.25

220

Cholecystectomy

262

2080

1.11

0.97

1.1

1.2

42.41

42.39

mg/l

0.00

219

1736

Early onset COPD

531

1.24

0.96

1.3

1.2

72.48

44.02

mg/l

0.41

446

Antenatal screening

104

696

0.84

0.96

1.1

40.07

37.92

mg/l

0.10

557

Mental and behavioural disorders due to sedatives or hypnotics

224

1.39

0.96

1.1

1.2

38.30

41.80

mg/l

0.28

179

Other disorders of kidney and ureter

284

1.34

0.96

1.1

102.67

43.12

mg/l

0.55

232

COPD (mode)

456

1.24

0.96

1.2

1.1

72.55

46.90

mg/l

0.40

394

Contact with sharp glass

125

1.53

0.94

1.2

33.00

44.29

mg/l

0.70

Secondary thrombocytopenia

2.24

0.94

1.5

1.1

71.00

39.31

mg/l

—

Malignant neoplasm of breast, HER-positive

844

0.82

0.93

1.2

45.51

40.11

mg/l

0.19

707

Acne vulgaris

391

1.28

0.93

1.3

1.1

63.45

38.56

mg/l

0.79

316

Corneal scars and opacities

1.74

0.92

1.1

1.0

37.22

43.45

mg/l

—

Gastric ulcer

330

1.30

0.92

1.1

42.53

46.02

mg/l

0.23

268

Use of disulfiram, acamprosate or naltrexone

278

1.33

0.91

1.2

32.98

45.41

mg/l

2.22

225

Peripheral arterial reconstruction

256

0.66

0.91

1.1

58.78

46.90

mg/l

0.53

212

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

128

1104

1.16

0.91

1.2

1.1

39.59

40.26

mg/l

0.06

108

925

Other/unspecified rheumatoid arthritis

261

1.34

0.91

1.1

44.15

41.11

mg/l

0.13

219

Acne

491

1.24

0.90

1.4

1.1

57.59

37.97

mg/l

0.75

398

Deep bite

351

1.27

0.90

1.2

33.68

38.25

mg/l

0.40

288

Other condition

429

1.26

0.89

1.2

1.1

34.44

40.16

mg/l

0.73

355

Cellulitis of external ear

2.08

0.89

1.0

1.1

31.35

37.26

mg/l

—

Malignant neoplasm of bladder

102

0.49

0.89

1.2

1.1

30.40

46.43

mg/l

—

Single delivery by caesarean section

589

0.83

0.89

1.3

1.2

33.87

36.98

mg/l

0.28

491

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

700

0.82

0.89

1.2

45.34

38.07

mg/l

0.28

584

Erosion of teeth, including avohilmo

748

1.19

0.88

1.1

39.06

37.75

mg/l

0.13

631

Atrial fibrillation and flutter

107

593

1.18

0.88

1.1

1.2

62.87

42.84

mg/l

0.46

494

Impetigo

152

1.45

0.88

1.2

1.1

27.92

37.06

mg/l

1.10

117

Schizophrenia or delusion

143

1248

1.15

0.88

1.1

1.2

36.88

42.26

mg/l

1.18

118

1048

Ischaemic heart disease, wide definition

254

1432

1.11

0.87

1.1

1.2

40.50

46.60

mg/l

1.31

209

1191

Benign neoplasm: Skin of other and unspecified parts of face

246

1.34

0.87

1.1

40.13

41.05

mg/l

0.06

201

Gestational [pregnancy-induced] hypertension

137

1191

1.15

0.86

1.2

1.1

34.21

36.70

mg/l

0.32

118

994

Thyrotoxicosis

750

1.19

0.85

1.2

1.1

41.60

38.83

mg/l

0.18

635

Ulcer of oesophagus

120

1.50

0.85

1.3

1.1

31.08

48.07

mg/l

2.34

102

Schizophrenia, schizotypal and delusional disorders

143

1252

1.14

0.85

1.1

1.2

36.88

42.36

mg/l

1.21

118

1052

Sequelae of injuries of head

145

1.45

0.85

1.0

1.2

149.34

46.54

mg/l

0.44

116

Hypertensive Renal Disease

1.78

0.84

1.0

35.25

35.15

mg/l

—

Dislocation, sprain and strain of joints and ligaments of head

137

1.47

0.84

1.1

25.23

44.40

mg/l

2.29

109

Injury of muscle and tendon at hip and thigh level

265

1.32

0.84

1.1

1.2

46.90

42.09

mg/l

0.25

223

Pregnancy, childbirth and the puerperium

102

626

0.85

0.83

1.1

1.2

28.72

35.44

mg/l

1.69

514

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

301

1.28

0.83

1.0

1.1

54.40

41.10

mg/l

0.98

258

Lichen planus

274

1.32

0.83

1.1

1.2

44.41

40.29

mg/l

0.20

232

Suggestive for eosinophilic asthma

222

1.35

0.83

1.1

44.73

44.12

mg/l

0.02

181

Trigger finger

318

1.29

0.83

1.1

52.17

43.23

mg/l

0.34

260

LSIL lesion of the cervix uteri

488

1.23

0.83

1.1

1.2

33.45

34.71

mg/l

0.11

411

Idiopathic pulmonary fibrosis

113

0.53

0.83

1.3

1.1

38.23

44.14

mg/l

—

Loose body in joint

1.75

0.82

1.4

1.1

47.13

43.67

mg/l

—

Other and unspecified intracranial injuries

1.70

0.82

1.0

1.1

24.45

41.54

mg/l

1.63

Other eating disorders

240

1.34

0.82

1.3

1.1

25.51

36.63

mg/l

2.28

191

Galactorrhea

1.89

0.82

1.8

1.1

33.50

25.78

mg/l

—

Salpingitis and oophoritis

516

1.22

0.82

1.1

1.2

31.78

38.07

mg/l

1.04

425

Artificial joint operation, meniscal resection

331

2020

1.09

0.81

1.1

1.2

40.68

45.03

mg/l

0.99

275

1694

Other surgical follow-up care

1.61

0.81

1.1

1.2

33.35

31.16

mg/l

0.15

Hallux valgus (acquired)

111

691

1.16

0.81

1.2

42.73

41.65

mg/l

0.06

574

Paralytic ileus and intestinal obstruction

589

1.21

0.81

1.2

38.08

44.04

mg/l

0.91

482

Pregnancy with abortive outcome

316

1511

1.09

0.81

1.2

39.21

37.99

mg/l

0.17

268

1248

severe traumatic brain injury, does not include concussion

488

0.78

0.81

1.2

1.1

93.86

44.49

mg/l

0.43

397

ILD, hospital admissions

267

1.31

0.80

1.2

1.1

50.98

44.59

mg/l

0.31

219

Other benign neoplasms of skin

116

986

1.15

0.80

1.1

1.2

41.77

40.57

mg/l

0.11

821

Thyrotoxicosis with diffuse goitre

436

1.24

0.80

1.2

1.1

44.21

40.00

mg/l

0.24

364

Ulcerative rectosigmoiditis

268

1.31

0.79

1.1

1.2

48.08

43.59

mg/l

0.17

221

Adalimumab

321

1.28

0.79

1.2

43.20

39.08

mg/l

0.21

265

Disorders of continuity of bone

277

1.30

0.78

1.1

1.2

23.70

41.27

mg/l

6.01

240

Abscess of lung

0.00

0.78

0.0

1.1

—

56.37

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

339

1.27

0.78

1.0

1.2

33.26

37.85

mg/l

0.71

286

Other salmonella infections

1.56

0.78

1.1

35.93

37.73

mg/l

0.12

Anisometropia and aniseikonia

1.59

0.78

1.2

1.1

23.13

39.76

mg/l

—

Dental operations, only avohilmo

289

1351

1.10

0.78

1.1

1.2

40.12

46.86

mg/l

1.42

236

1143

Malignant neoplasm of respiratory system and intrathoracic organs

320

1.27

0.78

1.0

1.1

63.28

44.62

mg/l

1.20

265

Other diseases of anus and rectum

757

1.18

0.78

1.1

44.56

42.52

mg/l

0.12

620

Valvular operations

304

0.72

0.77

1.1

32.41

46.06

mg/l

1.77

258

Alcohol dependence

814

1.17

0.77

1.2

1.1

35.79

46.04

mg/l

2.32

690

Other interstitial pulmonary diseases

269

1.30

0.77

1.2

1.1

50.98

44.36

mg/l

0.32

221

Primary gonarthrosis, bilateral

131

1005

1.14

0.77

1.1

45.82

46.88

mg/l

0.07

113

850

Other benign neoplasms of skin

116

1010

1.15

0.76

1.1

1.2

41.77

40.87

mg/l

0.08

844

Acute renal failure

403

1.24

0.76

1.3

1.2

43.97

46.03

mg/l

0.12

328

Unequal limb length (acquired)

0.00

0.76

0.0

1.3

—

44.51

—

Heart failure, not strict

248

1554

1.10

0.76

1.2

1.1

40.09

45.72

mg/l

1.16

209

1305

Primary open-angle glaucoma

525

1.21

0.76

1.1

46.58

43.88

mg/l

0.14

449

Angina pectoris

171

1029

1.12

0.76

1.1

41.40

48.05

mg/l

1.11

144

872

Superficial injury of forearm

332

1.27

0.76

1.2

34.89

39.73

mg/l

0.31

273

Interstitial lung disease endpoints

270

1.30

0.75

1.2

1.1

50.98

44.36

mg/l

0.32

221

Interstitial lung disease

270

1.30

0.75

1.2

1.1

50.98

44.36

mg/l

0.32

221

Muscle strain

1.65

0.75

1.2

1.1

37.65

40.80

mg/l

0.16

Other dialysis

1.61

0.75

1.1

39.67

44.33

mg/l

—

Seminoma of testis

2.10

0.75

1.0

1.3

60.40

47.97

mg/l

—

Polycythaemia vera

1.67

0.74

1.1

41.00

33.13

mg/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

240

1283

1.10

0.74

1.1

1.2

32.14

39.10

mg/l

2.25

200

1058

Cardiac murmurs and other cardiac sounds

294

1.28

0.74

1.3

1.1

29.57

44.30

mg/l

1.41

235

Benign lipomatous neoplasm

799

1.17

0.74

1.2

36.36

38.96

mg/l

0.47

666

Mental and behavioural disorders due to tobacco

236

1.32

0.74

1.1

32.34

42.23

mg/l

1.21

196

Glomerular disorders in diseases classified elsewhere

280

1.29

0.74

1.3

1.1

45.16

44.00

mg/l

0.05

226

Dislocation, sprain and strain of joints and ligaments of elbow

210

1.34

0.73

1.1

1.2

54.73

38.70

mg/l

0.40

172

Contraceptive management

212

1348

1.11

0.73

1.2

37.08

42.24

mg/l

0.79

183

1110

Ulcerative colitis, NAS

469

1.22

0.73

1.2

40.57

40.61

mg/l

0.00

395

Lumbosacral root disorders, not elsewhere classified

2.01

0.73

1.2

1.1

29.80

30.99

mg/l

—

Other bursal cyst

2.01

0.73

1.2

31.00

40.18

mg/l

—

HSIL lesion of the vulva

1.80

0.72

1.0

1.1

29.14

24.72

mg/l

—

Coxarthrosis [arthrosis of hip](FG)

147

943

1.13

0.72

1.1

1.2

48.68

44.20

mg/l

0.31

116

784

Benign neoplasm: Liver

1.59

0.71

1.2

1.1

33.44

31.41

mg/l

—

Malignant neoplasm, wide definition for exclusion

397

2185

1.07

0.70

1.2

1.1

55.87

40.81

mg/l

1.44

333

1827

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

397

2185

1.07

0.70

1.2

1.1

55.87

40.81

mg/l

1.44

333

1827

Postprocedural musculoskeletal disorders, not elsewhere classified

143

1.40

0.70

1.2

1.1

36.46

43.32

mg/l

0.45

121

Peritonsillar abscess

804

1.16

0.70

1.1

1.2

43.59

40.35

mg/l

0.15

663

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

367

2410

0.93

0.70

1.1

1.2

46.56

43.09

mg/l

0.58

311

2027

Maternal care for known or suspected malpresentation of fetus

761

0.86

0.69

1.2

36.59

37.62

mg/l

0.09

632

Etanercept

195

1.34

0.69

1.0

1.1

32.06

39.85

mg/l

0.72

159

Foreign body in genitourinary tract

1.86

0.68

1.0

1.1

41.20

32.69

mg/l

—

Burns and corrosions

464

1.21

0.68

1.1

1.2

30.95

41.19

mg/l

3.02

381

Embolic stroke

1.53

0.68

1.0

1.1

60.36

43.35

mg/l

—

Cholecystitis

275

1.27

0.68

1.3

1.1

45.86

41.65

mg/l

0.14

221

Smoking dependency

240

1.29

0.67

1.1

1.2

32.34

42.03

mg/l

1.18

198

Macular pucker

240

1.29

0.67

1.1

50.97

41.04

mg/l

0.51

209

Malignant neoplasm of testis

1.64

0.67

1.0

1.2

55.71

54.22

mg/l

—

Gout, FINNGEN

511

1.19

0.67

1.0

1.1

56.16

45.62

mg/l

0.76

426

Nonalcoholic fatty liver disease

267

1.28

0.66

1.2

1.1

34.19

42.93

mg/l

1.31

221

Unspecified threat to breathing

1.80

0.66

1.8

1.1

28.46

42.37

mg/l

—

Seminoma of testis, excluding all cancers (controls excluding all cancers)

1.80

0.66

1.0

1.2

60.40

46.32

mg/l

—

1.52

0.66

1.1

1.2

20.14

32.78

mg/l

—

Personal history of other diseases and conditions

473

1.20

0.66

1.1

1.2

32.52

37.01

mg/l

0.52

402

Puerperal sepsis

375

1.23

0.66

1.1

37.94

35.79

mg/l

0.11

318

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

396

2186

1.07

0.66

1.2

1.1

55.75

40.79

mg/l

1.42

332

1828

Parodontitis and operation codes

334

2415

1.08

0.65

1.2

39.71

44.12

mg/l

1.04

280

2025

Persons encountering health services in circumstances related to reproduction

281

1759

1.08

0.64

1.2

1.1

39.78

43.09

mg/l

0.55

246

1451

Malignant neoplasm of bronchus and lung

276

1.26

0.64

1.0

1.1

56.52

46.80

mg/l

0.51

229

Nonischemic cardiomyopathy

129

0.62

0.64

1.0

1.1

28.88

45.47

mg/l

—

109

Gonarthrosis,primary

293

1705

1.08

0.63

1.1

1.2

44.30

45.68

mg/l

0.17

251

1418

Mucosal proctocolitis

450

1.20

0.63

1.1

1.2

41.19

42.16

mg/l

0.05

374

Insulin, combination of fast acting with intermediate-acting or long-acting

215

1814

1.09

0.63

1.1

1.2

49.78

43.37

mg/l

0.89

173

1538

Endometriosis of ovary

633

1.17

0.63

1.1

1.2

35.67

38.95

mg/l

0.37

534

Parodontitis, under 40 years and operation codes

478

1.20

0.63

1.1

1.2

35.34

37.34

mg/l

0.18

396

Delivery, wide proxy

124

743

0.89

0.63

1.2

30.96

37.91

mg/l

1.66

610

Leiomyoma of uterus

210

1079

1.10

0.63

1.1

1.2

41.01

37.62

mg/l

0.31

172

907

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

220

1765

1.09

0.62

1.2

1.1

34.97

38.20

mg/l

0.59

191

1462

Coronary angioplasty

611

0.85

0.62

1.1

39.14

46.74

mg/l

0.69

517

Parodontitis, operation under 40 years and operation codes

479

1.19

0.62

1.1

1.2

35.34

37.28

mg/l

0.17

397

Thyrotoxicosis, other and/or unspecified

590

1.17

0.61

1.2

1.1

38.56

39.88

mg/l

0.09

493

Delivery

151

888

0.90

0.61

1.2

34.18

38.16

mg/l

0.73

121

737

Redundant prepuce, phimosis and paraphimosis

634

1.16

0.61

1.2

47.70

50.46

mg/l

0.16

542

Certain conditions originating in the perinatal period

344

1.21

0.60

1.1

32.71

35.86

mg/l

0.23

279

Infective dermatitis

289

1.25

0.60

1.2

1.1

30.94

43.44

mg/l

2.46

239

Melanoma of uvea

0.00

0.60

0.0

1.1

—

49.80

—

Exposure to excessive natural cold

0.00

0.60

0.0

1.1

—

55.27

—

Bitten or struck by other mammals

398

1.21

0.60

1.1

1.2

39.34

37.75

mg/l

0.11

337

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

110

856

1.13

0.60

1.2

1.1

51.79

42.21

mg/l

0.93

721

Alcoholic liver disease

218

1.29

0.60

1.3

1.1

43.88

45.47

mg/l

0.10

183

Varicose veins of other sites

174

1.32

0.60

1.1

1.2

41.89

45.82

mg/l

0.14

144

Mandibular retrognathia

253

1.26

0.60

1.1

1.2

38.40

39.94

mg/l

0.08

213

Hypertrophy of breast

583

1.17

0.59

1.2

1.1

43.62

37.98

mg/l

0.16

480

Other interventions on the root canals of the tooth

1.54

0.59

1.0

1.1

26.89

41.38

mg/l

—

Tumor necrosis factor alpha inhibitors

537

1.17

0.59

1.2

38.59

39.41

mg/l

0.05

451

Disorders of gallbladder, biliary tract and pancreas

401

2427

1.06

0.59

1.1

1.2

40.99

43.53

mg/l

0.46

330

2035

Hypertrophy of breast in women and men

658

1.16

0.59

1.2

1.1

43.36

39.79

mg/l

0.11

543

Viral pneumonia (unknown virus, not influenza)

201

1.30

0.59

1.1

1.2

41.81

42.93

mg/l

0.07

165

Endometriosis of intestine

1.57

0.59

1.4

1.2

27.02

30.74

mg/l

—

Malignant neoplasm of other and unspecified parts of biliary tract

0.00

0.58

0.0

1.1

—

57.69

—

Parodontitis or operation codes

355

2451

1.07

0.57

1.1

1.2

39.61

44.43

mg/l

1.24

297

2058

Skin changes due to chronic exposure to nonionizing radiation

606

1.16

0.57

1.1

40.84

44.31

mg/l

0.24

519

Parodontitis, under 40 years

502

1.18

0.57

1.1

1.2

34.98

37.63

mg/l

0.26

418

673

1.15

0.57

1.1

39.27

44.21

mg/l

0.43

573

Diverticular disease of intestine

219

1339

1.09

0.57

1.1

39.08

45.79

mg/l

1.59

193

1111

Other endocrine disorders

169

1.31

0.56

1.1

1.2

41.09

34.19

mg/l

0.33

132

Parodontitis, under 40 years, or operation codes

503

1.18

0.56

1.1

1.2

34.98

37.63

mg/l

0.26

419

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

0.57

0.56

1.2

1.1

84.00

37.36

mg/l

—

IBD patients in KELA-register

104

925

1.13

0.56

1.1

1.2

39.40

41.29

mg/l

0.18

780

Pregnancy hypertension

203

1684

1.09

0.55

1.3

1.1

35.38

37.60

mg/l

0.34

176

1400

Family history of certain disabilities and chronic diseases leading to disablement

159

1.32

0.55

1.1

1.2

29.81

37.80

mg/l

0.54

128

Benign leiomyoma with endometriosis

375

1.20

0.55

1.2

42.88

36.39

mg/l

0.22

313

Biguanides

345

2265

0.94

0.55

1.2

47.81

42.32

mg/l

1.09

297

1893

Allergic urticaria

275

1.24

0.55

1.2

31.31

38.51

mg/l

0.80

222

Any event in cancer register

424

2373

1.06

0.55

1.2

1.1

53.93

40.82

mg/l

1.29

350

1981

Aortic aneurysm

410

0.81

0.55

1.1

43.33

46.42

mg/l

0.14

346

Parodontitis

354

2452

1.06

0.54

1.1

1.2

39.61

44.43

mg/l

1.24

297

2058

Benign neoplasm: Liver

1.51

0.54

1.2

1.1

33.44

31.87

mg/l

—

Other obstructed labour

258

1.24

0.53

1.1

1.2

29.23

35.33

mg/l

0.88

214

Seborrhoeic dermatitis

240

1.25

0.53

1.3

1.2

40.11

44.00

mg/l

0.20

195

Other fall from one level to another

796

1.13

0.53

1.3

1.1

40.40

40.97

mg/l

0.04

663

Melanocytic naevi of scalp and neck

1.46

0.53

1.1

60.11

41.06

mg/l

—

Single spontaneous delivery

151

884

0.91

0.53

1.2

36.51

38.19

mg/l

0.23

120

734

5-aminosalicylic acid

750

1.13

0.52

1.1

41.77

42.55

mg/l

0.05

636

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

359

1.20

0.52

1.0

1.2

33.26

40.31

mg/l

1.21

302

Lichen simplex chronicus and prurigo

143

1.33

0.52

1.2

1.1

31.14

40.24

mg/l

0.74

120

Benign leiomyoma with endometriosis

378

1.19

0.52

1.2

42.88

34.88

mg/l

0.29

329

Dialysis

100

1.40

0.52

1.1

60.67

45.22

mg/l

—

Inflammation of lacrimal passages (acute and unspecified)

1.50

0.51

1.7

1.2

65.67

33.36

mg/l

—

Benign neoplasm: Liver/bile ducts

1.39

0.50

1.2

1.1

33.44

34.00

mg/l

—

Psoriatic and enteropathic arthropathies

315

1.21

0.50

1.1

1.2

40.94

41.32

mg/l

0.02

257

Diseases of arteries, arterioles and capillaries

188

1293

1.09

0.50

1.2

1.1

52.67

44.09

mg/l

0.33

152

1103

Carcinoma in situ of other and unspecified genital organs

1.47

0.50

1.0

1.1

20.37

25.03

mg/l

—

Unspecified misadventure during surgical and medical care

127

1.34

0.49

1.1

1.2

27.71

37.58

mg/l

0.87

105

Intestinal adhesions without obstruction

180

1.28

0.49

1.4

1.1

40.71

45.21

mg/l

0.25

147

Premature rupture of membranes

104

851

0.90

0.49

1.1

1.2

32.59

37.29

mg/l

0.80

712

Other appendicitis

243

1.24

0.49

1.2

32.67

43.52

mg/l

1.87

200

Alopecia areata

1.43

0.49

1.0

1.2

30.94

29.18

mg/l

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

198

1.26

0.49

1.5

1.1

35.48

37.92

mg/l

0.12

165

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

566

1.15

0.49

1.1

1.2

31.15

41.54

mg/l

2.78

466

Psoriasis

888

1.12

0.48

1.1

1.2

40.99

40.17

mg/l

0.06

741

Alcohol-induced chronic pancreatitis

154

1.30

0.48

1.2

1.1

39.06

46.36

mg/l

0.69

127

Foreign body in ear

1.53

0.48

1.0

1.1

45.86

44.38

mg/l

—

COPD, hospital admissions 1, only main diagnosis

551

0.86

0.48

1.1

76.85

45.38

mg/l

0.38

468

Complications following abortion and ectopic and molar pregnancy

1.42

0.47

1.1

31.66

30.11

mg/l

0.07

Schizoid personality disorder

1.46

0.47

1.0

1.1

27.43

35.33

mg/l

—

Acquired haemolytic anaemia

1.46

0.47

1.1

65.00

31.97

mg/l

—

Impacted maxillary molar

266

0.79

0.46

1.1

28.58

37.27

mg/l

0.79

217

Nontoxic goitre/thyroid nodule

782

0.88

0.46

1.2

1.1

47.57

40.82

mg/l

0.39

654

Seropositive rheumatoid arthritis, wide

683

1.13

0.46

1.1

42.92

39.61

mg/l

0.28

586

Unstable angina pectoris

628

1.12

0.46

1.1

42.43

46.40

mg/l

0.59

537

Leiomyoma of uterus

250

1330

1.07

0.46

1.1

1.2

41.65

39.27

mg/l

0.22

208

1122

Chronic periodontitis, including avohilmo

350

2451

1.06

0.45

1.1

1.2

39.80

44.44

mg/l

1.16

293

2057

Malignant neoplasm of stomach

0.60

0.45

1.2

1.1

84.00

43.13

mg/l

—

Actinic keratosis

577

1.14

0.45

1.1

42.24

45.07

mg/l

0.17

496

Single delivery by forceps and vacuum extractor

522

0.89

0.45

1.2

32.81

37.14

mg/l

0.60

437

241

1.22

0.45

1.1

52.36

42.83

mg/l

0.54

206

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

192

1.25

0.45

1.2

29.18

33.61

mg/l

0.37

160

Personal history of malignant neoplasm

1.40

0.44

1.4

1.2

27.58

39.30

mg/l

0.72

Ovarian hyperstimulation (induction)

1.46

0.44

1.0

1.1

31.09

32.37

mg/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

146

1335

1.09

0.44

1.1

1.2

34.16

37.56

mg/l

0.59

115

1121

Endocarditis

1.45

0.44

1.2

1.1

41.05

47.69

mg/l

—

Acute pancreatitis

497

1.15

0.44

1.2

34.53

41.82

mg/l

0.99

404

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

1.38

0.44

1.0

1.2

55.71

43.95

mg/l

—

Other disorders of prostate

1.37

0.44

1.1

44.00

56.52

mg/l

—

Scoliosis

247

1.22

0.44

1.1

46.28

42.05

mg/l

0.16

204

Effects of foreign body entering through natural orifice

857

1.11

0.43

1.2

1.1

58.54

42.31

mg/l

0.34

713

Inflammatory bowel disease, strict (require KELA)

104

943

1.10

0.43

1.1

1.2

39.40

41.05

mg/l

0.15

793

Foreign body or object entering through skin

211

1.23

0.43

1.1

1.2

33.79

44.88

mg/l

1.82

172

Other and unspecified corneal deformities and disorders

1.41

0.43

1.1

68.59

39.14

mg/l

0.43

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

1.41

0.43

1.5

1.1

60.34

35.02

mg/l

0.93

AV-block

300

1.18

0.42

1.1

42.26

45.65

mg/l

0.23

254

Other/unspecified seropositive rheumatoid arthritis

678

1.12

0.42

1.1

43.19

39.72

mg/l

0.29

582

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

147

925

1.09

0.42

1.1

61.35

41.74

mg/l

0.73

124

779

Diabetes medication

428

2725

0.95

0.42

1.2

1.1

45.94

42.47

mg/l

0.64

362

2290

Malignant neoplasm of pancreas

0.63

0.42

1.5

1.1

84.10

42.82

mg/l

—

Blood alcohol or alcohol intoxication level

1.43

0.42

1.4

1.2

41.99

41.24

mg/l

—

Psoriatic arthropathies

258

1.20

0.41

1.1

1.2

37.96

41.22

mg/l

0.18

212

Other congenital malformations of female genitalia

1.52

0.41

1.2

30.40

28.99

mg/l

—

Other dermatomyositis

0.00

0.41

0.0

1.1

—

29.88

—

Arthropathy in ulcerative colitis

1.52

0.41

1.2

1.1

58.00

26.84

mg/l

—

In situ neoplasms

105

956

1.10

0.41

1.1

1.2

38.62

40.31

mg/l

0.14

810

Non-ischemic cardiomyopathy

506

0.88

0.41

1.2

37.23

46.46

mg/l

1.10

430

Other congenital malformations of upper alimentary tract

0.00

0.41

0.0

1.1

—

42.45

—

Hernia

386

2494

1.05

0.41

1.2

1.1

41.35

44.48

mg/l

0.47

327

2093

Benign lipomatous neoplasm

842

1.11

0.41

1.2

36.36

40.47

mg/l

0.88

709

Malignant neoplasm of eye and adnexa

0.00

0.41

0.0

1.1

—

35.48

—

Venous complications and haemorrhoids in the puerperium

1.48

0.40

1.8

1.1

31.60

26.23

mg/l

—

Pollen allergy

872

1.10

0.40

1.2

31.45

37.45

mg/l

1.44

719

Intentional self-harm by jumping from a high place

0.00

0.40

0.0

1.1

—

31.52

—

Blepharochalasis

587

1.13

0.40

1.1

43.28

43.88

mg/l

0.03

489

Long labour

110

1049

0.91

0.40

1.2

34.65

37.53

mg/l

0.44

867

Evidence of alcohol involvement determined by blood alcohol level

1.43

0.39

1.2

1.1

39.60

39.32

mg/l

—

Acute epiglottitis

1.43

0.39

1.0

1.1

37.60

mg/l

—

Thyrotoxicosis with toxic single thyroid nodule

0.00

0.39

0.0

1.1

—

27.13

—

Other follicular disorders

251

1.20

0.39

1.1

1.2

48.46

41.06

mg/l

0.36

203

Diabetic nephropathy

312

1.17

0.38

1.2

50.77

46.30

mg/l

0.24

261

Benign neoplasm: Liver/bile ducts

1.37

0.38

1.2

1.1

33.44

32.32

mg/l

—

Thyroiditis, unspecified

1.39

0.38

1.2

1.1

27.20

30.39

mg/l

—

Spontaneous abortion

210

1342

1.06

0.38

1.2

36.92

38.30

mg/l

0.17

176

1115

Erysipelas

161

1369

1.07

0.37

1.1

60.94

42.55

mg/l

0.68

132

1158

Fracture of skull and facial bones

714

1.11

0.37

1.2

1.1

70.59

41.55

mg/l

0.61

611

Idiopathic urticaria

1.31

0.37

1.3

1.1

25.78

32.37

mg/l

—

Melanocytic naevi of scalp and neck

1.31

0.37

1.1

60.11

33.97

mg/l

—

Ulcer of vagina/vulva

1.31

0.37

1.0

1.2

34.98

29.53

mg/l

—

Conduction disorders

601

1.11

0.37

1.1

40.36

43.11

mg/l

0.25

507

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

103

771

0.92

0.37

1.1

46.80

42.78

mg/l

0.30

654

Simple and mucopurulent chronic bronchitis

1.39

0.37

1.2

1.1

70.80

34.58

mg/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

667

1.11

0.36

1.1

43.26

39.69

mg/l

0.29

572

Other menopausal disorders

102

537

1.10

0.36

1.2

35.41

41.64

mg/l

0.84

449

Injury of muscle and tendon at lower leg level

431

1.14

0.36

1.2

1.1

46.31

43.19

mg/l

0.20

353

Coronary atherosclerosis

175

1204

0.94

0.35

1.2

1.1

42.69

46.77

mg/l

0.60

138

1011

Cholelithiasis, broad definition with cholecystitis

331

2164

1.05

0.35

1.1

1.2

39.77

43.22

mg/l

0.62

272

1820

Insulin, fast-acting

130

1206

1.08

0.35

1.1

1.2

38.84

40.53

mg/l

0.29

101

1018

Carcinoma in situ of other and unspecified genital organs

1.40

0.35

1.0

1.1

20.37

25.94

mg/l

—

Helminthiases

1.40

0.35

1.0

1.1

92.17

35.59

mg/l

—

349

1.14

0.35

1.2

1.1

51.59

45.19

mg/l

0.49

302

Acute pancreatitis (for exclusion)

508

1.12

0.35

1.2

34.53

43.07

mg/l

1.24

421

Type 1 diabetes

110

1014

1.08

0.34

1.2

44.35

40.06

mg/l

0.39

852

Bursitis of shoulder

1.37

0.34

1.7

1.1

43.67

40.56

mg/l

—

Valvular heart disease excluding rheumatic fever

123

969

0.93

0.34

1.1

47.11

44.53

mg/l

0.19

823

Arthropathic psoriasis

311

1.16

0.34

1.1

1.2

45.37

40.51

mg/l

0.18

256

Lactose intolerance

1.32

0.34

1.1

1.2

22.41

29.73

mg/l

1.47

Failed induction of labour

286

0.84

0.33

1.1

1.2

36.41

36.05

mg/l

0.02

231

Malignant neoplasm

373

2120

1.04

0.33

1.2

1.1

56.32

41.33

mg/l

1.36

313

1774

In situ neoplasms

105

925

1.08

0.33

1.1

38.62

39.54

mg/l

0.07

774

Insulin, fast-acting (human)

572

0.89

0.33

1.1

35.67

39.77

mg/l

0.62

479

Conotruncal defects

1.28

0.32

1.0

1.1

25.90

31.18

mg/l

—

Mandibular prognathia

1.28

0.32

1.0

1.1

33.53

30.38

mg/l

—

Congenital malformations of the respiratory system

1.28

0.32

1.2

1.1

38.33

33.32

mg/l

—

Erythema intertrigo

1.28

0.32

1.8

1.1

27.67

48.49

mg/l

—

Conductive hearing loss, unspecified

229

1.18

0.32

1.2

1.1

25.53

44.40

mg/l

3.88

191

Other malignant neoplasms of skin (=non-melanoma skin cancer)

102

871

0.92

0.32

1.1

68.08

44.86

mg/l

0.57

741

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.33

0.32

1.2

1.1

53.09

37.89

mg/l

0.48

Eustachian salpingitis and obstruction

332

1.15

0.32

1.1

1.2

37.39

37.78

mg/l

0.03

271

Carbimazole or st.post thyroidectomy, condition for graves disease

655

1.10

0.32

1.2

1.1

41.27

39.54

mg/l

0.10

549

Diabetic nephropathy, excluding more controls

269

1.15

0.31

1.2

1.1

50.77

mg/l

0.00

226

Urethritis and urethral syndrome

1.35

0.31

1.1

73.89

35.57

mg/l

—

Use of levodopa decarbox-comt-inhibitor

1.35

0.31

2.1

1.1

68.57

46.06

mg/l

—

Coxarthrosis

137

869

1.07

0.30

1.1

1.2

49.01

45.88

mg/l

0.19

108

721

Cholelithiasis

316

2123

1.04

0.30

1.1

1.2

40.08

43.27

mg/l

0.53

260

1782

Acute posthaemorrhagic anaemia

1.30

0.30

1.1

46.71

40.13

mg/l

—

Acute alcohol intoxication

782

1.09

0.30

1.2

32.45

42.64

mg/l

2.96

657

Major coronary heart disease event excluding revascularizations

157

1151

0.94

0.30

1.1

43.90

46.98

mg/l

0.42

133

973

Atrophic disorders of skin

381

1.13

0.30

1.3

1.2

37.50

38.11

mg/l

0.03

323

Abscess of anal and rectal regions

268

1.16

0.30

1.2

48.26

45.42

mg/l

0.08

213

Fracture of forearm

200

1777

1.05

0.30

1.1

1.2

47.93

41.55

mg/l

0.55

158

1493

Other viral hepatitis

231

1.17

0.29

1.2

48.89

41.91

mg/l

0.22

187

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

601

1.10

0.29

1.1

1.2

43.08

40.28

mg/l

0.19

500

Eating disorders

496

1.11

0.29

1.2

1.1

35.83

35.98

mg/l

0.01

404

Major coronary heart disease event

179

1261

0.95

0.29

1.1

43.31

46.83

mg/l

0.47

155

1063

Haemangioma and lymphangioma, any site

249

0.84

0.29

1.2

1.1

27.50

41.66

mg/l

2.77

209

Haemorrhage in early pregnancy

130

1190

1.07

0.29

1.2

32.88

36.46

mg/l

0.47

113

990

Motorcycle rider injured in other and unspecified transport accidents

204

1.18

0.28

1.0

1.2

43.20

46.95

mg/l

0.20

161

Chronic periodontitis

345

1.13

0.28

1.2

1.1

49.08

43.98

mg/l

0.29

283

Melanocytic naevi of other and unspecified parts of face

162

0.80

0.28

1.2

39.63

40.28

mg/l

0.02

135

Lactose intolerance, other/unspecified

1.32

0.28

1.1

1.2

22.89

29.74

mg/l

—

Superficial injury of neck

1.29

0.28

1.5

1.1

39.61

33.62

mg/l

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

214

1.17

0.27

1.2

40.32

32.74

mg/l

0.26

179

Postpartum care and examination

519

1.08

0.27

1.1

35.63

36.91

mg/l

0.09

411

Anorexia (incl.atypical)

252

1.15

0.27

1.2

1.1

30.87

36.19

mg/l

0.35

207

Iron deficiency anaemia secondary to blood loss (chronic)

356

1.12

0.27

1.2

37.72

40.72

mg/l

0.22

291

Ulcerative colitis (strict definition, require KELA)

624

1.09

0.27

1.1

1.2

42.56

40.28

mg/l

0.15

521

Eating disorder

432

1.11

0.27

1.2

1.1

34.10

35.41

mg/l

0.05

350

Polyp of the female genital tract

111

690

0.94

0.26

1.1

38.19

40.62

mg/l

0.22

577

Supervision of high-risk pregnancy

114

646

1.07

0.25

1.2

1.1

37.17

38.13

mg/l

0.04

517

Other diseases of intestine

263

1.14

0.25

1.1

1.2

47.52

45.08

mg/l

0.11

211

Ulcer of lower limb, not elsewhere classified

263

1.14

0.25

1.1

127.32

45.96

mg/l

0.47

216

Burns and corrosions of external body surface, specified by site

358

1.12

0.25

1.1

1.2

29.96

41.19

mg/l

2.64

293

Acute nasopharyngitis (common cold)

413

1.11

0.25

1.1

43.87

42.45

mg/l

0.09

344

Maternal care for cervical incompetence

114

1.23

0.25

1.2

25.25

36.57

mg/l

—

Postpartum haemorrhage due to anatomy

508

0.90

0.25

1.0

1.2

29.13

35.36

mg/l

1.04

425

Type 1 diabetes, wide definition

901

0.93

0.25

1.1

1.2

37.08

39.83

mg/l

0.49

761

Fracture of femur

416

0.90

0.24

1.1

1.2

42.30

44.78

mg/l

0.14

344

Chronic viral hepatitis

198

1.16

0.24

1.2

54.51

41.82

mg/l

0.36

157

Major anomalies of jaw size

1.27

0.24

1.3

1.2

36.00

34.51

mg/l

0.05

Clear cell adenocarcinoma of kidney

1.27

0.24

1.5

1.1

60.34

46.62

mg/l

0.40

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

686

1.08

0.24

1.1

41.62

40.36

mg/l

0.08

574

Contact with heat and hot substances

169

0.83

0.24

1.1

36.56

41.45

mg/l

—

134

Congenital malformations of heart and great arteries

441

1.10

0.23

1.1

1.2

28.69

40.98

mg/l

3.00

360

Insulin, intermediate and long-acting

178

1667

1.05

0.23

1.1

1.2

45.60

43.57

mg/l

0.24

145

1410

Other congenital malformations of peripheral vascular system

1.32

0.23

1.4

1.3

43.00

28.84

mg/l

—

Other and unspecified injuries of abdomen, lower back and pelvis

1.32

0.23

1.2

1.1

26.00

35.99

mg/l

—

Non-rheumatic valve diseases

123

949

0.95

0.23

1.1

47.11

44.81

mg/l

0.17

807

Other (not insulin) diabetes medications

368

2289

0.97

0.23

1.2

47.75

42.55

mg/l

1.04

313

1918

Unspecified maternal hypertension

1.29

0.23

1.0

1.2

37.66

29.04

mg/l

—

Alcohol abuse counselling and surveillance

1.28

0.23

1.2

1.1

42.86

38.44

mg/l

—

Fracture of shoulder and upper arm

1051

0.94

0.22

1.1

1.2

44.53

39.93

mg/l

0.36

887

Hypertensive Heart Disease

336

0.90

0.22

1.2

40.82

43.00

mg/l

0.13

287

Insulin, fast-acting or short human

130

1233

1.05

0.22

1.1

1.2

38.84

40.99

mg/l

0.40

101

1039

Prolapse and hernia of ovary and fallopian tube

1.24

0.22

1.0

1.1

36.00

33.33

mg/l

—

Gout, unspecified

362

1.11

0.22

1.1

1.2

52.56

46.10

mg/l

0.31

304

Other specified and unspecified disorders of iris and ciliary body

0.00

0.21

0.0

1.0

—

26.36

—

Complications specific to multiple gestation

0.00

0.21

0.0

1.2

—

23.50

—

Type 2 diabetes, definitions combined, including avohilmo

372

2268

0.97

0.21

1.2

46.98

42.30

mg/l

0.91

317

1907

Left side

0.00

0.21

0.0

1.2

—

39.14

—

Melanocytic naevi of other and unspecified parts of face

156

0.83

0.21

1.2

39.63

39.94

mg/l

0.01

128

Pilonidal cyst

363

1.10

0.21

1.2

57.24

41.67

mg/l

1.26

297

Suppurative and necrotic conditions of lower respiratory tract

105

0.76

0.21

1.1

42.38

45.33

mg/l

—

Coxarthrosis, primary, with hip surgery

906

0.94

0.21

1.1

43.84

45.40

mg/l

0.14

770

Mental and behavioural disorders due to hallucinogens

0.00

0.21

0.0

1.1

—

37.25

—

Thoracic aortic aneurysm

272

0.88

0.20

1.1

48.47

47.25

mg/l

0.03

228

Type 1 diabetes, wide definition, subgroup 1

872

0.94

0.20

1.1

1.2

37.47

39.81

mg/l

0.39

736

Persistent delusional disorders

198

0.86

0.20

1.0

1.2

34.38

42.63

mg/l

0.54

164

Complications associated with artificial fertilization

1.25

0.20

1.0

1.2

31.09

30.61

mg/l

—

Other benign neoplasms of connective and other soft tissue

249

1.13

0.20

1.3

1.2

35.85

38.26

mg/l

0.18

207

Postmenopausal bleeding

390

0.93

0.20

1.2

1.1

39.79

42.32

mg/l

0.11

324

Enterobiasis

0.00

0.20

0.0

1.1

—

36.63

—

Other disorders of iris and ciliary body

1.25

0.20

1.5

1.1

34.50

41.51

mg/l

—

Varicose veins

187

1357

1.04

0.20

1.2

1.1

37.02

44.02

mg/l

1.87

155

1127

Total colectomy operation

111

0.81

0.20

1.2

1.1

38.56

37.85

mg/l

—

Total colectomy

111

0.81

0.20

1.2

1.1

38.56

37.85

mg/l

—

All dysplastic lesions of the cervix uteri

128

1218

1.05

0.19

1.1

1.2

32.96

36.77

mg/l

0.65

100

1022

Insulin medication

215

1773

1.04

0.19

1.1

1.2

49.78

42.97

mg/l

0.97

173

1501

Pleural effusion

279

1.11

0.19

1.2

1.1

41.90

44.44

mg/l

0.12

229

Type 2 diabetes, strict (exclude DM1)

366

2245

0.97

0.19

1.1

1.2

47.15

42.29

mg/l

0.95

310

1881

Benign neoplasm of middle ear and respiratory system

165

1.15

0.19

1.1

47.97

37.30

mg/l

0.31

135

Type 2 diabetes

420

2431

1.03

0.19

1.2

1.1

46.24

42.47

mg/l

0.75

356

2046

Seropositive rheumatoid arthritis, strict definition

374

0.91

0.18

1.1

40.41

40.11

mg/l

0.02

313

Inguinal hernia

202

1412

0.96

0.18

1.2

1.1

43.79

46.09

mg/l

0.22

169

1192

Nontoxic multinodular goitre

446

0.92

0.18

1.2

1.1

46.88

38.77

mg/l

0.40

378

483

1.08

0.18

1.1

1.2

32.82

34.20

mg/l

0.17

404

Abnormal spermatozoa

216

0.88

0.17

1.1

67.00

51.11

mg/l

0.42

184

Heart failure and antihypertensive medication

402

1.07

0.17

1.2

1.1

38.66

47.08

mg/l

0.65

336

Diabetes mellitus in pregnancy

186

1163

1.04

0.17

1.1

1.2

39.21

36.32

mg/l

0.36

161

956

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

1.13

0.17

1.1

1.2

27.43

30.51

mg/l

—

Other renal tubulo-interstitial diseases

1.13

0.17

1.0

1.1

46.73

30.04

mg/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

339

1.09

0.17

1.1

43.03

33.54

mg/l

0.32

287

Calcific aortic valvular stenosis

435

0.92

0.17

1.1

38.63

46.91

mg/l

0.90

367

Calcific aortic valvular stenosis, operated

435

0.92

0.17

1.1

38.63

46.91

mg/l

0.90

367

Contusion of ankle

131

0.84

0.17

1.2

1.1

41.18

37.05

mg/l

0.17

103

Acute alcohol intoxication, ICD10

679

1.06

0.17

1.2

33.00

41.99

mg/l

2.00

570

Calcific aortic valvular stenosis, including rheumatic fever

434

0.92

0.17

1.1

38.63

46.79

mg/l

0.88

366

Haemangioma and lymphangioma, any site

236

0.89

0.16

1.2

1.1

27.50

36.91

mg/l

1.69

195

Lesion of sciatic nerve

1.18

0.16

1.1

56.75

40.24

mg/l

—

Calcific aortic valvular stenosis, diagnosis (helper)

434

0.92

0.16

1.1

38.63

46.79

mg/l

0.88

366

Operations 2 for CAVS

434

0.92

0.16

1.1

38.63

46.79

mg/l

0.88

366

Sub-endpoint used in defining T1D endpoints

112

1053

1.05

0.16

1.2

1.1

44.42

40.71

mg/l

0.33

884

Seborrhoeic keratosis

456

1.07

0.16

1.1

45.01

41.68

mg/l

0.17

386

Lichen planus, including avohilmo

427

1.08

0.16

1.1

1.2

43.89

42.18

mg/l

0.09

357

Foreign body on external eye

495

1.07

0.16

1.2

84.04

44.96

mg/l

0.45

408

Family history of malignant neoplasm

360

1.08

0.16

1.1

46.45

37.15

mg/l

0.41

308

Benign neoplasm: Rectosigmoid junction

1.10

0.15

1.1

47.58

33.72

mg/l

—

Congenital malformations of the urinary system

168

1.13

0.15

1.0

1.2

44.15

37.63

mg/l

0.46

132

Kidney transplant status

149

1.14

0.15

1.2

45.58

43.31

mg/l

0.12

126

Postmenopausal atrophic vaginitis

415

0.94

0.15

1.2

1.1

33.75

43.71

mg/l

1.47

346

Dental caries 3 and operation codes, only avohilmo

150

726

1.04

0.15

1.1

1.2

38.84

40.03

mg/l

0.10

118

634

Cutaneous abscess, furuncle and carbuncle

908

1.05

0.15

1.1

1.2

44.51

40.08

mg/l

0.48

761

Type 2 diabetes, definitions combined

366

2232

0.98

0.14

1.1

1.2

47.15

42.31

mg/l

0.94

310

1874

Cholera

0.79

0.14

1.1

38.77

39.54

mg/l

—

Obstructed labour due to maternal pelvic abnormality

440

1.07

0.14

1.2

34.30

39.10

mg/l

0.52

367

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

189

1.11

0.13

1.2

1.1

185.19

39.19

mg/l

0.70

157

Malignant neoplasm of prostate

465

0.95

0.13

1.1

49.78

55.68

mg/l

0.36

403

Presence of cardiac and vascular implants and grafts

711

0.96

0.13

1.1

40.80

48.85

mg/l

1.08

612

Superficial injury of ankle and foot

461

1.06

0.13

1.1

41.02

36.56

mg/l

0.38

382

Polypectomy (DHB20)

159

0.88

0.13

1.1

63.87

44.37

mg/l

0.43

130

Poor fetal growth

608

1.05

0.13

1.2

32.63

35.04

mg/l

0.19

512

Congenital malformations of eye, ear, face and neck

242

0.91

0.13

1.2

22.53

39.13

mg/l

4.59

195

Childhood allergy (age < 16)

695

1.04

0.12

1.2

34.14

39.91

mg/l

0.72

573

COPD

785

1.04

0.12

1.2

1.1

61.32

46.21

mg/l

0.31

666

Postpartum haemorrhage

122

1098

0.97

0.12

1.1

1.2

32.65

37.76

mg/l

0.98

101

906

Malignant neoplasm of skin

140

1021

1.03

0.12

1.1

62.61

44.79

mg/l

0.59

117

864

Postpartum hemorraghe, all women as controls

122

1255

0.97

0.12

1.1

1.2

32.65

36.13

mg/l

0.62

101

1051

Pre-eclampsia or eclampsia

885

1.04

0.12

1.3

1.1

33.87

36.77

mg/l

0.33

738

Acute and transient psychotic disorders

405

1.06

0.11

1.1

1.2

33.16

40.02

mg/l

1.17

336

Retained placenta and membranes, without haemorrhage

415

1.06

0.11

1.1

1.2

31.46

38.07

mg/l

1.18

345

Medical treatment for female infertility

105

1084

0.97

0.11

1.1

1.2

29.04

36.84

mg/l

3.11

905

Pacemaker

542

0.95

0.11

1.1

36.87

45.28

mg/l

1.13

453

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

710

1.04

0.11

1.1

1.2

42.24

41.31

mg/l

0.07

589

Other and unspecified injuries of wrist and hand

115

1.13

0.10

1.1

1.2

22.87

36.83

mg/l

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

309

1.07

0.10

1.2

45.55

45.44

mg/l

0.01

259

Peripheral artery operations in Hilmo

208

0.91

0.10

1.2

1.1

175.55

46.82

mg/l

0.50

173

Hypertensive heart and/or renal disease

368

0.95

0.10

1.2

41.05

43.01

mg/l

0.14

314

Graves disease, strict definition

329

1.06

0.10

1.3

1.1

42.93

36.37

mg/l

0.30

281

Basal cell carcinoma, including avohilmo

115

933

0.97

0.10

1.1

65.32

44.65

mg/l

0.57

789

Entropion and trichiasis of eyelid

125

1.12

0.10

1.4

1.1

29.31

40.88

mg/l

1.14

104

D07AA Corticosteroids, weak (group I)

613

1.04

0.10

1.1

40.75

38.50

mg/l

0.15

513

Use of biperiden

135

1.11

0.09

1.2

1.1

35.62

40.63

mg/l

—

112

Adhesive middle ear disease

1.09

0.09

1.0

1.2

33.60

37.51

mg/l

—

Carcinoma in situ of cervix uteri

379

1.06

0.09

1.1

36.54

35.30

mg/l

0.07

313

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.04

0.09

1.0

1.1

35.80

32.83

mg/l

—

COPD, hospital admissions

795

0.97

0.09

1.2

1.1

63.91

45.87

mg/l

0.34

677

Congenital malformations of ovaries, fallopian tubes and broad ligaments

223

1.08

0.09

1.0

1.2

27.65

32.27

mg/l

0.37

185

Ulcerative colitis (strict definition, all Crohn cases excluded)

517

1.04

0.09

1.1

45.60

40.87

mg/l

0.30

429

Abrasion of teeth

684

1.03

0.09

1.1

40.31

40.62

mg/l

0.02

581

Impacted teeth

902

0.97

0.09

1.2

30.75

37.97

mg/l

2.38

745

Hyperaldosteronism

1.11

0.09

1.0

1.1

26.33

41.01

mg/l

—

Coxarthrosis, primary

137

1160

1.02

0.09

1.1

49.02

44.53

mg/l

0.30

110

981

Embedded teeth, including avohilmo

441

0.95

0.08

1.1

30.31

38.01

mg/l

1.44

361

COPD, early/later onset

800

0.97

0.08

1.2

1.1

63.99

45.90

mg/l

0.35

682

Pedal cyclist injured in other and unspecified transport accidents

351

1.05

0.08

1.1

64.62

40.38

mg/l

0.59

288

Benign neoplasm of middle ear and respiratory system

175

1.09

0.08

1.1

47.97

42.03

mg/l

0.15

145

Pre-eclampsia

834

1.03

0.08

1.3

1.1

34.92

37.19

mg/l

0.23

698

COPD, hospital admission 2, with asthma infections

497

0.96

0.08

1.2

1.1

84.63

46.88

mg/l

0.42

417

Renal cell carcinoma of kidney

0.82

0.08

1.0

1.1

40.60

42.80

mg/l

—

Other and unspecified disease of Bartholin gland

0.79

0.08

1.0

1.1

38.90

28.60

mg/l

—

Maxillary retrognathism

0.78

0.08

1.2

26.00

30.73

mg/l

—

Combinations of oral blood glucose lowering drugs

693

0.97

0.08

1.1

55.14

42.97

mg/l

1.15

585

Acute appendicitis, with complications

579

1.04

0.07

1.1

65.09

42.39

mg/l

1.04

477

Disorders of tooth development and eruption

200

1.07

0.07

1.0

1.1

35.20

40.92

mg/l

0.22

158

Supervision of normal pregnancy

116

679

0.98

0.07

1.2

1.1

34.85

38.05

mg/l

0.37

543

Other ulcerative colitis

186

1.08

0.07

1.2

35.25

43.81

mg/l

0.51

153

Benign neoplasm: Rectosigmoid junction

1.03

0.07

1.1

1.2

47.57

38.33

mg/l

—

Psoriasis vulgaris

560

1.04

0.07

1.1

1.2

47.19

40.68

mg/l

0.38

467

Other acute skin changes due to ultraviolet radiation

0.86

0.07

1.4

1.2

29.29

36.89

mg/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

353

1.05

0.07

1.1

1.2

43.03

35.48

mg/l

0.25

296

Pyothorax

0.83

0.07

1.1

43.14

45.87

mg/l

—

Gout, strict definition

304

1.05

0.07

1.1

53.42

48.02

mg/l

0.20

253

Glucagon-like peptide-1 (GLP-1) analogues

142

1145

1.02

0.07

1.1

47.24

46.12

mg/l

0.09

125

961

Gout, idiopatic and unspecified

452

1.04

0.07

1.1

51.21

46.25

mg/l

0.27

380

Schizoaffective disorder

265

0.94

0.07

1.1

1.2

29.61

40.54

mg/l

1.68

217

Ulcerative enterocolitis

0.89

0.06

1.1

1.2

34.20

40.48

mg/l

—

Rubella [German measles]

0.88

0.06

1.3

1.1

42.17

49.86

mg/l

—

Crohn's disease of large intestine

173

0.92

0.06

1.1

1.2

24.47

42.83

mg/l

3.26

140

Basal cell carcinoma

112

912

0.98

0.06

1.1

66.46

44.94

mg/l

0.58

772

Non-allergic asthma

236

1.06

0.06

1.2

1.1

57.16

41.99

mg/l

0.21

191

Labour and delivery complicated by fetal stress [distress]

139

945

0.98

0.06

1.2

31.92

36.51

mg/l

1.02

119

774

Ventral hernia

588

0.97

0.06

1.1

42.62

42.02

mg/l

0.03

493

Other chronic obstructive pulmonary disease

747

1.02

0.06

1.2

1.1

63.99

46.36

mg/l

0.34

634

HSIL lesion of the cervix uteri, vagina or vulva

890

1.02

0.05

1.1

1.2

32.44

35.98

mg/l

0.62

751

Abnormalities of forces of labour

405

1.04

0.05

1.2

52.45

38.65

mg/l

0.30

336

Lichen ruber planus, wide definition including periferal and oral lichen planus

524

1.03

0.05

1.1

1.2

41.91

40.93

mg/l

0.06

439

Congenital malformations of genital organs

403

1.04

0.05

1.1

28.81

35.69

mg/l

1.00

340

Primary coxarthrosis, bilateral

544

1.03

0.05

1.2

65.80

43.65

mg/l

0.79

465

Umbilical hernia

828

0.98

0.05

1.2

1.1

39.08

42.78

mg/l

0.42

697

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

105

738

0.98

0.05

1.1

67.07

42.26

mg/l

0.65

623

Ectopic pregnancy

646

0.98

0.05

1.3

1.2

30.99

38.02

mg/l

1.26

552

Other Crohn's disease

252

0.95

0.05

1.1

1.2

29.94

41.81

mg/l

2.07

207

Complications of labour and delivery

277

1560

0.99

0.04

1.2

35.53

38.39

mg/l

0.54

241

1279

Other benign neoplasms of connective and other soft tissue

268

1.05

0.04

1.3

1.1

35.85

41.06

mg/l

0.44

224

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

278

1.04

0.04

1.4

1.1

32.67

42.55

mg/l

1.36

222

Carcinoma in situ of cervix uteri

387

1.03

0.04

1.1

36.54

34.69

mg/l

0.12

324

Alcohol abuse, main dg

526

1.03

0.04

1.2

34.07

42.57

mg/l

1.38

436

Pedal cyclist injured in transport accident

804

1.02

0.04

1.1

45.96

40.92

mg/l

0.23

676

Hernia of abdominal wall

133

1349

0.99

0.04

1.2

40.79

43.75

mg/l

0.30

111

1142

Pre-eclampsia or poor fetal growth

145

1428

1.01

0.04

1.2

1.1

33.81

36.43

mg/l

0.36

120

1194

Left ventricular outflow tract obstruction (LVOTO), broad definition

291

0.96

0.04

1.0

1.2

28.52

45.48

mg/l

3.68

236

Cyst of Bartholin Gland

119

0.92

0.04

1.1

1.2

21.00

33.02

mg/l

2.32

Other psoriatic arthropathies

299

1.04

0.03

1.1

1.2

37.96

41.70

mg/l

0.21

246

Diabetes mellitus

452

2713

0.99

0.03

1.2

46.61

42.21

mg/l

0.90

384

2281

Diabetes, varying definitions

447

2686

0.99

0.03

1.1

1.2

46.38

42.36

mg/l

0.79

378

2260

Injuries to unspecified part of trunk, limb or body region

270

0.96

0.03

1.0

1.2

33.15

41.68

mg/l

0.93

220

Intrahepatic Cholestasis of Pregnancy (ICP)

310

1.03

0.03

1.1

46.60

32.95

mg/l

0.40

260

Gonarthrosis, primary, with knee surgery

126

1017

1.01

0.03

1.1

41.26

47.12

mg/l

0.68

100

858

Injury of unspecified body region

191

1.05

0.03

1.0

1.2

32.67

42.44

mg/l

0.89

158

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

414

1.02

0.02

1.1

55.15

46.21

mg/l

0.74

355

Arthropod-borne viral fevers and viral haemorrhagic fevers

251

1.04

0.02

1.3

1.2

44.27

42.40

mg/l

0.08

207

Benign neoplasm of ovary

440

0.98

0.02

1.2

44.42

37.42

mg/l

0.29

366

Other chronic obstructive pulmonary disease, including avohilmo

121

1017

0.99

0.02

1.2

1.1

56.09

45.30

mg/l

0.26

861

Myocardial infarction, without ST-elevation

654

1.02

0.02

1.1

42.11

45.33

mg/l

0.34

558

Tooth eruption problems

673

0.99

0.02

1.1

1.2

26.04

38.02

mg/l

4.30

554

Obstructed labour due to malposition and malpresentation of fetus

111

1056

0.99

0.02

1.2

1.1

43.73

37.40

mg/l

0.40

100

869

Maternal care for known or suspected fetal abnormality and damage

738

1.01

0.02

1.2

30.12

36.76

mg/l

1.15

612

Viral hepatitis

262

1.03

0.02

1.2

48.89

41.36

mg/l

0.24

214

Embedded and impacted teeth

137

1174

0.99

0.02

1.1

1.2

30.52

39.07

mg/l

4.25

114

978

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

108

750

0.99

0.01

1.1

65.83

42.26

mg/l

0.63

635

Other abnormal uterine and vaginal bleeding

520

0.99

0.01

1.2

34.57

36.56

mg/l

0.20

434

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

452

1.02

0.01

1.1

52.52

40.66

mg/l

0.91

393

Duodenal ulcer

187

0.96

0.01

1.1

34.06

50.31

mg/l

1.82

153

COPD related to multimorbidity

613

0.99

0.01

1.2

1.1

70.29

45.53

mg/l

0.37

522

Maternal care for other known or suspected fetal problems

135

860

1.01

0.01

1.1

1.2

36.08

37.73

mg/l

0.17

110

712

HSIL lesion of the cervix uteri

838

0.99

0.01

1.1

1.2

32.01

35.60

mg/l

0.56

710

Pregnancy examination and test

569

1.01

0.01

1.2

1.1

30.64

38.76

mg/l

1.13

447

Benign neoplasm of ovary

437

0.98

0.01

1.2

44.42

36.11

mg/l

0.36

374

Parodontitis or/and operation codes

274

1623

1.00

0.01

1.2

1.1

38.03

40.36

mg/l

0.43

231

1366

Other blood glucose lowering drugs, excl. Insulins

336

0.98

0.00

1.2

1.1

42.97

43.16

mg/l

0.01

278

Postpartum hemorraghe, parous women as controls

122

1067

1.00

0.00

1.1

1.2

32.65

35.75

mg/l

0.52

101

888

Maternal care for known or suspected abnormality of pelvic organs

126

873

1.00

0.00

1.3

1.2

31.91

38.92

mg/l

1.49

107

728

Other disorders of amniotic fluid and membranes

690

1.01

0.00

1.1

38.69

36.43

mg/l

0.19

571

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

325

0.98

0.00

1.1

1.2

46.60

34.88

mg/l

0.33

271

Postpartum haemorrhage due to retained placenta

515

0.99

0.00

1.2

36.80

36.98

mg/l

0.01

432

Other and unspecified injuries of head

156

1.03

0.00

1.3

1.1

37.36

42.72

mg/l

0.38

126

Contact with machinery

286

1.01

0.00

1.2

1.1

49.78

48.76

mg/l

0.04

230

Later onset COPD, excluding more controls

203

1.00

0.00

1.0

1.1

42.59

46.68

mg/l

0.21

172

Dental caries 1 and operation codes, only avohilmo

119

600

1.00

0.00

1.2

40.69

41.35

mg/l

0.05

524

Other or unspecified ileus, impaction or obstruction

385

1.01

0.00

1.2

41.23

45.99

mg/l

0.37

312

Aortic valve malfunction, age under 60 years

259

1.00

0.00

1.0

1.2

27.88

44.18

mg/l

3.50

216

Psoriatic arthropathies, ICD10

309

1.00

0.00

1.1

1.2

37.96

41.84

mg/l

0.22

255

COPD, hospital admissions 3, with asthma pneumonia sepsis

390

1.00

0.00

1.2

1.1

89.83

46.36

mg/l

0.44

328

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

366

1.00

0.00

1.1

52.02

46.56

mg/l

0.37

321

malignant neoplasm of male genital organs

500

1.00

0.00

1.1

53.00

55.04

mg/l

0.11

427

Injury of muscle and tendon at forearm level

1.00

0.00

1.0

1.1

27.60

46.53

mg/l

—

Eccrine sweat disorders

0.00

0.0

1.0

—

43.97

—

Benign neoplasm: Skin of scalp and neck

0.86

0.00

1.2

1.1

64.60

39.49

mg/l

—

Photocontact dermatitis [berloque dermatitis]

0.00

0.0

1.2

—

40.56

—

Other specified disorders of kidney and ureter

0.99

0.00

1.3

1.1

279.14

38.43

mg/l

—

Carcinoma in situ of oropharynx, excluding all cancers

0.00

0.0

1.2

—

54.50

—

Benign neoplasm: Skin of scalp and neck

0.86

0.00

1.2

1.1

64.60

32.64

mg/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.98

0.00

1.0

1.1

35.80

39.53

mg/l

—

Haematosalpinx/Haematoma of broad ligament

0.00

0.0

1.0

—

19.57

—

Pterygium

0.94

0.00

1.2

1.1

45.10

43.72

mg/l

—

Brain mixed glioma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

38.40

—

Induced delusional disorder

0.00

0.0

1.2

—

35.00

—

Cystic kidney disease

0.90

0.00

1.0

1.2

48.14

41.04

mg/l

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.0

1.2

—

38.50

—

Otosclerosis

170

1.00

0.00

1.2

1.1

31.42

43.35

mg/l

0.97

146

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

0.93

0.00

1.0

1.1

40.60

36.25

mg/l

—

Secondary sideroblastic anaemia

0.00

0.0

1.0

—

31.80

—

Defect, injury or illness of face

0.00

0.0

1.2

—

48.16

—

Injury of blood vessels of thorax

0.00

0.0

1.2

—

39.20

—

Cleft lip, lip and palate or palate

1.02

0.00

1.0

1.2

85.20

34.12

mg/l

—

Folliculitis decalvans

0.00

0.0

1.2

—

41.33

—

Carcinoma in situ of larynx

0.00

0.0

1.2

—

49.80

—

Carcinoma in situ of larynx

0.00

0.0

1.2

—

49.80

—

Filling of root of tooth

0.90

0.00

1.1

34.57

42.30

mg/l

—

Other and unspecified hereditary haemolytic anaemias

0.00

0.0

1.4

—

24.40

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgG [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS